<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-1791467271689801021</id><updated>2011-12-28T06:37:42.574+02:00</updated><category term='Periodicals'/><category term='Editorials'/><category term='New Flu Virus A-H1N1'/><category term='Videos'/><category term='Sites and Blogs'/><category term='Tests'/><category term='Advanced Articles'/><category term='Graphics Galleries'/><category term='Virtual Labs'/><category term='Case Studies'/><category term='Weekly BioNews'/><category term='Articles'/><category term='Swine influenza'/><category term='Books'/><title type='text'>Biotechnology</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default?start-index=101&amp;max-results=100'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>145</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6865279596324842944</id><published>2009-05-20T13:30:00.001+03:00</published><updated>2009-05-20T13:32:34.990+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>Influenza Gateway by BioMed Central</title><content type='html'>&lt;p align="center"&gt;&lt;img src="http://blogs.mysanantonio.com/weblogs/clockingin/pig.jpg" /&gt;&lt;/p&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cases of the influenza A(H1N1) virus, known commonly as swine flu, continue to be recorded on a daily basis to the understandable unease of the general population. Whilst the media hype slowly dies down, BioMed Central continues to publish research investigating the H1N1 virus and has now compiled a &lt;a href="http://news.biomedcentral.com/t/3291794/7667678/1343240/0/?u=aHR0cDovL3d3dy5iaW9tZWRjZW50cmFsLmNvbS9nYXRld2F5cy9pbmZsdWVuemE%3d&amp;amp;x=85d1e80c"&gt;collection&lt;/a&gt; of recently published research articles, commentaries, reviews and editorials relating to H1N1.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.biomedcentral.com/gateways/influenza"&gt;http://www.biomedcentral.com/gateways/influenza&lt;/a&gt;&lt;a href="http://news.biomedcentral.com/t/3291794/7667678/1343240/0/?u=aHR0cDovL3d3dy5iaW9tZWRjZW50cmFsLmNvbS9nYXRld2F5cy9pbmZsdWVuemE%3d&amp;amp;x=85d1e80c"&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-6865279596324842944?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/6865279596324842944/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=6865279596324842944' title='40 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6865279596324842944'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6865279596324842944'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/influenza-gateway-by-biomed-central.html' title='Influenza Gateway by BioMed Central'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>40</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6877670183328105659</id><published>2009-05-07T18:03:00.001+03:00</published><updated>2009-05-09T15:44:21.039+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>HealthMap</title><content type='html'>Global Disease Map&lt;br /&gt;&lt;br /&gt;&lt;a href="http://healthmap.org/swineflu"&gt;http://healthmap.org/swineflu&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;By &lt;a href="http://people.thirteen.net/~clark"&gt;Clark Freifeld&lt;/a&gt; and &lt;a href="http://www.chip.org/research/people/john_brownstein.htm"&gt;John Brownstein&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-6877670183328105659?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/6877670183328105659/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=6877670183328105659' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6877670183328105659'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6877670183328105659'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/healthmap.html' title='HealthMap'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-2126153551389133922</id><published>2009-05-07T17:51:00.003+03:00</published><updated>2009-05-09T15:45:18.773+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>Predicting the future</title><content type='html'>&lt;div align="justify"&gt;&lt;span style="color:#ff0000;"&gt;&lt;span style="color:#000099;"&gt;There is an on going debate about the future of the current pandemic. This debate is portrayed superbly in the following articles by the BBC. The first was published on May the 1st and the second only five days later. It is important to understand that scientific knowledge cannot predict the evolution of the virus; this is why the global scientific community is monitoring the progress of the pandemic in such an intense manner.&lt;/span&gt; &lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;What scientists know about swine flu&lt;/span&gt;&lt;/strong&gt; &lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Emma Wilkinson Health reporter, BBC News 13:17 GMT, Friday, 1 May 2009 14:17 UK&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Preliminary analysis of the swine flu virus suggests it is a fairly mild strain, scientists say. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It is believed that a further mutation would be needed in order for the H1N1 virus to cause the mass deaths that have been estimated by some. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But at this point, it is impossible to predict with any accuracy how the virus will continue to evolve. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;UK experts at the National Institute for Medical Research outlined on Friday the work they are due to start on samples of the virus sent from the US. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research, being done at the World Influenza Centre in Mill Hill, will be vital for working out the structure of the virus, where it came from, how quickly it is capable of spreading and its potential to cause illness. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;Structure&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Analysis done so far suggests what they are dealing with is a mild virus and nowhere near as dangerous as the H5N1 avian flu strain that has caused scientists so much concern over the past decade. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Influenza A viruses are classified according to two proteins on the outer surface of the virus - hemagglutinin (H) and neuraminidase (N). &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The swine flu strain is a H1N1 virus, the same type as seasonal flu which circulates throughout the world every year, and kills roughly 0.1% of those infected or higher in an epidemic year. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Professor Wendy Barclay, chair in influenza virology at Imperial College London says initial indications suggest there is nothing about the genetic make-up of the new virus which is a cause for particular concern. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The key to its potential lies largely in the H1 protein. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"There are two aspects - one is which receptors the virus tends to bind to and what we see is that it is binding to the upper respiratory tract rather than deep in the lungs." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;When a flu virus binds to the upper respiratory tract, it tends to cause mild illness but can be easily spread as people cough and sneeze, Professor Barclay explains. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;If a virus binds further down in the lungs, it tends to cause much more severe illness, as in the case of the H5N1 avian flu virus which has caused concern in recent years. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"With the H1 gene we also look at the cleavage site," she adds. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The virus has to be cut into two pieces to be active and it uses an enzyme in the host to do that.&lt;br /&gt;"Most influenza viruses are restricted to the respiratory tract because they use enzymes in the lungs. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"But some, like H5 viruses can evolve to cut into two pieces outside the lungs, so they can replicate outside the respiratory tract." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;Analysis&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;These initial indications are largely guesswork from looking at the genetic sequence of the virus and comparing that to what is known from work on other influenza viruses. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It will take weeks and months of biological analysis to properly get a handle on the potential of the H1N1 virus. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The team at Mill Hill, one of four World Health Organisation's centres for influenza research will be working in close collaboration with the Health Protection Agency who are carrying out testing in the UK, and their findings will also feed into the development of a potential vaccine. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Soon, the Wellcome Trust Sanger Institute in Cambridge will begin the genetic sequencing of the virus and will also be monitoring any mutations or changes in how virulent it is. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;However, there is one other reassuring aspect about what is known so far. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;That is there seems to be nothing unusual as yet in another protein in the centre of the virus, called NS1, which is linked to the strength of the immune response the virus produces. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In some more pathogenic viruses, it is this NS1 protein which initiates a "cytokine storm", a particularly severe immune reaction that can be fatal in even healthy young people. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;Predictions&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists have also played down concerns that the milder H1N1 virus, could combine with the more dangerous H5N1 avian flu virus, causing a super virus that has the ability to both spread easily between humans and cause severe illness. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;This is unlikely - or at least just as unlikely as it ever was and the H5N1 virus has been around for a decade without combining with normal seasonal flu. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Professor Jonathan Ball, an expert in molecular virology at the University of Nottingham said: "The chance of swine H1N1 combining with H5N1 is as likely as any other strain recombining.&lt;br /&gt;"What this outbreak does highlight is how difficult it is to predict new pandemic strains. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Many people suspected that H5N1 was the most likely candidate for the next pandemic strain, but now it appears that this was a mistake - but that's not to say H5N1 or another reassortment containing parts of H5N1 may not happen in the future. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"That's the trouble - you can't predict." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://news.bbc.co.uk/1/hi/health/8028371.stm"&gt;http://news.bbc.co.uk/1/hi/health/8028371.stm&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="font-size:130%;color:#ff0000;"&gt;&lt;strong&gt;'Too early' to say flu virus mild&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;16:55 GMT, Tuesday, 5 May 2009 &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Sir Liam, who updated the government's weekly cabinet meeting on the flu situation, told BBC News: "We may see an apparent peak in the incidents over the next month or so, but that doesn't mean it's gone away. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It could be that we'll see a resurgence of the virus in the autumn and winter when the normal flu season starts. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We must not be complacent. We know that flu viruses can change their character very rapidly as they move through populations." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;He added: "These next few months are vitally important in understanding what sort of virus we're dealing with." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The latest case of swine flu, confirmed on Tuesday, was in an adult from the Slough area of Berkshire, the South Central Strategic Health Authority said. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;'Quarantine rooms'&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The individual, who is associated with travel to Mexico, is responding well to antiviral drugs, the authority added. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It brings the overall totals to 24 in England and four in Scotland. (5/5)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Meanwhile Department of Health leaflets, stressing the importance of good hygiene, are being delivered across the UK.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A spokesman said: "It is right that we are preparing for the possibility of a global pandemic.&lt;br /&gt;"The UK's arrangements are continuing to ensure that we are well-placed to deal with this new infection." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Five UK schools hit by the virus have begun rescheduling GCSEs and A-levels as the summer exam season begins. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Three of the schools are in London, with one in Devon and one in South Gloucestershire. Four are secondary schools. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The latest to be hit by the virus is Alleyn's School in Dulwich, London, where five year-seven pupils were diagnosed on Monday. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A sixth pupil from the independent school, who visited the US during the Easter holidays, was diagnosed with the virus on Sunday. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The school said it was rescheduling A-level exams in art, biology and foreign languages for next week. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In a statement it said: "In line with procedure, the school will be writing to the examination boards who are always sympathetic to students in these circumstances."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Nine out of 10 of the parents had now collected the Tamiflu anti-viral medication offered by the Health Protection Agency, the school added. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;More than 1,200 private schools have been given legal advice by the Independent Schools Council, which suggests setting up "quarantine rooms" for pupils suspected of having the virus.&lt;br /&gt;It also says schools should provide a policy on what to do in case of a pandemic. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Governors at Dolphin School in Battersea, London, closed its doors as a precaution after it emerged that two pupils - siblings of pupils at Alleyn's - had been confirmed with the virus. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Swine flu has already closed South Hampstead High School in north west London, Downend in South Gloucestershire and Paignton Community and Sports College in Devon. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Around 300 other people in the UK are currently awaiting the results of tests to determine whether they have the virus. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://news.bbc.co.uk/1/hi/uk/8034260.stm"&gt;http://news.bbc.co.uk/1/hi/uk/8034260.stm&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-2126153551389133922?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/2126153551389133922/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=2126153551389133922' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2126153551389133922'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2126153551389133922'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/predicting-future.html' title='Predicting the future'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-8253496547836937210</id><published>2009-05-07T00:15:00.002+03:00</published><updated>2009-05-09T15:45:18.773+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>WHO says H1N1 pigs must be kept out of food supply</title><content type='html'>&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;Wed May 6, 2009 4:16pm EDT&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;ul&gt;&lt;li&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;WHO expert says flu viruses can survive freezing &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;ul&gt;&lt;li&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Blood of H1N1 infected pigs may also contain virus&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;ul&gt;&lt;li&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Meat from sick pigs or pigs found dead must not be eaten&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;ul&gt;&lt;li&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Existing food safety, trade checks offer ample protection (Recasts with more comments on food safety standards)&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;By Tan Ee Lyn&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;HONG KONG, May 6 (Reuters)&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;Meat from pigs infected with H1N1 flu should not be eaten by humans, a WHO official said on Wednesday, while stressing that existing checks were sufficient to safeguard the food supply from the new virus strain.Jorgen Schlundt, director of the World Health Organisation's Department of Food Safety, Zoonoses and Foodborne Diseases, said care must be taken to ensure that pigs and their meat were checked for all diseases, including the H1N1 virus that may be present in the blood of infected animals."Meat from sick pigs or pigs found dead should not be processed or used for human consumption under any circumstances," he told Reuters.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;It is possible for flu viruses such as the new H1N1 strain to survive the freezing process and be present in thawed meat, as well as in blood, the expert said. But he stressed that there was no risk of infection from eating or handling pork so long as normal precautions were adhered to."While it is possible for influenza viruses to survive the freezing process and be present on thawed meat, there are no data available on the survival of Influenza A/H1N1 on meat nor any data on the infectious dose for people," he wrote in an email reply to questions from Reuters about risks from the respiratory secretions and blood of infected pigs.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;Schlundt said it was still unclear whether and how long the virus, which is commonly known as swine flu but also contains human and avian flu pieces, would be present in the blood and meat-juices of animals which contracted it."The likelihood of influenza viruses to be in the blood of an infected animal depends on the specific virus. Blood (and meat-juice) from influenza H1N1-infected pigs may potentially contain virus, but at present, this has not been established," he said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;The WHO has urged veterinarians, farm hands and slaughterhouse workers to exercise caution in their contact with pigs to avoid contamination until more is known about how it manifests in the animals."In general, we recommend that persons involved in activities where they could come in contact with large amounts of blood and secretions, such as those slaughtering/eviscerating pigs, wear appropriate protective equipment," Schlundt said.The Food and Agriculture Organisation (FAO) and World Organisation for Animal Health (OIE) have said import bans on pigs and pork are not required to safeguard public health because the disease is not food-borne and does not pose a threat in dead animal tissue.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;BASIC GUIDANCE&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;While acknowledging technical questions remain about the conditions in which the virus may be present, Schlundt stressed that the WHO had not changed its basic guidance that pork is safe to eat.International trade and food safety guidelines -- drawn up well before the latest flu scare -- provide ample protection and ensure meat is not sourced from sick animals, he said."Sick animals should not enter the food chain. If you are following existing guidelines it (the virus) will not get into the human food chain," he said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;The Paris-based OIE has also said the new flu strain does not require supplemental care or checks besides those in place for other diseases, and stressed live pigs can continue to be traded using normal health inspection standards.The new H1N1 swine flu virus is being transmitted from person to person, not from pigs to people.Its global spread has prompted many countries to limit pork imports, however. As many as 20 governments have imposed import bans on live pigs and meat from affected countries to prevent exposure to the virus.Such fears increased after Canadian authorities said on Saturday a herd of swine was infected by a farmer who had returned from Mexico.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;The WHO said its laboratories have confirmed more than 1,500 cases of the flu virus in 22 countries.While the strain is mainly spread from person to person through coughing and sneezing, experts do not know for sure how this virus came to be, which animal passed it to the first human patient and when that occurred.But the case of the farmer infecting the pigs in Canada fuelled fears of the virus yet again jumping the species barrier -- this time from pig to human -- and possibly becoming more virulent in the process. &lt;/div&gt;&lt;br /&gt;(Additional reporting by Laura Macinnis in Geneva; Editing by Alison Williams)&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.reuters.com/article/swineFlu/idUSL6299708?feedType=RSS&amp;amp;feedName=swineFlu&amp;amp;virtualBrandChannel=10521"&gt;http://www.reuters.com/article/swineFlu/idUSL6299708?feedType=RSS&amp;amp;feedName=swineFlu&amp;amp;virtualBrandChannel=10521&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-8253496547836937210?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/8253496547836937210/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=8253496547836937210' title='4 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8253496547836937210'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8253496547836937210'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/who-says-h1n1-pigs-must-be-kept-out-of.html' title='WHO says H1N1 pigs must be kept out of food supply'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>4</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-8671874621410399708</id><published>2009-05-05T10:13:00.001+03:00</published><updated>2009-05-09T15:45:18.773+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>What happens if swine flu goes away?</title><content type='html'>&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Tue May 5, 2009 2:45am EDT&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;By &lt;a href="http://blogs.reuters.com/search/journalist.php?edition=us&amp;amp;n=Maggie.Fox"&gt;Maggie Fox&lt;/a&gt;, &lt;a href="http://blogs.reuters.com/search/journalist.php?edition=us&amp;amp;n=Health.and"&gt;Health and&lt;/a&gt; &lt;a href="http://blogs.reuters.com/search/journalist.php?edition=us&amp;amp;n=Science.Editor"&gt;Science Editor&lt;/a&gt; - Analysis&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;WASHINGTON (Reuters) - With Mexico saying the worst may be over and the new &lt;a title="Full coverage of the swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu"&gt;H1N1&lt;/a&gt; virus starting to look more like a seasonal flu strain in the United States and elsewhere, critics are going to start asking if public health officials overreacted to the outbreak.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Since the new &lt;a title="Full coverage of the swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu"&gt;swine flu&lt;/a&gt; virus was first identified two weeks ago in two children in Texas and California, the World Health Organization pushed its pandemic alert level from a three to a five, meaning a pandemic is imminent.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Mexico closed schools, stopped public events and took a big hit to tourism. The U.S. government mobilized 25 percent of its stockpile of antiviral drugs and started work on a vaccine against the new strain.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But the death toll is being rolled back as Mexican officials realize it will be impossible to know if long-buried or cremated victims died of &lt;a title="Full coverage of the swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu"&gt;H1N1&lt;/a&gt; &lt;a title="Full coverage of the swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu"&gt;swine flu&lt;/a&gt;. And while the infection is spreading rapidly across the United States, it appears to be no worse than seasonal flu.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists who study flu say the coordinated, global response was appropriate.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"If it doesn't become more virulent, first of all, many people will heave a great sigh of relief," said Dr. Scott Lillibridge, who helped set up the Center for Disease Control and Prevention's Bioterrorism Preparedness and Response Program and who is now at the University of Texas Health Sciences Center in Houston.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But Lillibridge echoes what the WHO and CDC have been saying: viruses mutate and change all the time and it is too early to say how bad this virus really is.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We are only a few days into a major international mobilization for an outbreak that could continue months into the future," Lillibridge said in a telephone interview.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The U.S. government has been preparing for this scenario for years.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;One of the messages that has come up repeatedly is that the 1918 pandemic, cited as the worst-case scenario because it killed upwards of 40 million people, started with a mild arrival of a new virus, now identified as &lt;a title="Full coverage of the swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu"&gt;H1N1&lt;/a&gt;, in the spring.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It disappeared over the summer, but roared back with a vengeance in August.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;REPEATING HISTORY&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Will there be later disease, and if so, will it be more severe?" CDC acting director Dr. Richard Besser asked on Monday.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"There is no doubt in my mind that CDC, the Department of Homeland Security, and the Health and Human Services Department will use the lull to get ready," said risk communications consultant Peter Sandman, who has taken a special interest in pandemic flu.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"They will stay focused on this problem. They will continue to get ready for a possible pandemic in the fall.".....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.reuters.com/article/swineFlu/idUSTRE54418Q20090505?feedType=RSS&amp;amp;feedName=swineFlu&amp;amp;virtualBrandChannel=10521&amp;amp;pageNumber=2"&gt;(art. cont.)&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-8671874621410399708?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/8671874621410399708/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=8671874621410399708' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8671874621410399708'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8671874621410399708'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/what-happens-if-swine-flu-goes-away.html' title='What happens if swine flu goes away?'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-166217825386550866</id><published>2009-05-05T00:37:00.002+03:00</published><updated>2009-05-09T15:45:18.774+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>Influenza A(H1N1) - update 14 by the WORLD HEALTH ORGANIZATION</title><content type='html'>&lt;a href="http://3.bp.blogspot.com/_5C_306IztQU/Sf9gkkvPCvI/AAAAAAAADfQ/W3THK2qvLJw/s1600-h/poy.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5332086665283308274" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 250px; CURSOR: hand; HEIGHT: 243px; TEXT-ALIGN: center" alt="" src="http://3.bp.blogspot.com/_5C_306IztQU/Sf9gkkvPCvI/AAAAAAAADfQ/W3THK2qvLJw/s400/poy.jpg" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="justify"&gt;4 May 2009&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;As of 18:00 GMT, 4 May 2009&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;21 &lt;/span&gt;&lt;/strong&gt;countries have officially reported &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;1085 &lt;/strong&gt;&lt;/span&gt;cases of influenza A (H1N1) infection.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Mexico has reported 590 laboratory confirmed human cases of infection, including 25 deaths. The United States has reported 286 laboratory confirmed human cases, including one death.&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The following countries have reported laboratory confirmed cases with no deaths - &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Austria (1), Canada (101), China, Hong Kong Special Administrative Region (1), Costa Rica (1), Colombia (1), Denmark (1), El Salvador (2), France (4), Germany (8), Ireland (1), Israel (4), Italy (2), Netherlands (1), New Zealand (6), Portugal (1), Republic of Korea (1), Spain (54), Switzerland (1) and the United Kingdom (18). &lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;It is considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention, in line with guidance from national authorities. Individuals are advised to wash hands thoroughly with soap and water on a regular basis and should seek medical attention if they develop any symptoms of influenza-like illness. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;WHO advises no restriction of regular travel or closure of borders.&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;There is no risk of infection from this virus from consumption of well-cooked pork and pork products.&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Further information on the situation will be available on the WHO website on a regular basis. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-166217825386550866?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/166217825386550866/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=166217825386550866' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/166217825386550866'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/166217825386550866'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/influenza-ah1n1-update-14-by-world.html' title='Influenza A(H1N1) - update 14 by the WORLD HEALTH ORGANIZATION'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_5C_306IztQU/Sf9gkkvPCvI/AAAAAAAADfQ/W3THK2qvLJw/s72-c/poy.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-8882160228741016787</id><published>2009-05-04T09:49:00.001+03:00</published><updated>2009-05-09T15:45:18.774+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>Influenza A(H1N1) - update 13 by the WORLD HEALTH ORGANIZATION</title><content type='html'>&lt;div align="justify"&gt;4 May 2009 of 06:00 GMT&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;20 countries have officially reported 985 cases of influenza A (H1N1) infection.&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Mexico has reported 590 laboratory confirmed human cases of infection, including 25 deaths&lt;/strong&gt;&lt;/span&gt;. The higher number of cases from Mexico reflects ongoing testing of previously collected specimens. &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;The United States has reported 226 laboratory confirmed human cases, including one death.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The following countries have reported laboratory confirmed cases with no deaths - &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Austria (1), Canada (85), China, Hong Kong Special Administrative Region (1), Costa Rica (1), Colombia (1), Denmark (1), El Salvador (2), France (2), Germany (8), Ireland (1), Israel (3), Italy (1), Netherlands (1), New Zealand (4), Republic of Korea (1), Spain (40), Switzerland (1) and the United Kingdom (15). &lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;There is no risk of infection from this virus from consumption of well-cooked pork and pork products. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It is considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention, in line with guidance from national authorities. Individuals are advised to wash hands thoroughly with soap and water on a regular basis and should seek medical attention if they develop any symptoms of influenza-like illness. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;WHO advises no restriction of regular travel or closure of borders. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Further information on the situation will be available on the WHO website on a regular basis. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.who.int/csr/don/2009_05_04/en/index.html"&gt;http://www.who.int/csr/don/2009_05_04/en/index.html&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-8882160228741016787?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/8882160228741016787/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=8882160228741016787' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8882160228741016787'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8882160228741016787'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/influenza-ah1n1-update-13-by-world.html' title='Influenza A(H1N1) - update 13 by the WORLD HEALTH ORGANIZATION'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-5964233792367962967</id><published>2009-05-04T02:08:00.001+03:00</published><updated>2009-05-09T15:45:18.774+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>No meeting scheduled to review pandemic level - WHO</title><content type='html'>&lt;div align="justify"&gt;No meeting scheduled to review pandemic level - WHO&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;GENEVA, May 3 (Reuters)&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;The World Health Organisation's emergency committee has no meeting currently scheduled to review the global pandemic level, a WHO spokesman said on Sunday.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Last week the WHO increased its pandemic level two notches, from 3 to 5 on a 6-point scale. Asked if that level may be raised again to the top level, which would trigger a series of measures to help poor countries fight an outbreak, the spokesman said: "That is not very easy to predict.""We cannot lower our guard," he told a news briefing.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;He also said that world trade in meat should not be restricted as a result of the outbreak. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;(Reporting by Laura MacInnis, edited by Richard Meares) (For more Reuters swine flu coverage, please see: http:/www.reuters.com/news/globalcoverage/swineflu )&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-5964233792367962967?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/5964233792367962967/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=5964233792367962967' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/5964233792367962967'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/5964233792367962967'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/no-meeting-scheduled-to-review-pandemic.html' title='No meeting scheduled to review pandemic level - WHO'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-1718624216664596290</id><published>2009-05-04T02:00:00.002+03:00</published><updated>2009-05-09T15:45:18.775+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>Influenza A(H1N1) - update 12 by the WORLD HEALTH ORGANIZATION</title><content type='html'>&lt;a href="http://3.bp.blogspot.com/_5C_306IztQU/Sf4ijBzysBI/AAAAAAAADfA/rypYZr_8SSo/s1600-h/poy.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5331736994029678610" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 250px; CURSOR: hand; HEIGHT: 243px; TEXT-ALIGN: center" alt="" src="http://3.bp.blogspot.com/_5C_306IztQU/Sf4ijBzysBI/AAAAAAAADfA/rypYZr_8SSo/s400/poy.jpg" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;3 May 2009 &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;As of 1600 GMT, 3 May 2009, 18 countries have officially reported 898 cases of influenza A(H1N1) infection.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Mexico has reported 506 confirmed human cases of infection, including 19 deaths&lt;/strong&gt;&lt;/span&gt;. The higher number of cases from Mexico in the past 48 hours reflects ongoing testing of previously collected specimens. &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;The United States Government has reported 226 laboratory confirmed human cases, including one death.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The following countries have reported laboratory confirmed cases with no deaths - &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Austria (1), Canada (85), China, Hong Kong Special Administrative Region (1), Costa Rica (1), Denmark (1), France (2), Germany (8), Ireland (1), Israel (3), Italy (1), Netherlands (1), New Zealand (4), Republic of Korea (1), Spain (40), Switzerland (1) and the United Kingdom (15).&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Further information on the situation will be available on the WHO website on a regular basis.&lt;br /&gt;WHO advises no restriction of regular travel or closure of borders.It is considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention, in line with guidance from national authorities.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Canada on 2 May reported the identification of the A(H1N1) virus in a swine herd in Alberta. It is highly probable that the pigs were exposed to the virus from a Canadian farm worker recently returned from Mexico, who had exhibited flu-like symptoms and had contact with the pigs. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;There is no indication of virus adaptation through transfer from human to pigs at this time.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;There is no risk of infection from this virus from consumption of well-cooked pork and pork &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;products. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Individuals are advised to wash hands thoroughly with soap and water on a regular basis and should seek medical attention if they develop any symptoms of influenza-like illness. &lt;/div&gt;&lt;br /&gt;&lt;p&gt; &lt;/p&gt;&lt;p&gt;&lt;a href="http://www.who.int/csr/don/2009_05_03a/en/index.html"&gt;http://www.who.int/csr/don/2009_05_03a/en/index.html&lt;/a&gt;&lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-1718624216664596290?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/1718624216664596290/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=1718624216664596290' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1718624216664596290'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1718624216664596290'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/influenza-ah1n1-update-12-by-world.html' title='Influenza A(H1N1) - update 12 by the WORLD HEALTH ORGANIZATION'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_5C_306IztQU/Sf4ijBzysBI/AAAAAAAADfA/rypYZr_8SSo/s72-c/poy.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6329913377316976619</id><published>2009-05-03T17:21:00.002+03:00</published><updated>2009-05-09T15:45:18.775+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>Influenza A(H1N1) - update 11 by the WORLD HEALTH ORGANIZATION</title><content type='html'>&lt;p align="center"&gt;&lt;a href="http://1.bp.blogspot.com/_5C_306IztQU/Sf2pUXfcdhI/AAAAAAAADe4/6ey3rqV14ig/s1600-h/poy.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5331603701244917266" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 250px; CURSOR: hand; HEIGHT: 243px; TEXT-ALIGN: center" alt="" src="http://1.bp.blogspot.com/_5C_306IztQU/Sf2pUXfcdhI/AAAAAAAADe4/6ey3rqV14ig/s400/poy.jpg" border="0" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;3 May 2009 -- As of 0600 GMT, 3 May 2009,&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;17 countries have officially reported 787 cases of influenza A(H1N1) infection.&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Mexico has reported 506 confirmed human cases of infection, including 19 deaths&lt;/strong&gt;&lt;/span&gt;. The higher number of cases from Mexico in the past 48 hours reflects ongoing testing of previously collected specimens. &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;The United States Government has reported 160 laboratory confirmed human cases, including one death.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;The following countries have reported laboratory confirmed cases with no deaths - &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Austria (1), Canada (70), China, Hong Kong Special Administrative Region (1), Costa Rica (1), Denmark (1), France (2), Germany (6), Ireland (1), Israel (3), Netherlands (1), New Zealand (4), Republic of Korea (1), Spain (13), Switzerland (1) and the United Kingdom (15). &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Further information on the situation will be available on the WHO website on a regular basis.&lt;br /&gt;WHO advises no restriction of regular travel or closure of borders. It is considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention, in line with guidance from national authorities.&lt;br /&gt;&lt;br /&gt;Canada on 2 May reported the identification of the A(H1N1) virus in a swine herd in Alberta. It is highly probable that the pigs were exposed to the virus from a Canadian farm worker recently returned from Mexico, who had exhibited flu-like symptoms and had contact with the pigs. There is no indication of virus adaptation through transfer from human to pigs at this time.&lt;br /&gt;There is no risk of infection from this virus from consumption of well-cooked pork and pork products.&lt;br /&gt;&lt;br /&gt;Individuals are advised to wash hands thoroughly with soap and water on a regular basis and should seek medical attention if they develop any symptoms of influenza-like illness.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related links&lt;a href="http://www.who.int/entity/csr/disease/swineflu/en/index.html"&gt;Influenza A(H1N1) web site&lt;/a&gt;&lt;br /&gt;Daily updates will be posted on this site.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-6329913377316976619?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/6329913377316976619/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=6329913377316976619' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6329913377316976619'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6329913377316976619'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/influenza-ah1n1-update-11.html' title='Influenza A(H1N1) - update 11 by the WORLD HEALTH ORGANIZATION'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_5C_306IztQU/Sf2pUXfcdhI/AAAAAAAADe4/6ey3rqV14ig/s72-c/poy.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-336017255918440573</id><published>2009-05-03T17:19:00.001+03:00</published><updated>2009-05-09T15:45:18.775+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><title type='text'>Canada pig flu case shows need for surveillance: FAO</title><content type='html'>Sun May 3, 2009 9:00am EDT&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;By &lt;a href="http://blogs.reuters.com/search/journalist.php?edition=us&amp;amp;n=Silvia.Aloisi"&gt;Silvia Aloisi&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;ROME (Reuters) - The transmission of the new H1N1 virus from a man to a herd of swine in Canada is a reason for concern and confirms the need for increased surveillance of pig farms, the United Nations food agency said on Sunday.&lt;br /&gt;&lt;br /&gt;However, Joseph Domenech, chief veterinary officer at the Food and Agriculture Organization, said the incident was not surprising and reiterated pork and pork products handled in accordance with good hygienic practices were safe to eat.&lt;br /&gt;&lt;br /&gt;"We are concerned that this happened but we are not panicking," Domenech told Reuters. "It just reinforces the principle that surveillance of pigs must be intensified."&lt;br /&gt;&lt;br /&gt;Canadian health officials said on Saturday a swine herd in the western province of Alberta had apparently caught the virus from a carpenter who recently traveled to Mexico, the epicenter of a swine flu outbreak that has spread to 19 countries and may have killed more than 100 people, all but one in Mexico.&lt;br /&gt;&lt;br /&gt;It was the first time the Canadian Food Inspection Agency had reported a case of the virus being transmitted from a human to a pig in Canada.&lt;br /&gt;&lt;br /&gt;"It's rare but we have said from the beginning of this flu outbreak that this might happen," Domenech said.&lt;br /&gt;&lt;br /&gt;He said FAO was awaiting the results of tests conducted in at least two laboratories in the United States and Canada, where strains of the virus isolated in humans in Mexico had been inoculated into pigs.&lt;br /&gt;&lt;br /&gt;The Canadian Food Inspection Agency said the infected herd was quarantined pending more testing and the chance the pigs could transfer the virus to humans was remote. It said all the infected pigs had recovered or were recovering.&lt;br /&gt;&lt;br /&gt;"That means it could be one of the viruses variously circulating in pigs that are not too severe, that can be dealt with in a normal way by strengthening surveillance and biosecurity of the pig population," Domenech said.&lt;br /&gt;&lt;br /&gt;Doctor Alex Thiermann, advisor to the director general of the World Organization for Animal Health, also said surveillance was key.&lt;br /&gt;&lt;br /&gt;"One has to monitors the health of all pigs ... Animals that are showing signs of illness cannot be marketed and cannot be slaughtered. After this event there is no need to make any changes in the recommendations," Thiermann said.&lt;br /&gt;&lt;br /&gt;"Pigs are occasionally known to have influenza and they fully recover and are no longer infectious. In the pigs, once they recover, you can detect antibodies ... that the virus is no longer there," he added.&lt;br /&gt;&lt;br /&gt;(Additional reporting by Anna Willard in Paris; Editing by Sophie Hares)&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.reuters.com/article/swineFlu/idUSTRE54217F20090503?feedType=RSS&amp;amp;feedName=swineFlu&amp;amp;virtualBrandChannel=10521"&gt;http://www.reuters.com/article/swineFlu/idUSTRE54217F20090503?feedType=RSS&amp;amp;feedName=swineFlu&amp;amp;virtualBrandChannel=10521&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-336017255918440573?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/336017255918440573/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=336017255918440573' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/336017255918440573'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/336017255918440573'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/canada-pig-flu-case-shows-need-for.html' title='Canada pig flu case shows need for surveillance: FAO'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-887155888115294525</id><published>2009-05-02T16:32:00.002+03:00</published><updated>2009-05-09T15:45:18.776+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>WHO says 615 people infected in 15 countries</title><content type='html'>Sat May 2, 2009 5:39am EDT&lt;br /&gt;&lt;br /&gt;GENEVA (Reuters) - The World Health Organization said on Saturday that 15 countries have reported 615 infections with the new flu virus A-H1N1, widely known as &lt;a title="Full coverage of the swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu"&gt;swine flu&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;Most of the increase from Friday's 331 toll reflects the results of ongoing tests from Mexico, which had a backlog of samples in WHO labs, the United Nations agency said.&lt;br /&gt;&lt;br /&gt;Mexico, the epicenter of the disease outbreak, now has 397 laboratory-confirmed human cases including 16 deaths, according to the WHO, whose data has been lagging national figures and is considered most authoritative.&lt;br /&gt;&lt;br /&gt;The second-most affected country, the &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;United States&lt;/strong&gt;&lt;/span&gt;, has &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;141&lt;/strong&gt;&lt;/span&gt; cases confirmed in WHO labs including one death, the Mexican infant whose family crossed the border to seek medical help. Other countries have had the following number of confirmed H1N1 infections, with no deaths: &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Austria (1), Canada (34), Hong Kong - China (1), Denmark (1), France (1), Germany (4), Israel (2), Netherlands (1), New Zealand (4), South Korea (1), Spain (13), Switzerland (1) and Britain (13).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Mexico&lt;/span&gt;&lt;/strong&gt; has cut its suspected death toll to &lt;span style="color:#ff0000;"&gt;&lt;strong&gt;101&lt;/strong&gt;&lt;/span&gt; from as many as 176 because of test samples coming back negative in its labs, the government said late on Friday, in a sign the flu pandemic the WHO says is "imminent" may not be as severe as first feared.&lt;br /&gt;&lt;br /&gt;On Saturday, the WHO repeated its view that borders should stay open and travel should not be limited as a result of the virus, but said "it is considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention.&lt;br /&gt;&lt;br /&gt;"Individuals are advised to wash hands thoroughly with soap and water on a regular basis and should seek medical attention if they develop any symptoms of influenza-like illness," the WHO said on its website.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;(Reporting by Laura MacInnis)&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.reuters.com/article/swineFlu/idUSTRE5410YG20090502?feedType=RSS&amp;amp;feedName=swineFlu&amp;amp;virtualBrandChannel=10521"&gt;http://www.reuters.com/article/swineFlu/idUSTRE5410YG20090502?feedType=RSS&amp;amp;feedName=swineFlu&amp;amp;virtualBrandChannel=10521&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-887155888115294525?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/887155888115294525/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=887155888115294525' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/887155888115294525'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/887155888115294525'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/05/who-says-615-people-infected-in-15.html' title='WHO says 615 people infected in 15 countries'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-7570773544974895450</id><published>2009-04-30T08:44:00.001+03:00</published><updated>2009-05-09T15:45:18.776+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Swine Flu: Statistical Model Predicts Spread in U.S.</title><content type='html'>&lt;div align="justify"&gt;Apr 28, 2009, By &lt;a href="http://www.govtech.com/dc/more.php?code=GT_WRITER&amp;amp;format=tag_articles_simple&amp;amp;writer=Blake+Harris"&gt;Blake Harris&lt;/a&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;Two different swine influenza infection computer models from Indiana and Northwestern Universities, generated on April 27, both predict about 1,000 cases in the United States within three weeks.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;However, as of 6 a.m., April 28, there had only been 40 cases of swine influenza (H1N1) reported in the U.S. according to the national Centers for Disease Control and Prevention.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;According to Indiana University Rudy Professor of Informatics Alessandro Vespignani, an internationally recognized expert on the statistical analysis and computer modeling of epidemics, the prediction of 1000 cases is actually pretty good news and it might not actually get that bad.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This is a worst-case scenario, as we are always working in a worst-case scenario setting," Vespignani said in a press statement today. "What we are finding is that this is not a panic situation and that this thing is not ramping up in some crazy way. Right now we are confident that in the next few days things will be more optimistic."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;His optimism is based largely upon the actions taken worldwide: the medical alert in Mexico, school closures in Texas, World Health Organization warnings, increased controls at international airports and the availability of an anti-viral drug for treatment.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;However, Vespignani also pointed out that the next 72 hours would be critical. Even the computer model predictions could change as often as every 12 to 24 hours, depending upon what happens in the world.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;Alessandro Vespignani is an internationally recognized expert on the statistical analysis and computer modeling of epidemics. (Indiana University)&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.govtech.com/dc/articles/649458?utm_source=rss&amp;amp;utm_medium=link"&gt;http://www.govtech.com/dc/articles/649458?utm_source=rss&amp;amp;utm_medium=link&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-7570773544974895450?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/7570773544974895450/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=7570773544974895450' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7570773544974895450'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7570773544974895450'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/swine-flu-statistical-model-predicts.html' title='Swine Flu: Statistical Model Predicts Spread in U.S.'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-796925852492982104</id><published>2009-04-30T08:32:00.003+03:00</published><updated>2009-05-09T15:45:18.776+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>WHO raises pandemic alert to second-highest level</title><content type='html'>&lt;div align="justify"&gt;GENEVA, Switzerland CNN&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;The World Health Organization on Wednesday raised its pandemic alert to 5, its second-highest level, warning of widespread human infection from the swine flu outbreak that originated in Mexico.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;Dr. Margaret Chan, the U.N. agency's director-general, said the decision to raise the alert on the 6-point scale indicated that all countries should "immediately" activate pandemic preparedness plans.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This change to a higher phase of alert is a signal to governments, to ministries of health and other ministries, to the pharm industry and the business community that certain actions now should be taken with increased urgency and at an accelerated pace," Chan said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The announcement came as the number of confirmed cases increased rapidly across the world.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The WHO and national governments have confirmed 148 cases in nine countries. Most of those cases are in the United States, where the Centers for Disease Control and Prevention has confirmed 91 cases.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The figures include seven deaths in &lt;a class="cnnInlineTopic" href="http://topics.edition.cnn.com/topics/Mexico" _extended="true"&gt;Mexico&lt;/a&gt; and one in the United States. More than 2,700 other patients worldwide are believed to be suffering from the virus that government officials call by its technical name, 2009 H1N1.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The first cases of the virus were detected in Mexico, where health officials suspect swine flu in more than 150 other deaths and roughly 2,500 illnesses. As of late Wednesday, 99 cases had been confirmed -- up from 26, Mexico's health secretary reported. An eighth fatality was also confirmed. &lt;a href="http://www.ireport.com/docs/DOC-250851" _extended="true"&gt;iReport.com: "Regular life" in Mexico with masks&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The additional cases and fatality were not immediately confirmed by WHO&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers do not know how the &lt;a class="cnnInlineTopic" href="http://topics.edition.cnn.com/topics/Influenza" _extended="true"&gt;virus&lt;/a&gt; is jumping relatively easily from person to person, or why it's affecting what should be society's healthiest demographic. Many of the victims who have died in Mexico have been young and otherwise healthy.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The outbreak has prompted Mexican authorities to order about 35,000 public venues in Mexico City to shut down and restrict restaurants to serving only take-out meals.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;All nonessential government offices and private business were ordered to close between May 1-5, with only skeletal staffing allowed when necessary, Mexico's health secretary announced Wednesday.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Mexican officials said it was too soon to determine what kind of economic impact the decision would have on the country.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Germany and Austria became the latest European countries to report swine flu on Wednesday, while the number of cases increased in the United Kingdom and Spain. Peru reported its first case late Wednesday. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Yet Chan reiterated the WHO's recommendation not to close borders or restrict trade in response to the outbreak, saying the world "is better prepared for an influenza pandemic than at any time" in history. &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://edition.cnn.com/2009/HEALTH/04/29/swine.flu/index.html#cnnSTCVideo" _extended="true"&gt;Watch how the U.S. is preparing for the worst »&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We need to maintain a level of calmness so that we will continue to manage this in a rational manner," she said, adding that pork is safe for consumption as long as it is cooked properly.&lt;br /&gt;President Obama downplayed the possibility of closing the U.S. border with Mexico, where the recent occurrence of the deadly virus began.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It would be akin to closing the barn door after the horses are out," Obama said during his Wednesday evening news conference. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Obama said he'll be looking to health officials for guidance on how to handle travel between the two countries.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The $1.5 billion Obama requested from Congress to help fight the outbreaks will help health officials monitor and track the virus and replenish the supply of anti-viral drugs, he said. &lt;a href="http://edition.cnn.com/2009/HEALTH/04/29/swine.flu/index.html#cnnSTCVideo" _extended="true"&gt;Watch President Obama caution Americans on swine flu »&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Swine influenza, or flu, is a contagious respiratory disease that affects pigs. When the flu spreads person to person, instead of from animals to humans, it can continue to mutate, making it harder to treat or fight, because people have no natural immunity. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Symptoms include fever, runny nose, sore throat, nausea, vomiting and diarrhea.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The WHO's "Phases of Pandemic Alert," which has been in existence for five years, characterizes phase 5 as a human-to-human spread of the virus into at least two countries in one WHO region, signaling that a pandemic is imminent.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The highest level, phase 6, is defined by community-level outbreaks in at least one other country in a different WHO region, according to the agency.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;About a quarter of the U.S. stockpile of anti-viral drugs will be distributed to states by Sunday, Homeland Security Secretary Janet Napolitano said. &lt;a href="http://edition.cnn.com/2009/HEALTH/04/29/swine.flu/index.html#cnnSTCVideo" _extended="true"&gt;Watch how U.S. officials are reacting to the virus »&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;U.S. officials also are asking scientists whether additional measures to screen for flu symptoms were needed at U.S. ports of entry, she said. Already, customs officers have asked 49 people to submit to tests for the H1N1 virus, she said. Of those tests, 41 have been negatives and the remaining eight have not yet come back.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers in the United States have already taking steps to crack the genetic code of the virus behind the swine flu outbreak in order to produce a vaccine, U.S. officials said Wednesday.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The U.S. government is distributing 25 percent of its stockpile of antiviral medications Tamiflu and Relenza to all states, Homeland Security Secretary Janet Napolitano said Wednesday. Health officials stress that the medications are effective only if taken in the early stages of the infection. &lt;a href="http://edition.cnn.com/2009/HEALTH/04/29/swine.flu/index.html#cnnSTCOther1" _extended="true"&gt;Learn more about swine flu and how to treat it »&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The 91 confirmed cases in the United States includes the country's first swine flu fatality: a 23-month-old child visiting from Mexico who died Monday at a Houston, Texas, hospital. &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;A U.S. Marine in California is the military's first suspected case of swine flu, and three military family members in San Diego have confirmed cases, the CDC said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As a precaution, the military is banning travel to Mexico for nonessential personnel.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Mexican officials also said they believe they may have found "patient zero" -- the first case of the global outbreak -- in the small mountain village of La Gloria.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Edgar Hernandez, 5, survived the earliest documented case of swine flu. He lives near a pig farm, though experts have not established a connection between that and his illness.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Edgar has managed to bounce back from his symptoms and playfully credits ice cream for helping him feel better.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the United States, at least 74 elementary, junior high and high schools have closed across the country due to confirmed or probable cases of swine flu, the Department of Education said Wednesday.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Another 30 schools have closed as a precautionary measure, Department of Education spokesman Massie Ritsch said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Governments around the world are scrambling to prevent further outbreak.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Some countries, such as China and Russia, have banned pork imports from the United States and Mexico, though the WHO said the disease is not transmitted through eating or preparing pig meat. Several other countries, such as Japan and Indonesia, are using thermographic devices to test the temperature of passengers arriving from Mexico.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;Egypt reportedly is considering culling all pigs although there have been no reported cases of swine flu there.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Common seasonal flu kills 250,000 to 500,000 people every year worldwide, far more than the current outbreak of swine flu. But there is a vaccine for seasonal flu&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;CNN's Dr. Sanjay Gupta and Barbara Starr contributed to this report.&lt;/div&gt;&lt;p&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://edition.cnn.com/2009/HEALTH/04/29/swine.flu/index.html"&gt;http://edition.cnn.com/2009/HEALTH/04/29/swine.flu/index.html&lt;/a&gt; &lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-796925852492982104?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/796925852492982104/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=796925852492982104' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/796925852492982104'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/796925852492982104'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/who-raises-pandemic-alert-to-second.html' title='WHO raises pandemic alert to second-highest level'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-744553622136572069</id><published>2009-04-30T08:29:00.001+03:00</published><updated>2009-05-09T15:45:18.777+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>EU health ministers to hold swine flu talks</title><content type='html'>&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;The Associated Press April 29, 2009, 11:47AM ET &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;By CONSTANT BRAND&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;BRUSSELS &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;EU officials say a Europe-wide travel advisory to avoid Mexico and unified prevention and treatment measures for swine flu will top the agenda Thursday at an emergency meeting of European Union health ministers.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;EU spokeswoman Nina Papadoulaki said top EU health officials met with European drugmakers on Wednesday to hear their efforts to find a treatment for the flu and EU envoys were looking at other joint measures to take to contain the virus.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"There is a certain level of concern, but it should not give rise to panic," Papadoulaki said.&lt;br /&gt;Britain, Spain, Austria and Germany already have confirmed cases of the disease, which is blamed for over 150 deaths and 2,400 infections in Mexico.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Health ministers from across the 27-nation bloc will meet in Luxembourg on Thursday to go over additional measures. French Health minister Roselyne Bachelot said she would push at those talks for the EU to suspend flights to Mexico to curb the spread of the disease.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;National authorities are already sharing information on diagnosis and lab results through the European Center for Disease Prevention and Control in Stockholm, which has strongly advised against traveling to Mexico because of the outbreak there.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;EU Health Commissioner Androulla Vassiliou also urged Europeans to avoid nonessential travel to Mexico and to affected parts of the United States, but that was strongly criticized by airlines on Wednesday.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Ulrich Schulte-Strathaus, secretary general of the Association of European Airlines called the warnings "irresponsible and ill-advised." He warned that advisories could do more harm than good and said airlines are "well-prepared to handle health crises."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Airline stocks dropped Monday on concerns that swine flu would keep travelers off planes, much as Asia's 2003 SARS epidemic did.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;He said his group's 34 member airlines, including carriers like Lufthansa, British Airways and Air France-KLM, were informing passengers about the disease, risks and precautions.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"A priority now is to establish a coordinated European response and avoid a diversity of national rules and requirements," he said.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.businessweek.com/ap/financialnews/D97S7D680.htm"&gt;http://www.businessweek.com/ap/financialnews/D97S7D680.htm&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-744553622136572069?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/744553622136572069/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=744553622136572069' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/744553622136572069'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/744553622136572069'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/eu-health-ministers-to-hold-swine-flu.html' title='EU health ministers to hold swine flu talks'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-9120067160654436820</id><published>2009-04-29T23:49:00.004+03:00</published><updated>2009-05-09T15:45:18.777+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Current level of influenza pandemic alert raised from phase 4 to 5</title><content type='html'>&lt;a href="http://1.bp.blogspot.com/_5C_306IztQU/Sfi-QHFmeOI/AAAAAAAADew/-UjFoQUzUxM/s1600-h/who.bmp"&gt;&lt;img id="BLOGGER_PHOTO_ID_5330219342982707426" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 212px; CURSOR: hand; HEIGHT: 65px; TEXT-ALIGN: center" alt="" src="http://1.bp.blogspot.com/_5C_306IztQU/Sfi-QHFmeOI/AAAAAAAADew/-UjFoQUzUxM/s400/who.bmp" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;Based on assessment of all available information and following several expert consultations, Dr Margaret Chan, WHO's Director-General raised the current level of influenza pandemic alert from phase 4 to 5. She stated that all countries should immediately activate their pandemic preparedness plans. At this stage, effective and essential measures include heightened surveillance, early detection and treatment of cases, and infection control in all health facilities.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;span style="color:#cc0000;"&gt;&lt;strong&gt;Statement by WHO Director-General, Dr Margaret Chan 29 April 2009&lt;/strong&gt; &lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#cc0000;"&gt;Swine influenza&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Ladies and gentlemen,&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Based on assessment of all available information, and following several expert consultations, I have decided to raise the current level of influenza pandemic alert from phase 4 to phase 5. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Influenza pandemics must be taken seriously precisely because of their capacity to spread rapidly to every country in the world. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;On the positive side, the world is better prepared for an influenza pandemic than at any time in history. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Preparedness measures undertaken because of the threat from H5N1 avian influenza were an investment, and we are now benefitting from this investment.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;For the first time in history, we can track the evolution of a pandemic in real-time. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;I thank countries who are making the results of their investigations publicly available. This helps us understand the disease.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;I am impressed by the work being done by affected countries as they deal with the current outbreaks.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;I also want to thank the governments of the USA and Canada for their support to WHO, and to Mexico.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Let me remind you. New diseases are, by definition, poorly understood. Influenza viruses are notorious for their rapid mutation and unpredictable behaviour. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;WHO and health authorities in affected countries will not have all the answers immediately, but we will get them.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;WHO will be tracking the pandemic at the epidemiological, clinical, and virological levels. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The results of these ongoing assessments will be issued as public health advice, and made publicly available.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;All countries should immediately activate their pandemic preparedness plans. Countries should remain on high alert for unusual outbreaks of influenza-like illness and severe pneumonia. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;At this stage, effective and essential measures include heightened surveillance, early detection and treatment of cases, and infection control in all health facilities. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;This change to a higher phase of alert is a signal to governments, to ministries of health and other ministries, to the pharmaceutical industry and the business community that certain actions should now be undertaken with increased urgency, and at an accelerated pace.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;I have reached out to donor countries, to UNITAID, to the GAVI Alliance, the World Bank and others to mobilize resources.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;I have reached out to companies manufacturing antiviral drugs to assess capacity and all options for ramping up production. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;I have also reached out to influenza vaccine manufacturers that can contribute to the production of a pandemic vaccine. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The biggest question, right now, is this: how severe will the pandemic be, especially now at the start?&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;It is possible that the full clinical spectrum of this disease goes from mild illness to severe disease. We need to continue to monitor the evolution of the situation to get the specific information and data we need to answer this question.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;From past experience, we also know that influenza may cause mild disease in affluent countries, but more severe disease, with higher mortality, in developing countries. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;No matter what the situation is, the international community should treat this as a window of opportunity to ramp up preparedness and response.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Above all, this is an opportunity for global solidarity as we look for responses and solutions that benefit all countries, all of humanity. After all, it really is all of humanity that is under threat during a pandemic.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;As I have said, we do not have all the answers right now, but we will get them.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Thank you.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;a href="http://www.who.int/mediacentre/news/statements/2009/h1n1_20090429/en/index.html"&gt;http://www.who.int/mediacentre/news/statements/2009/h1n1_20090429/en/index.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;watch the statement here&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;a href="http://news.bbc.co.uk/1/hi/health/8025979.stm"&gt;http://news.bbc.co.uk/1/hi/health/8025979.stm&lt;/a&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-9120067160654436820?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/9120067160654436820/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=9120067160654436820' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9120067160654436820'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9120067160654436820'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/current-level-of-influenza-pandemic_29.html' title='Current level of influenza pandemic alert raised from phase 4 to 5'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_5C_306IztQU/Sfi-QHFmeOI/AAAAAAAADew/-UjFoQUzUxM/s72-c/who.bmp' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-1516418786540187512</id><published>2009-04-29T18:18:00.000+03:00</published><updated>2009-05-09T15:45:18.777+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>H1N1 Swine Flu - Google Maps</title><content type='html'>&lt;div align="center"&gt;&lt;iframe marginwidth="0" marginheight="0" src="http://maps.google.com/maps/ms?ie=UTF8&amp;amp;hl=en&amp;amp;t=p&amp;amp;msa=0&amp;amp;msid=106484775090296685271.0004681a37b713f6b5950&amp;amp;ll=32.639375,-110.390625&amp;amp;spn=15.738151,25.488281&amp;amp;output=embed" frameborder="0" width="425" scrolling="no" height="350"&gt;&lt;/iframe&gt;&lt;br /&gt;&lt;small&gt;View &lt;a style="COLOR: #0000ff; TEXT-ALIGN: left" href="http://maps.google.com/maps/ms?ie=UTF8&amp;amp;hl=en&amp;amp;t=p&amp;amp;msa=0&amp;amp;msid=106484775090296685271.0004681a37b713f6b5950&amp;amp;ll=32.639375,-110.390625&amp;amp;spn=15.738151,25.488281&amp;amp;source=embed"&gt;H1N1 Swine Flu&lt;/a&gt; in a larger map&lt;/small&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-1516418786540187512?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/1516418786540187512/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=1516418786540187512' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1516418786540187512'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1516418786540187512'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/h1n1-swine-flu-google-maps.html' title='H1N1 Swine Flu - Google Maps'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6391452397319687444</id><published>2009-04-29T18:14:00.001+03:00</published><updated>2009-05-09T15:45:18.778+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Has globalization made us more catastrophe-prone?</title><content type='html'>&lt;p align="center"&gt;&lt;img src="http://graphics8.nytimes.com/images/2009/04/28/science/28doc-600.jpg" /&gt;&lt;/p&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Wed Apr 29, 2009 10:36am EDT  &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;By Andrew Marshall, Asia Political Risk Correspondent&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;SINGAPORE (Reuters) - As the world grapples with the worst economic downturn in decades and the possibility of a flu pandemic, a growing body of research suggests the complexity of the modern global economy may make us more vulnerable than ever to catastrophe.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The financial crisis began as turmoil in one small segment of the U.S. mortgage market. Within months it had morphed into a global meltdown affecting almost everyone on earth.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The speed at which these events unfolded was unprecedented," said the World Economic Forum's 2009 report on global risk.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It has demonstrated just how tightly interconnected globalization has made the world and its systems."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Disease, too, can spread faster than ever before. Modern air travel means that any contagious outbreak can be worldwide in a matter of days. In the past, it would have taken months or years.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The more complex and efficient a system, the faster and wider any contagion can spread. Yet this interdependence is by no means always negative. The complexity of the world economy means risk can be more easily distributed, and often more easily mitigated.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Complex systems can often be adaptable -- if one part fails, other parts of the network can assume the burden.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Network theory suggests that complex diversified systems can often bring greater stability. But only to a point.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"While this helps the system diversify across small shocks, it also exposes the system to large systemic shocks," Raghuram Rajan, who has been an IMF chief economist and adviser to Indian Prime Minister Manmohan Singh, wrote in a 2005 research paper.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It is possible that these developments...create a greater (albeit still small) probability of a catastrophic meltdown."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;BUTTERFLIES, BLACK SWANS AND SWINE FLU&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;One key issue is the so-called "butterfly effect" -- in highly complex systems, even a small event can be magnified and transmitted with highly unpredictable results. Edward Lorenz, a pioneer of chaos theory, noted that a butterfly flapping its wings in one corner of the world could cause a tornado far away.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Benoit Mandelbrot, a French mathematician and the father of fractal geometry, applied the theory to markets to show how "wild variability" is intrinsic to the system.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In network theory, one key finding is that complex interconnected systems organize themselves around key nodes. If one of these is hit, the whole house of cards can collapse.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;This is one reason the damage done by the subprime crisis to major global investment banks had such a devastating impact.....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.reuters.com/article/healthNews/idINTRE53S4NU20090429?pageNumber=2&amp;amp;virtualBrandChannel=0"&gt;art. cont.&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-6391452397319687444?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/6391452397319687444/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=6391452397319687444' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6391452397319687444'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6391452397319687444'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/has-globalization-made-us-more.html' title='Has globalization made us more catastrophe-prone?'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-1800099905068991404</id><published>2009-04-28T10:50:00.001+03:00</published><updated>2009-05-09T15:45:18.778+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Swine Flu</title><content type='html'>&lt;p align="center"&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/vqnYJIdj--g&amp;amp;hl=en&amp;amp;fs=1&amp;amp;color1=0x006699&amp;amp;color2=0x54abd6"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;param name="allowscriptaccess" value="always"&gt;&lt;embed src="http://www.youtube.com/v/vqnYJIdj--g&amp;hl=en&amp;fs=1&amp;color1=0x006699&amp;color2=0x54abd6" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-1800099905068991404?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/1800099905068991404/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=1800099905068991404' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1800099905068991404'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1800099905068991404'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/swine-flu.html' title='Swine Flu'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6389654590879391813</id><published>2009-04-28T10:49:00.000+03:00</published><updated>2009-05-09T15:45:18.779+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Pandemic: What would happen next?</title><content type='html'>&lt;div align="justify"&gt;By Kevin VoigtCNN.com/heatlh&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The world hasn't seen a pandemic in 41 years, when the "Hong Kong" flu crossed the globe and killed about one million people worldwide. If swine flu reaches pandemic levels, what would happen next?&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Recurrent outbreaks of Avian Influenza and the outbreak of SARS in 2003 rang alarm bells as potential pandemics. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Although both jumped the "animal-to-human" barrier, neither disease mutated enough to enable sustained human-to-human infection, said Dr. K.Y. Yuen, head of microbiology at Hong Kong University.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Strictly speaking, Avian Influenza and SARS did not become pandemics because they were too good at killing their hosts.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"For a sustained pandemic, it needs to be able to maintain human-to-human contact without killing its host off," he said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Avian influenza "never became a man-to-man disease," said Dr. Lo Wing-Luk, an infectious disease expert. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Swine flu is already a man-to-man disease, which makes it much more difficult to manage . and swine flu appears much more infectious than SARS."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But the WHO cautions, it cannot say whether or not it will indeed cause a pandemic. According to epidemiologists and health experts, here's what the world might see if there is another pandemic, based on past experience:&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The disease would skip from city to city over an 18-to-24 month period, infecting more than a third of the population. World health Organization officials believe as many as 1.5 billion people around the globe would seek medical care and nearly 30 million would seek hospitalization. Based on the last pandemic and current world population, as many as 7 million people could die, epidemiologists said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Hospitals will become overcrowded, schools will close, businesses will close, airports will be empty," Dr. Lo said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Business will become very bad, as people avoid as much social contact as possible," added Dr. Yuen.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Health facilities will become overrun with patients and there would be less-than-adequate staffing, as medical health professionals fall ill themselves, experts say. "We saw cases in SARS where people who should have gone to the hospital for things like cancer treatment didn't go, and that resulted in higher deaths," Dr. Lo said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The very young and very old will likely be the most susceptible to the illness.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Experts caution, much is still unknown about the current swine flu virus and its severity and it is too early to say whether it will lead to a pandemic. Right now, the focus is on finding answers and containing the spread.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://edition.cnn.com/2009/HEALTH/04/27/pandemic.next/index.html"&gt;http://edition.cnn.com/2009/HEALTH/04/27/pandemic.next/index.html&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-6389654590879391813?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/6389654590879391813/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=6389654590879391813' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6389654590879391813'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6389654590879391813'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/pandemic-what-would-happen-next.html' title='Pandemic: What would happen next?'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-7622156221726665765</id><published>2009-04-28T10:22:00.002+03:00</published><updated>2009-05-09T15:45:18.779+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>The current WHO phase of pandemic alert is 4</title><content type='html'>&lt;a href="http://2.bp.blogspot.com/_5C_306IztQU/SfavAnknd6I/AAAAAAAADeo/1gHeVRdyApc/s1600-h/untitled.bmp"&gt;&lt;img id="BLOGGER_PHOTO_ID_5329639634196985762" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 400px; CURSOR: hand; HEIGHT: 191px; TEXT-ALIGN: center" alt="" src="http://2.bp.blogspot.com/_5C_306IztQU/SfavAnknd6I/AAAAAAAADeo/1gHeVRdyApc/s400/untitled.bmp" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;div align="justify"&gt;27 April 2009 -- The Emergency Committee, established in compliance with the International Health Regulations (2005), held its second meeting on 27 April 2009. The Committee considered available data on confirmed outbreaks of A/H1N1 swine influenza in the United States of America, Mexico, and Canada. The Committee also considered reports of possible spread to additional countries. On the advice of the Committee, the WHO Director-General has raised the level of influenza pandemic alert from the current phase 3 to phase 4.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the 2009 revision of the phase descriptions, WHO has retained the use of a six-phased approach for easy incorporation of new recommendations and approaches into existing national preparedness and response plans. The grouping and description of pandemic phases have been revised to make them easier to understand, more precise, and based upon observable phenomena. Phases 1–3 correlate with preparedness, including capacity development and response planning activities, while Phases 4–6 clearly signal the need for response and mitigation efforts. Furthermore, periods after the first pandemic wave are elaborated to facilitate post pandemic recovery activities.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In nature, influenza viruses circulate continuously among animals, especially birds. Even though such viruses might theoretically develop into pandemic viruses, in &lt;span style="color:#339999;"&gt;&lt;strong&gt;Phase 1&lt;/strong&gt;&lt;/span&gt; no viruses circulating among animals have been reported to cause infections in humans. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#339999;"&gt;&lt;strong&gt;In Phase 2&lt;/strong&gt;&lt;/span&gt; an animal influenza virus circulating among domesticated or wild animals is known to have caused infection in humans, and is therefore considered a potential pandemic threat. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#339999;"&gt;&lt;strong&gt;In Phase 3&lt;/strong&gt;&lt;/span&gt;, an animal or human-animal influenza reassortant virus has caused sporadic cases or small clusters of disease in people, but has not resulted in human-to-human transmission sufficient to sustain community-level outbreaks. Limited human-to-human transmission may occur under some circumstances, for example, when there is close contact between an infected person and an unprotected caregiver. However, limited transmission under such restricted circumstances does not indicate that the virus has gained the level of transmissibility among humans necessary to cause a pandemic.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#ff9900;"&gt;&lt;strong&gt;Phase 4&lt;/strong&gt;&lt;/span&gt; is characterized by verified human-to-human transmission of an animal or human-animal influenza reassortant virus able to cause “community-level outbreaks.” The ability to cause sustained disease outbreaks in a community marks a significant upwards shift in the risk for a pandemic. Any country that suspects or has verified such an event should urgently consult with WHO so that the situation can be jointly assessed and a decision made by the affected country if implementation of a rapid pandemic containment operation is warranted. Phase 4 indicates a significant increase in risk of a pandemic but does not necessarily mean that a pandemic is a forgone conclusion. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#cc0000;"&gt;&lt;strong&gt;Phase 5&lt;/strong&gt;&lt;/span&gt; is characterized by human-to-human spread of the virus into at least two countries in one WHO region. While most countries will not be affected at this stage, the declaration of Phase 5 is a strong signal that a pandemic is imminent and that the time to finalize the organization, communication, and implementation of the planned mitigation measures is short. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#cc0000;"&gt;&lt;strong&gt;Phase 6&lt;/strong&gt;&lt;/span&gt;, the pandemic phase, is characterized by community level outbreaks in at least one other country in a different WHO region in addition to the criteria defined in Phase 5. Designation of this phase will indicate that a global pandemic is under way.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;During the post-peak period, pandemic disease levels in most countries with adequate surveillance will have dropped below peak observed levels. The post-peak period signifies that pandemic activity appears to be decreasing; however, it is uncertain if additional waves will occur and countries will need to be prepared for a second wave. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Previous pandemics have been characterized by waves of activity spread over months. Once the level of disease activity drops, a critical communications task will be to balance this information with the possibility of another wave. Pandemic waves can be separated by months and an immediate “at-ease” signal may be premature. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the post-pandemic period, influenza disease activity will have returned to levels normally seen for seasonal influenza. It is expected that the pandemic virus will behave as a seasonal influenza A virus. At this stage, it is important to maintain surveillance and update pandemic preparedness and response plans accordingly. An intensive phase of recovery and evaluation may be required. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Director-General's statement  - Swine influenza&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The Emergency Committee, established in compliance with the International Health Regulations (2005), held its second meeting on 27 April 2009. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The Committee considered available data on confirmed outbreaks of A/H1N1 swine influenza in the United States of America, Mexico, and Canada. The Committee also considered reports of possible spread to additional countries.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;On the advice of the Committee, the WHO Director-General decided on the following.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The Director-General has raised the level of influenza pandemic alert from the current phase 3 to phase 4.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The change to a higher phase of pandemic alert indicates that the likelihood of a pandemic has increased, but not that a pandemic is inevitable.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As further information becomes available, WHO may decide to either revert to phase 3 or raise the level of alert to another phase.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;This decision was based primarily on epidemiological data demonstrating human-to-human transmission and the ability of the virus to cause community-level outbreaks.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Given the widespread presence of the virus, the Director-General considered that containment of the outbreak is not feasible. The current focus should be on mitigation measures.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The Director-General recommended not to close borders and not to restrict international travel. It was considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The Director-General considered that production of seasonal influenza vaccine should continue at this time, subject to re-evaluation as the situation evolves. WHO will facilitate the process needed to develop a vaccine effective against A/H1N1 virus.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The Director-General stressed that all measures should conform with the purpose and scope of the International Health Regulations.&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.who.int/en/"&gt;http://www.who.int/en/&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-7622156221726665765?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/7622156221726665765/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=7622156221726665765' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7622156221726665765'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7622156221726665765'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/current-who-phase-of-pandemic-alert-is.html' title='The current WHO phase of pandemic alert is 4'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_5C_306IztQU/SfavAnknd6I/AAAAAAAADeo/1gHeVRdyApc/s72-c/untitled.bmp' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-2417967439640990133</id><published>2009-04-28T00:04:00.001+03:00</published><updated>2009-05-09T15:45:18.779+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Swine Flu Latest News</title><content type='html'>CDC Media Availability on Human Swine Influenza Cases&lt;br /&gt;&lt;br /&gt;April 27, 2009, 1 p.m. EST&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.cdc.gov/media/transcripts/2009/t090427.htm"&gt;Press Briefing Transcripts&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-2417967439640990133?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/2417967439640990133/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=2417967439640990133' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2417967439640990133'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2417967439640990133'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/swine-flu-latest-news.html' title='Swine Flu Latest News'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-277396442760360074</id><published>2009-04-27T10:24:00.002+03:00</published><updated>2009-05-09T15:45:18.780+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Swine influenza frequently asked questions</title><content type='html'>&lt;span style="color:#000099;"&gt;A pdf fact file by the World Health Organization, covering the following questions&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;25 April 2009&lt;br /&gt;&lt;br /&gt;• What is swine influenza?&lt;br /&gt;• What are the implications for human health?&lt;br /&gt;• Where have human cases occurred?&lt;br /&gt;• How do people become infected?&lt;br /&gt;• Is it safe to eat pork meet and products?&lt;br /&gt;• What about the pandemic risk?&lt;br /&gt;• Is there a human vaccine to protect swine influenza?&lt;br /&gt;• What drugs are available for treatment?&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://rapidshare.com/files/226232121/swineflu_qanda_20090425.pdf"&gt;Download &lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-277396442760360074?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/277396442760360074/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=277396442760360074' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/277396442760360074'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/277396442760360074'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/swine-influenza-frequently-asked.html' title='Swine influenza frequently asked questions'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-5805191392842275817</id><published>2009-04-27T10:11:00.003+03:00</published><updated>2009-05-09T15:45:18.780+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Influenza A virus subtype H1N1 and the Pandemic of 1918</title><content type='html'>&lt;div align="justify"&gt;&lt;a href="http://4.bp.blogspot.com/_5C_306IztQU/SfVbum0y9bI/AAAAAAAADeA/mzdR5nCoFiA/s1600-h/2.gif"&gt;&lt;img id="BLOGGER_PHOTO_ID_5329266590316950962" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 400px; CURSOR: hand; HEIGHT: 359px; TEXT-ALIGN: center" alt="" src="http://4.bp.blogspot.com/_5C_306IztQU/SfVbum0y9bI/AAAAAAAADeA/mzdR5nCoFiA/s400/2.gif" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Influenza A virus subtype H1N1&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;H1N1 is a subtype of the species Influenza A virus. The "H" refers to the Hemagglutinin protein, and the "N" refers to the Neuraminidase protein. H1N1 has mutated into various strains including the Spanish Flu strain (now extinct in the wild), mild human flu strains, endemic pig strains, and various strains found in birds. A variant of H1N1 was responsible for the Spanish flu pandemic that killed some 50 million to 100 million people worldwide from 1918 to 1919. A different variant exists in pig populations.&lt;br /&gt;&lt;br /&gt;Low pathogenic H1N1 strains still exist in the wild today, causing roughly half of all flu infections in 2006. When the 1918 virus was compared with human flu viruses in 2005, it was noticed that it had alterations in just 25 to 30 of the virus's 4,400 amino acids. These changes were enough to turn a bird virus into a version that was human-transmissible.&lt;br /&gt;&lt;br /&gt;In April 2009, an H1N1 outbreak killed over one hundred (100) in Mexico, and was believed to have infected more than 1600 individuals worldwide as of April 27, 2009. The U.S. Centers for Disease Control warned that it was possible the outbreak could develop into a pandemic.&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;Spanish Flu &lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;The 1918 flu pandemic (commonly referred to as the Spanish flu) was an influenza pandemic that spread to nearly every part of the world. It was caused by an unusually virulent and deadly Influenza A virus strain of subtype H1N1. Historical and epidemiological data are inadequate to identify the geographic origin of the virus. Most of its victims were healthy young adults, in contrast to most influenza outbreaks which predominantly affect juvenile, elderly, or otherwise weakened patients. The pandemic lasted from March 1918 to June 1920, spreading even to the Arctic and remote Pacific islands. It is estimated that anywhere from 20 to 100 million people were killed worldwide, or the approximate equivalent of one third of the population of Europe, more than double the number killed in World War I. This extraordinary toll resulted from the extremely high illness rate of up to 50% and the extreme severity of the symptoms, suspected to be caused by cytokine storms. The pandemic is estimated to have affected up to one billion people: half the world's population at the time.&lt;br /&gt;&lt;br /&gt;Some scholars have theorized that the flu probably originated in the Far East. Scholar John Barry has proposed that Haskell County, Kansas was the location of the first outbreak of flu. The disease was first observed at Fort Riley, Kansas, United States, on March 4, 1918,and Queens, New York, on March 11, 1918. In August 1918, a more virulent strain appeared simultaneously in Brest, France, in Freetown, Sierra Leone, and in the U.S. at Boston, Massachusetts. The Allies of World War I came to call it the Spanish flu, primarily because the pandemic received greater press attention after it moved from France to Spain in November 1918. Spain was not involved in the war and had not imposed wartime censorship.&lt;br /&gt;&lt;br /&gt;Scientists have used tissue samples from frozen victims to reproduce the virus for study. Given the strain's extreme virulence there has been controversy regarding the wisdom of such research. Among the conclusions of this research is that the virus kills via a cytokine storm (overreaction of the body's immune system) which explains its unusually severe nature and the concentrated age profile of its victims. The strong immune systems of young adults ravaged the body, whereas the weaker immune systems of children and middle-aged adults caused fewer deaths.&lt;br /&gt;&lt;br /&gt;The global mortality rate from the 1918/1919 pandemic is not known, but is estimated at 2.5 to 5% of the human population, with 20% or more of the world population suffering from the disease to some extent. Influenza may have killed as many as 25 million in its first 25 weeks (in contrast, AIDS killed 25 million in its first 25 years).Older estimates say it killed 40–50 million people while current estimates say 50 million to 100 million people worldwide were killed. This pandemic has been described as "the greatest medical holocaust in history" and may have killed more people than the Black Death.&lt;br /&gt;&lt;br /&gt;An estimated 17 million died in India, about 5% of India's population at the time.In the Indian Army, almost 22% of troops who caught the disease died of it. In the U.S., about 28% of the population suffered, and 500,000 to 675,000 died.In Britain as many as 250,000 died; in France more than 400,000. In Canada approximately 50,000 died. Entire villages perished in Alaska and southern Africa. Ras Tafari (the future Haile Selassie) was one of the first Ethiopians who contracted influenza but survived, although many of his subjects did not; estimates for the fatalities in the capital city, Addis Ababa, range from 5,000 to 10,000, with some experts opining that the number was even higher, while in British Somaliland one official there estimated that 7% of the native population died from influenza. In Australia an estimated 12,000 people died and in the Fiji Islands, 14% of the population died during only two weeks, and in Western Samoa 22%.&lt;br /&gt;&lt;br /&gt;This huge death toll was caused by an extremely high infection rate of up to 50% and the extreme severity of the symptoms, suspected to be caused by cytokine storms. Indeed, symptoms in 1918 were so unusual that initially influenza was misdiagnosed as dengue, cholera, or typhoid. One observer wrote, "One of the most striking of the complications was hemorrhage from mucous membranes, especially from the nose, stomach, and intestine. Bleeding from the ears and petechial hemorrhages in the skin also occurred." The majority of deaths were from bacterial pneumonia, a secondary infection caused by influenza, but the virus also killed people directly, causing massive hemorrhages and edema in the lung.&lt;br /&gt;&lt;br /&gt;The unusually severe disease killed between 2 and 20% of those infected, as opposed to the more usual flu epidemic mortality rate of 0.1%. Another unusual feature of this pandemic was that it mostly killed young adults, with 99% of pandemic influenza deaths occurring in people under 65, and more than half in young adults 20 to 40 years old. This is unusual since influenza is normally most deadly to the very young (under age 2) and the very old (over age 70), and may have been due to partial protection caused by exposure to a previous Russian flu pandemic of 1889.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Spanish flu research&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Spanish flu research concerns scientific research regarding the causes and characteristics of the "Spanish flu", a variety of influenza that in 1918 was responsible the worst influenza pandemic in modern history. Many theories about the origins and progress of the Spanish flu persisted in literature, but it wasn't until 2005, when various samples recovered from American World War I soldiers and an Inuit woman buried in the Alaskan tundra, that significant research has been possible.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Origin of Virus&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;One theory is that the virus strain originated at Fort Riley, Kansas, by two genetic mechanisms — genetic drift and antigenic shift — in viruses in poultry and swine which the fort bred for local consumption. Though initial data from a recent reconstruction of the virus suggested that it jumped directly from birds to humans, without traveling through swine, this has since been cast into doubt. One researcher argues that the disease was found in Haskell County, Kansas as early as January 1918.A similar and even more deadly virus had been seen earlier at British camps in France and at Aldershot.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Discovery of viral genomes&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;In February 1998, Johan Hultin recovered samples of the 1918 influenza from the frozen corpse of a Native Alaskan woman buried for nearly eight decades in permafrost near Brevig Mission, Alaska. He brought the samples to a team led by Jeffery Taubenberger of the US Armed Forces Institute of Pathology (AFIP). Brevig Mission lost approximately 85% of its population to the 1918 flu in November 1918. One of the four recovered samples contained viable genetic material of the virus. This sample provided scientists a first-hand opportunity to study the virus, which was inactivated with guanidinium thiocyanate before transport. This sample and others found in AFIP archives allowed researchers to completely analyze the critical gene structures of the 1918 virus. "We have now identified three cases: the Brevig Mission case and two archival cases that represent the only known sources of genetic material of the 1918 influenza virus", said Taubenberger, chief of AFIP's molecular pathology division and principal investigator on the project.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;The February 6, 2004 edition of Science magazine reported that two research teams, one led by Sir John Skehel, director of the National Institute for Medical Research in London, another by Professor Ian Wilson of The Scripps Research Institute in San Diego, had managed to synthesize the hemagglutinin protein responsible for the 1918 flu outbreak of 1918. They did this by piecing together DNA from a lung sample from an Inuit woman buried in the Alaskan tundra and a number of preserved samples from American soldiers of the First World War. The teams had analyzed the structure of the gene and discovered how subtle alterations to the shape of a protein molecule had allowed it to move from birds to humans with such devastating effects.&lt;br /&gt;&lt;br /&gt;On October 5, 2005, researchers at the Mount Sinai School of Medicine in New York announced that the genetic sequence of the 1918 flu strain, a subtype of avian strain H1N1, had been reconstructed using historic tissue samples.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Characteristics of virus&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;Influenza viruses have a relatively high mutation rate that is characteristic of RNA viruses. The H5N1 virus has mutated into a variety of types with differing pathogenic profiles; some pathogenic to one species but not others, some pathogenic to multiple species.The ability of various influenza strains to show species-selectivity is largely due to variation in the hemagglutinin genes. Genetic mutations in the hemagglutinin gene that cause single amino acid substitutions can significantly alter the ability of viral hemagglutinin proteins to bind to receptors on the surface of host cells. Such mutations in avian H5N1 viruses can change virus strains from being inefficient at infecting human cells to being as efficient in causing human infections as more common human influenza virus types. This doesn't mean one amino acid substitution can cause a pandemic but it does mean one amino acid substitution can cause an avian flu virus that is not pathogenic in humans to become pathogenic in humans.&lt;br /&gt;&lt;br /&gt;In July 2004, researchers led by H. Deng of the Harbin Veterinary Research Institute, Harbin, China and Robert Webster of the St Jude Children's Research Hospital, Memphis, Tennessee, reported results of experiments in which mice had been exposed to 21 isolates of confirmed H5N1 strains obtained from ducks in China between 1999 and 2002. They found "a clear temporal pattern of progressively increasing pathogenicity". Results reported by Webster in July 2005 reveal further progression toward pathogenicity in mice and longer virus shedding by ducks.&lt;br /&gt;&lt;br /&gt;In December, 2008, research by Yoshihiro Kawaoka of University of Wisconsin linked the presence of the three specific genes (termed PA, PB1, and PB2) and a nucleoprotein derived from the 1918 flu samples was enough to trigger similar symptoms in animal testing.&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;Research of viral pathogenesis&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Recent research of Taubenberger et al has suggested that the 1918 virus, like H5N1, could have arisen directly from an avian influenza virus. However, researchers at University of Virginia and Australian National University have suggested that there may be an alternative interpretation of the data used in the Taubenberger et al. paper.Taubenberger et al responded to these letters and defended their original interpretation. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Other research by Tumpey and colleagues who reconstructed the H1N1 virus of 1918 came to the conclusion that it is was most notably the polymerase genes and the HA and NA genes that caused the extreme virulence of this virus. The sequences of the polymerase proteins (PA, PB1, and PB2) of the 1918 virus and subsequent human viruses differ by only 10 amino acids from the avian influenza viruses. Viruses with seven of the ten amino acids in the human influenza locations have already been identified in currently circulating H5N1. This has led some researchers to suggest that other mutations may surface and make the H5N1 virus capable of human-to-human transmission. Another important factor is the change of the HA protein to a binding preference for alpha 2,6 sialic acid (the major form in the human respiratory tract). In avian virus the HA protein preferentially binds to alpha 2,3 sialic acid, which is the major form in the avian enteric tract. It has been shown that only a single amino acid change can result in the change of this binding preference. Altogether, only a handful of mutations may need to take place in order for H5N1 avian flu to become a pandemic virus like the one of 1918. However it is important to note that likelihood of mutation does not indicate the likelihood for the evolution of such a strain; since some of the necessary mutations may be constrained by stabilizing selection.&lt;br /&gt;&lt;br /&gt;On 18 January 2007, Kobasa et al reported that infected monkeys (Macaca fascicularis) exhibited classic symptoms of the 1918 pandemic and died from a cytokine storm.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Blood plasma as an effective treatment&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;In the event of another pandemic, US military researchers have proposed reusing a treatment from the deadly pandemic of 1918 in order to blunt the effects of the flu. Some military doctors injected severely afflicted patients with blood or blood plasma from people who had recovered from the flu. Data collected during that time indicates that the blood-injection treatment reduced mortality rates by as much as 50 percent. Navy researchers have launched a test to see if the 1918 treatment will work against deadly Asian bird flu. Results thus far have been inconclusive. Human H5N1 plasma may be an effective, timely, and widely available treatment for the next flu pandemic. A new international study using modern data collection methods, would be a difficult, slow process. But many flu experts, citing the months-long wait for a vaccine for the next pandemic, are of the opinion that the 1918 method is something to consider.&lt;br /&gt;&lt;br /&gt;In the world wide 1918 flu pandemic, "physicians tried everything they knew, everything they had ever heard of, from the ancient art of bleeding patients, to administering oxygen, to developing new vaccines and sera (chiefly against what we now call Hemophilus influenzae—a name derived from the fact that it was originally considered the etiological agent—and several types of pneumococci). Only one therapeutic measure, transfusing blood from recovered patients to new victims, showed any hint of success." &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;(modified articles from &lt;a href="http://en.wikipedia.org/wiki/Influenza_A_virus_subtype_H1N1"&gt;wikipedia&lt;/a&gt;) &lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-5805191392842275817?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/5805191392842275817/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=5805191392842275817' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/5805191392842275817'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/5805191392842275817'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/influenza-virus-subtype-h1n1-and.html' title='Influenza A virus subtype H1N1 and the Pandemic of 1918'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_5C_306IztQU/SfVbum0y9bI/AAAAAAAADeA/mzdR5nCoFiA/s72-c/2.gif' height='72' width='72'/><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6634469916663698067</id><published>2009-04-26T02:36:00.001+03:00</published><updated>2009-05-09T15:45:18.780+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='New Flu Virus A-H1N1'/><category scheme='http://www.blogger.com/atom/ns#' term='Swine influenza'/><title type='text'>Swine Flu Outbreak</title><content type='html'>&lt;div align="justify"&gt;&lt;span style="color:#000099;"&gt;The news from Mexico are alarming, at least. The global scientific community is very concerned with the rapid development of events in that part of the world. First of all it is important to keep in mind that panic is our worst enemy. It is true that an influenza pandemic is possible nevertheless, we must remain calm. It is imperative that information about this matter should flood the internet in order to create a spherical and scientific based awareness to all.&lt;/span&gt;  &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img src="http://farm1.static.flickr.com/102/317122327_1d6dd083f7.jpg?v=1192463009" /&gt;&lt;/p&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;BBC News &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Mexico flu 'a potential pandemic'&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;A new flu virus suspected of killing at least 60 people in Mexico has the potential to become a pandemic, the World Health Organization's chief says. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Margaret Chan said the outbreak was a "health emergency of international concern" and must be closely monitored. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Health experts say tests so far seem to link the illnesses in Mexico with a swine flu virus in the southern US. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Several people have also fallen ill in the US, and the authorities there are watching the situation.&lt;br /&gt;A top US health official said the strain of swine flu had spread widely and could not be contained.&lt;br /&gt;Ms Chan cut short a visit to the US and returned to Geneva where the WHO's emergency committee met. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The committee can recommend declaring an international public health emergency and raise the global pandemic alert level - a move that could lead to travel advisories, trade restrictions and border closures. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The WHO says it does not know the full risk yet but it quoted Mrs Chan as saying that "the current events constitute a public health emergency of international concern". &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It is advising all member states to be vigilant for seasonally unusual flu or pneumonia-like symptoms among their populations - particularly among young healthy adults. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Officials said most of those killed so far in Mexico were young adults - rather than more vulnerable children and the elderly....  &lt;a href="http://news.bbc.co.uk/1/hi/world/americas/8018356.stm"&gt;(full article here) &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-6634469916663698067?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/6634469916663698067/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=6634469916663698067' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6634469916663698067'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6634469916663698067'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2009/04/swine-flu-outbreak.html' title='Swine Flu Outbreak'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-575470539124997503</id><published>2008-10-15T17:37:00.002+03:00</published><updated>2008-10-15T17:43:37.206+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Articles'/><title type='text'>Fuel for Poverty</title><content type='html'>&lt;div align="justify"&gt;It was in back in 2007 when President Bush and the left-of-center Brazilian President Luis Inacio Lula da Silva, proclaimed a partnership between their countries in order to promote the use of biofuel as a source of alternative energy.&lt;br /&gt;&lt;br /&gt;That was an amazing turn of events, considering the fact that the American administration never had the best of relationships with governments that come from the left side of the political spectrum. Even more amazing was the fact, that George W. Bush, a person whose political career revolves around petroleum, would support partnerships involving alternative sources of energy.&lt;br /&gt;&lt;br /&gt;It seems that President Bush was a strong supporter of the “development and production of fuels and automobiles that would decrease the use of oil” way before his visit to Brazil. 1&lt;br /&gt;&lt;br /&gt;The consequences of this sudden interest on the future of the environment were extremely worrying. The prices of agricultural products rocketed, violent riots erupted in many of the underdeveloped countries and a climate of insecurity struck masses of people that already lived in abhorrent conditions.&lt;br /&gt;&lt;br /&gt;There are unconfirmed rumors that the increasing production of biofuel was responsible for 75% of the total increase in food prices. The correlation between biofuel production was described in the best way possible in the articles that follow, both by C. Ford Runge and Benjamin Senauer. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;"&gt;&lt;a href="http://www.america.gov/st/washfile-english/2007/January/20070124170334saikceinawz8.820742e-02.html"&gt;1 Bush Urges Cuts in Gasoline Use, More Biofuel Production&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img src="http://keetsa.com/blog/wp-content/uploads/2008/02/biofuel_main.jpg" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#3333ff;"&gt;How Biofuels Could Starve the PoorC. Ford Runge and Benjamin Senauer&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;From Foreign Affairs, May/June 2007&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Summary:  Thanks to high oil prices and hefty subsidies, corn-based ethanol is now all the rage in the United States. But it takes so much supply to keep ethanol production going that the price of corn -- and those of other food staples -- is shooting up around the world. To stop this trend, and prevent even more people from going hungry, Washington must conserve more and diversify ethanol's production inputs.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;C. Ford Runge is Distinguished McKnight University Professor of Applied Economics and Law and Director of the Center for International Food and Agricultural Policy at the University of Minnesota. Benjamin Senauer is Professor of Applied Economics and Co-director of the Food Industry Center at the University of Minnesota.....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.foreignaffairs.org/20070501faessay86305/c-ford-runge-benjamin-senauer/how-biofuels-could-starve-the-poor.html"&gt;Link to the article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#3333ff;"&gt;How Ethanol Fuels the Food Crisis&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;C. Ford Runge and Benjamin Senauer&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;From foreignaffairs.org - author update, May 28, 2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Summary:  Runge and Senauer's update to their May/June 2007 essay ''How Biofuels Could Starve the Poor.''&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the year since the publication of our article, "How Biofuels Could Starve the Poor" (May/June 2007), the average price of corn has increased by some 60 percent, soybeans by 76 percent, wheat by 54 percent, and rice by 104 percent. What at first seemed alarmist has turned out to be an underestimate of the effects of biofuels on both commodity prices and the natural environment. These price increases are substantial threats to the welfare of consumers, especially in poor developing countries facing food deficits. They are especially burdensome to the rural landless and the urban poor, who produce no food at all. Josette Sheeran, the Executive Director of the World Food Program, calls this a global "tsunami of hunger." Robert Zoellick, President of the World Bank, estimates that there are 100 million newly poor and hungry people as a result of rising food prices.....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.foreignaffairs.org/20080528faupdate87376/c-ford-runge-benjamin-senauer/how-ethanol-fuels-the-food-crisis.html"&gt;Link to the article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:85%;"&gt;C. Ford Runge is Distinguished McKnight University Professor of Applied Economics and Law at the University of Minnesota. Benjamin Senauer is Professor of Applied Economics at the University of Minnesota.&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-575470539124997503?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/575470539124997503/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=575470539124997503' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/575470539124997503'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/575470539124997503'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/10/fuel-for-poverty.html' title='Fuel for Poverty'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-1575109892528605838</id><published>2008-09-17T15:30:00.002+03:00</published><updated>2008-09-17T15:38:01.467+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 8 - 15 Sep 2008</title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Cryopreservation techniques bring hopes for women cancer victims and endangered species&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;September 10, 2008 09:39 AM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Emerging cryopreservation techniques are increasing hope of restoring fertility for women after diseases such as ovarian cancer that lead to destruction of reproductive tissue. The same techniques can also be used to maintain stocks of farm animals, and protect against extinction of endangered animal species by maintaining banks of ovarian tissue or even nascent embryos that can used to produce offspring at some point in the future. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Until now these clearly related fields of research concerning preservation of animal and human ovarian tissue have been largely separate, but are now coming together to reinforce each other, following a highly successful workshop on cryopreservation of ovarian tissue, organised by the European Science Foundation (ESF). The human and animals cryopreservation fields have much to teach each other, and progress in both is likely to be accelerated as a result of growing collaboration, according to the ESF workshop's convenor Claus Yding Andersen. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Both parties can learn from each other," said Andersen. "Experiments which cannot be performed in women can be done in animal species," he noted, pointing out that much of the progress in humans has come as a result of animal experiments. But it is in humans where most successful transplantations of frozen ovarian tissue after thawing have been carried out, and where greatest experience in the field has been gained. Therefore the ESF conference considered how this could be applied to conservation of endangered species. "The vast experience in women, with several children born as a result of transplantation of frozen/thawed ovarian tissue, can be applied in endangered species to know where to implant and how to obtain pregnancies," said Andersen. The techniques will also be valuable in agriculture, for preserving ovaries of farm animals in tissue banks with the potential for subsequent re-creation... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/09/10/cryopreservation_techniques_bring_hopes_for_women_cancer_victims_and_endangered_species.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Color-coded bacteria can spot oil spills or leaky pipes and storage tanks&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;September 10, 2008 11:39 PM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Oil spills and other environmental pollution, including low level leaks from underground pipes and storage tanks, could be quickly and easily spotted in the future using colour coded bacteria, scientists heard today (Thursday 11 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Because bacteria have simple single-celled bodies it is relatively easy to equip them with a sensor and a brightly coloured 'reporter protein' which shows up under a microscope, alerting us to different substances leaking into the soil or seawater from oil spills, agricultural chemicals or other pollutants," says Professor Jan Van der Meer from the University of Lausanne in Switzerland. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists have successfully shown that living bacteria can be used as a much more environmentally friendly way of detecting pollution than the currently used chemical methods of working out what has happened. "Chemical methods are often cumbersome, require sophisticated equipment, costly reagents or nasty materials," says Professor Van der Meer. "In comparison, our sensing bacteria are very simple to maintain. Tests with the bacteria are therefore extremely easy to carry out and do not require noxious chemicals." &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Our own tests, and checks by other laboratories, have shown that pollution testing using bacteria is a remarkably robust technique and produces reliable results," says Professor Van der Meer. "The heart of our colour sensor system is the bacteria themselves. They reproduce themselves in a growth medium, which makes the whole set-up really cheap," &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The new technique has already been successfully tested during a research expedition at sea, when the scientists demonstrated that the bacteria could measure different chemicals seeping from oil into the water, showing up as the blue light of bioluminescence in a simple light recording device... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/09/10/colorcoded_bacteria_can_spot_oil_spills_or_leaky_pipes_and_storage_tanks.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Researchers develop nano-sized 'cargo ships' to target and destroy tumors&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;September 11, 2008 11:19 PM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists have developed nanometer-sized 'cargo ships' that can sail throughout the body via the bloodstream without immediate detection from the body's immune radar system and ferry their cargo of anti-cancer drugs and markers into tumors that might otherwise go untreated or undetected. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;In a forthcoming issue of the Germany-based chemistry journal Angewandte Chemie, scientists at UC San Diego, UC Santa Barbara and MIT report that their nano-cargo-ship system integrates therapeutic and diagnostic functions into a single device that avoids rapid removal by the body's natural immune system. Their paper is now accessible in an early online version at: &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www3.interscience.wiley.com/journal/121376053/abstract?CRETRY=1&amp;amp;SRETRY=0"&gt;http://www3.interscience.wiley.com/journal/121376053/abstract?CRETRY=1&amp;amp;SRETRY=0&lt;/a&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The idea involves encapsulating imaging agents and drugs into a protective 'mother ship' that evades the natural processes that normally would remove these payloads if they were unprotected," said Michael Sailor, a professor of chemistry and biochemistry at UCSD who headed the team of chemists, biologists and engineers that turned the fanciful concept into reality. "These mother ships are only 50 nanometers in diameter, or 1,000 times smaller than the diameter of a human hair, and are equipped with an array of molecules on their surfaces that enable them to find and penetrate tumor cells in the body." &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;These microscopic cargo ships could one day provide the means to more effectively deliver toxic anti-cancer drugs to tumors in high concentrations without negatively impacting other parts of the body... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/09/11/researchers_develop_nanosized_cargo_ships_to_target_and_destroy_tumors.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;TGen investigators devise faster, cheaper way of analyzing the human genome&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;September 15, 2008 01:23 AM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Investigators at the Translational Genomics Research Institute (TGen) today announced a faster and less expensive way for scientists to find which genes might affect human health.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Using bar-codes, not unlike what shoppers find in grocery stores, TGen researchers found a way to index portions of the nearly 3-billion-base human genetic code, making it easier for scientists to zero in on the regions most likely to show variations in genetic traits. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The findings were published today in the online version of the journal Nature Methods. The study will be published in print in the journal's October edition. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr. David Craig, associate director of TGen's Neurogenomics Division, said the new method should cost only one-tenth, or less, of the current cost of sequencing genes commonly done to analyze Single Nucleotide Polymorphisms (SNPs), and in performing Genome-Wide Association (GWA) studies. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Our goal is to find the genetic basis of disease,'' said Craig, the study's lead author. "It (the new method) provides us a way to immediately use next-generation sequencing technology for studying hundreds to thousands of individuals.'' &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;John Pearson, the head of TGen's Bioinformatics Research Unit, said the new method would allow scientists worldwide to more easily tune their sequencing experiments, and conduct their experiments with greater speed... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/09/15/tgen_investigators_devise_faster_cheaper_way_of_analyzing_the_human_genome.html_genome.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Biological selenium removal: The solution to pollution?&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;September 15, 2008 01:03 PM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Selenium has been referred to as an "essential toxin" due to the fact that it shows only a marginal line between the nutritious requirement and toxic effects upon exposure. The steep dose response curve due to bioaccumulation effects have lead to the characterization of selenium as a "time bomb" that can be fused by exceeding a narrow threshold concentration in ecosystems through anthropogenic activities. Ironically, an estimated 0.5 to 1 billion people worldwide suffer from selenium deficiency, whereas areas of toxicity can be separated from selenium deficient areas by only 20 km.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The microbiological treatment of selenium - so called "dissimilatory metal reduction" - could supersede this problem, as selenium-reducing microorganisms are highly selective for selenate, reducing it to insoluble, less-toxic elemental selenium that can potentially be recovered from the process. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;A study funded by the European Union, published in the September-October issue of the Journal of Environmental Quality, demonstrates that the biological treatment is indeed efficient for selenate reduction, and substantial amounts of selenate are converted to methylated selenium species or nano-sized elemental selenium particles. The emission of nano-sized selenium particles is problematic, as these can become bioavailable by direct assimilation or reoxidize to selenite and selenate. Dimethlyselenide and dimethyldiselenide, two species with unknown ecotoxicological long-term effects, contributed substantially to selenium dissolved in the effluent. Their formation was induced by minor temperature changes during biological reduction, thus a careful process control might drastically increase removal success of existing biotreatment systems for selenium and is a prerequisite for successful removal in full scale applications... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/09/15/biological_selenium_removal_the_solution_to_pollution.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#33cc00;"&gt;&lt;strong&gt;DNA 'Tattoos' Link Adult, Daughter Stem Cells In Planarians&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 13, 2008)&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Unlike some parents, adult stem cells don't seem to mind when their daughters get a tattoo. In fact, they're willing to pass them along.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Using the molecular equivalent of a tattoo on DNA that adult stem cells (ASC) pass to their "daughter" cells in combination with gene expression profiles, University of Utah researchers have identified two early steps in adult stem cell differentiation—the process that determines whether cells will form muscle, neurons, skin, etc., in people and animals.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The U of U researchers, led by Alejandro Sanchez Alvarado, Ph.D., professor of neurobiology and anatomy, identified 259 genes that help defined the earliest steps in the differentiation of adult stem cells in planarians—tiny flatworms that have the uncanny ability to regenerate cells and may have much to teach about human stem cell biology.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The findings, reported in the Sept. 11 issue of Cell Stem Cell establish planarians as an excellent model for studying adult stem cells in a live animal, rather than a laboratory culture dish.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This allows us to study an entire stem cell population in its own environment," said Sanchez Alvarado, also an investigator with the Howard Hughes Medical Institute and the study's senior author. "It's likely that what we learned here can be applied to our own stem cell biology."&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Planarians share similar biology with humans in many ways. They also, for reasons unknown, regenerate cells unlike any other animal—an entirely new worm can form from just a fragment of another worm. Planarians constantly regenerate new cells to replace those that die naturally or from injury...&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/09/080910133702.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Photosynthesizing Bacteria With A Day-night Cycle Contain Rare Chromosome&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 15, 2008)&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers sequencing the DNA of blue-green algae found a linear chromosome harboring genes important for producing biofuels. Simultaneously analyzing the complement of proteins revealed more genes on the linear and the typical circular chromosomes then they'd have found with DNA sequencing alone.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The team recently reported the cyanobacterium Cyanothece 51142's genome in the Proceedings of the National Academy of Sciences Early Edition. Overlaying protein data let the researchers pinpoint about 16 percent more genes than by DNA sequencing alone. The collaboration included a proteomics team from the Department of Energy's Pacific Northwest National Laboratory, a gene sequencing team from the Washington University Genome Sequencing Center, and researchers from Washington University, Saint Louis University, and Purdue University.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This is the first time anything like this has been found in photosynthetic bacteria. It's extremely rare for bacteria to have a linear chromosome," said team leader Himadri Pakrasi from WUSTL. "Nearly 100 percent of them do not."&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cyanobacteria are unique among bacteria because they seem part plant-like and part microbe-like. They use the sun's energy to make sugar via photosynthesis like plants do. And like bacteria, Cyanothece 51142 has other key life-sustaining functions, such as doctoring atmospheric nitrogen so other species can use it. This so-called nitrogen fixation is performed by a handful of bacterial species in water and soil. Cyanothece also makes ethanol and hydrogen, activities that drew the attention of the DOE and others looking for new ways to make fuel...&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/09/080915174540.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Viruses Collectively Decide Bacterial Cell's Fate&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 15, 2008)&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;A new study suggests that bacteria-infecting viruses – called phages – can make collective decisions about whether to kill host cells immediately after infection or enter a latent state to remain within the host cell.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research, published in the September 15 issue of the Biophysical Journal, shows that when multiple viruses infect a cell, this increases the number of viral genomes and therefore the overall level of viral gene expression. Changes in viral gene expression can have a dramatic nonlinear effect on gene networks that control whether viruses burst out of the host cell or enter a latent state.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"What has confounded the virology community for quite some time is the observation that the cell fate of a bacteria infected by a single virus can be dramatically different than that infected by two viruses," said Joshua Weitz, an assistant professor in the School of Biology at the Georgia Institute of Technology. "Our study suggests that viruses can collectively decide whether or not to kill a host, and that individual viruses 'talk' to each other as a result of interactions between viral genomes and viral proteins they direct the infected host to produce."&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;To study viral infections, Weitz teamed with postdoctoral fellow Yuriy Mileyko, graduate student Richard Joh and Eberhard Voit, who is a professor in the Wallace H. Coulter Department of Biomedical Engineering, the David D. Flanagan Chair Georgia Research Alliance Eminent Scholar in Biological Systems and director of the new Integrative BioSystems Institute at Georgia Tech....&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/09/080915121231.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Purifying Parasites From Host Cells With Light&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 16, 2008)&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers have developed a clever method to purify parasitic organisms from their host cells, which will allow for more detailed proteomic studies and a deeper insight into the biology of organisms that cause millions of cases of disease each year.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Many infectious pathogens, like those that cause Toxoplasmosis or Leishmaniases, have a complex life cycle alternating between free-living creature and cell-enclosed parasite. A thorough analysis of the proteins that help these organisms undergo this lifestyle change would be tremendously useful for drug or vaccine development; however, it's extremely difficult to separate the parasites from their host cell for detailed study.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;As reported in the September Molecular &amp;amp; Cellular Proteomics, Toni Aebischer and colleagues worked around this problem by designing special fluorescent Leishmania mexicana (one of the many Leishmaniases parasites). They then passed infected cells through a machine that can separate cell components based on how much they glow. Using this approach, the researchers separated the Leishmania parasites with only about 2% contamination, far better than current methods...&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;img id="BLOGGER_PHOTO_ID_5246967466412488802" style="DISPLAY: block; MARGIN: 0px auto 10px; CURSOR: hand; TEXT-ALIGN: center" alt="" src="http://3.bp.blogspot.com/_5C_306IztQU/SND5HG-MOGI/AAAAAAAACQk/T2fkiwtk5kE/s400/080912132958-large.jpg" border="0" /&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;Electron micrographs (left=low, right=high magnification) highlighting the purification of Leishmania parasites (dark shapes) from their host cells. (Credit: MCP)&lt;/em&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/09/080912132958.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-1575109892528605838?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/1575109892528605838/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=1575109892528605838' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1575109892528605838'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1575109892528605838'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/09/weekly-bionews-8-15-sep-2008.html' title='Weekly BioNews 8 - 15 Sep 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_5C_306IztQU/SND5HG-MOGI/AAAAAAAACQk/T2fkiwtk5kE/s72-c/080912132958-large.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-7593305697255624342</id><published>2008-09-08T15:26:00.001+03:00</published><updated>2008-09-08T15:32:19.769+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 1 - 8 Sep 2008</title><content type='html'>&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Nature inspires new highly specific drugs and organic products&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;September 2, 2008 12:18 PM &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The best place to seek novel compounds for pharmaceutical drugs, alternative energy sources, and a host of industrial applications, is within natural systems that have evolved over millions of years. Scientists now realise that the precise molecular arrangements within natural pathways in organisms have been highly tuned for specific processes and provide both compounds that can be exploited directly and vital information over how to synthesise new products by mimicking biochemical processes. The bright future for research and development around such natural products was discussed recently at a conference organised by the European Science Foundaton (ESF), and the European Cooperation in the field of Scientific and Technical Research (COST). &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We found that natural products provide invaluable leads for drug discovery and opportunities to explore chemical and biological pathways, both of which are essential to advancing the life sciences," said the conference chair K.C. Nicolaou from the Scripps Research Institute in the US. Some of the products discussed at the conference were ready for preclinical development, having shown great potential for treating a range of infectious and metabolic diseases as well as cancers.&lt;br /&gt;Such products are creating excitement because they promise to combine more effective treatment with reduced side effects, as well exploiting clean non-toxic synthetic techniques. For example Maurizio Botta from the University of Sienna in Italy discussed the design, synthesis and biological evaluation of new compounds for tackling AIDS and HIV by inhibiting reverse transcriptase, the process by which this type of retrovirus virus hijacks the host cell's genetic machinery to replicate itself. Some of these compounds have already exhibited strong activity against the AIDS virus in the laboratory. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;There were also a number of promising anti-bacterial agents presented at the conference, which is an important development given the growing resistance of some bacterial species to existing antibiotics and the growing problem posed by MRSA, the "super bug" that plagues many hospitals and nursing homes. Dionisios Vourloumis, research director at the state run Greek research centre NCSR Demokritos, explained how bacteria could be disabled by targeting the RNA binding molecules needed for their genes to be expressed.... &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/09/02/nature_inspires_new_highly_specific_drugs_and_organic_products.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;New nano device detects immune system cell signaling&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;September 3, 2008 10:33 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The signals the researchers detected originated in dendritic cells – the sentinels of the immune system that do the initial detection of microscopic invaders – and were received by nearby T-cells, which play a number of crucial roles in the immune system, including coordination of attacks on agents that cause disease or infection. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The chemical signals cells exchange when they come into contact have been studied extensively. But it has not been possible to detect chemical messages that travel between cells that are nearby but not in contact – called paracrine signals – because they are highly localized and they are produced in concentrations that have been below detection levels. A new technology, called a multi-trap nanophysiometer, was required to demonstrate the existence of non-contact signaling. This is one of the first microfluidic devices that has been applied successfully to the study of cell-to-cell signaling in the immune system. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A detailed description of the multi-trap nanophysiometer (MTN) and how it enabled the accidental discovery of paracrine signaling has been published online by the Lab on a Chip journal. The new device was developed by a team of researchers at the Vanderbilt Institute for Integrative Biosystems Research and Education headed by John P. Wikswo, the Gordon A. Cain University Professor at Vanderbilt. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This is an important advance and potentially very useful technology," says co-author Derya Unutmaz, now an associate professor of microbiology at New York University's School of Medicine. "The ability to study the behavior of single cells may not be as critical if you are studying the heart or muscles, which are mostly formed by uniform cells, but it is crucial for understanding how the immune system functions. The wide surveillance of the body that it conducts requires extensive communication between dozens of different kinds of immune cells."&lt;br /&gt;The reason for this is that the dendritic cells, T-cells and B-cells in the immune system, which tend to concentrate in the lymph nodes spread throughout the body, function as individual, unattached cells. If dendritic cells detect invaders in the body, they rapidly migrate to lymph nodes and have to find the appropriate T-cells to alert them. But how dendritic cells attract the right T-cells among millions of cells within the lymph nodes remains an immunological puzzle....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/09/03/new_nano_device_detects_immune_system_cell_signaling.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;New Evidence On Folic Acid In Diet And Colon Cancer&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 5, 2008) &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers in the United Kingdom and Texas are reporting a new, more detailed explanation for the link between low folate intake and an increased risk for colon cancer, the second leading cause of cancer death in the United States.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Their study reinforces the importance of folate in a healthy diet.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Susan Duthie and colleagues note that researchers have known for years that a deficiency of folate, one of the B vitamins commonly called folic acid, increases the risk of birth defects. As a result, manufacturers enrich some foods with folate....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/09/080901215125.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;DNA Shows That Last Woolly Mammoths Had North American Roots&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 5, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In a surprising reversal of conventional wisdom, a DNA-based study has revealed that the last of the woolly mammoths—which lived between 40,000 and 4,000 years ago—had roots that were exclusively North American.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research, which appears in the September issue of Current Biology, is expected to cause some controversy within the paleontological community.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Scientists have always thought that because mammoths roamed such a huge territory—from Western Europe to Central North America—that North American woolly mammoths were a sideshow of no particular significance to the evolution of the species," said Hendrik Poinar, associate professor in the departments of Anthropology, and Pathology &amp;amp; Molecular Medicine at McMaster University.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Poinar and Regis Debruyne, a postdoctoral research fellow in Poinar's lab, spent the last three years collecting and sampling mammoths over much of their former range in Siberia and North America, extracting DNA and meticulously piecing together, comparing and overlapping hundreds of mammoth specimen using the second largest ancient DNA dataset available...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/09/080904145058.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Atomic Structure Of The Mammalian 'Fatty Acid Factory' Determined&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 8, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. Now researchers at ETH Zurich have determined the atomic structure of a mammalian fatty acid synthase.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Synthesis of fatty acids is a central cellular process that has been studied for many decades. Fatty acids are used in the cell as energy storage compounds, messenger molecules and building blocks for the cellular envelope. Until now, individual steps of this process have been investigated using isolated bacterial enzymes. However, in higher organisms – except plants – fatty acid synthesis is catalyzed by large multifunctional proteins where many individual enzymes are brought together to form a “molecular assembly line”.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The atomic structure is the result of many years of research&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As recently described in the journal Science, researchers at ETH Zurich, supported by the National Centre of Excellence in Research (NCCR) in Structural Biology at the Swiss National Science Foundation, determined the high-resolution structure of a mammalian fatty acid synthase using data collected at the Swiss Light Source (SLS) of the Paul Scherrer Institute (PSI) in Switzerland. These results crown the efforts begun in 2001 to determine the detailed structures of fatty acid synthases in higher organisms by a relatively small group of scientists at ETH Zurich...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/09/080905072124.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Aerosols in climate change&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 08/09/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A group of scientists affiliated with the International Geosphere-Biosphere Programme (IGBP) have proposed a new framework to account more accurately for the effects of aerosols on precipitation in climate models. Their work appears in the 5 September issue of Science magazine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The increase in atmospheric concentrations of man-made aerosols-tiny particles suspended in the air-from such sources as transportation, industry, agriculture, and urban land use not only poses serious problems to human health, but also has an effect on weather and climate.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Recent studies suggest that increased aerosol loading may have changed the energy balance in the atmosphere and at the Earth's surface, and altered the global water cycle in ways that make the climate system more prone to precipitation extremes.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It appears that aerosol effects on clouds can induce large changes in precipitation patterns, which in turn may change not only regional water resources, but also may change the regional and global circulation systems that constitute the Earth's climate.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The proposed framework improves scientists' ability to simulate present and future climates by integrating, for the first time, the radiative and microphysical effects of aerosols on clouds. The radiative effects of aerosols on clouds mostly act to suppress precipitation, because they decrease the amount of solar radiation that reaches the land surface, and therefore cause less heat to be available for evaporating water and energising convective rain clouds. Microphysical effects of aerosols can slow down the conversion of cloud drops into raindrops, which shuts off precipitation from very shallow and short-lived clouds...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/09/08/21026/Aerosols_in_climate_change/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Superbugs use poisons against defences&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 08/09/2008&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Colonies of hospital superbugs can make poisons similar to those found in rattlesnake venom to attack our bodies' natural defences, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.The toxins are manufactured by communities of the hospital superbug Pseudomonas aeruginosa called biofilms, which are up to a thousand times more resistant to antibiotics than free-floating single bacterial cells.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This is the first time that anyone has successfully proved that the way the bacteria grow - either as a biofilm, or living as individuals - affects the type of proteins they can secrete, and therefore how dangerous they can potentially be to our health," says Dr Martin Welch from the University of Cambridge, UK.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Acute diseases caused by bacteria can advance at an astonishing rate and tests have associated these types of disease with free-floating bacteria. Such free-floating bugs often secrete tissue-damaging poisons and enzymes to break down our cells, contributing to the way the disease develops, so it is natural to blame them. By contrast, chronic or long-term infections seem to be associated with biofilms, which were thought to be much less aggressive," says Dr Welch.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research team's findings are very important to the NHS, which spends millions of pounds every year fighting chronic long-term bacterial infections which are incredibly difficult to treat.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"For example, these chronic infections by bacteria are now the major cause of death and serious disability in cystic fibrosis patients - which is the most common lethal inherited disease in the UK and affects about 8,000 people," says Dr Welch.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In cystic fibrosis the gene defect means that people are very susceptible to a particular group of opportunistic bacteria including Pseudomonas aeruginosa, which is one of the three major hospital superbugs. Aggressive antibiotic treatment can usually control the infection in cystic fibrosis sufferers but eventually the strain becomes completely resistant to antibiotics, leading to respiratory failure and death, often while still in their thirties.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We think that the bacteria in a cystic fibrosis sufferer's lungs are partly living in communities called biofilms, and although medical scientists have investigated their strongly antibiotic-resistant properties, very little research has been done to investigate any active contribution the biofilms might have in causing diseases in the first place," says Dr Welch....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/09/08/21021/Superbugs_use_poisons_against_defences/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;The robustness of metabolic networks&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 05/09/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Biological systems are constantly evolving in ways that increase their fitness for survival amidst environmental fluctuations and internal errors. Now, in a study of cell metabolism, a Northwestern University research team has found new evidence that evolution has produced cell metabolisms that are especially well suited to handle potentially harmful changes like gene deletions and mutations.The results, published online this week in the journal PNAS, could be useful in areas where researchers want to manipulate metabolic network structure, such as in bioengineering and medicine, and in the design of robust synthetic networks for use in energy production and distribution networks and in critical infrastructures, such as transportation networks.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research was led by Julio M. Ottino, dean of the McCormick School of Engineering and Applied Science and Walter P. Murphy Professor of Chemical and Biological Engineering. Other authors of the paper, titled "Cascading failure and robustness in metabolic networks," are Luis A. Nunes Amaral, associate professor of chemical and biological engineering, and lead author Ashley Smart, who recently received his doctoral degree from Northwestern and is now a postdoctoral fellow at the California Institute of Technology.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cell metabolism is essentially a large network of reactions whose purpose is to convert nutrients into products and energy. Because the network is highly interconnected, it is possible for a single reaction failure (which may be precipitated by a gene deletion or mutation) to initiate a cascade that affects several other reactions in the system. This event could be likened to disturbing a small area of snow that may trigger a large avalanche or the failure of a single transmission line in an electric power grid that may cause a widespread blackout.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;By measuring the size of these "cascade" events in simulated metabolic networks, the Northwestern researchers were able to develop a quantitative measure of metabolic robustness: the more robust the network, the less the probability that small disturbances produce large cascades.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;They found that the likelihood of large failure cascades in a metabolic network is unusually small, compared to what they would expect from comparable, randomly structured networks.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In other words, these metabolic networks have evolved to be exceptionally robust, adopting organisational structures that help minimise the potentially harmful impacts of gene deletions and mutations. Ottino and his colleagues developed a mathematical model describing the cascading failure phenomenon as a percolation-like process.....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/09/05/21016/The_robustness_of_metabolic_networks/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Gene regulation makes the human&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;By Rachel EhrenbergWeb edition : Thursday, September 4th, 2008  &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Text Size A stretch of non-coding DNA revs up genes during development&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A human version of a stretch of DNA, when inserted into a mouse embryo, cranks up the activity of genes in the developing thumb (shown blue). But this activity was much lower with the chimp or rhesus macaque version of the same DNA sequence. The difference could point to the kinds of developmental changes that make us human.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Genes alone don’t make the man — after all, humans and chimps share roughly 98 percent of their DNA. But where, when and how much genes are turned on may be essential in setting people apart from other primates.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A stretch of human DNA inserted into mice embryos revs the activity of genes in the developing thumb, toe, forelimb and hind limb. But the chimp and rhesus macaque version of this same stretch of DNA spurs only faint activity in the developing limbs, reports a new study in the Sept. 5 Science. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research supports the notion that changes in the regulation of genes— rather than changes in the genes themselves — were crucial evolutionary steps in the human ability to use fire, invent wheels and ponder existential questions, like what distinguishes people from our primate cousins....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencenews.org/view/generic/id/36201/title/Gene_regulation_makes_the_human"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-7593305697255624342?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/7593305697255624342/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=7593305697255624342' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7593305697255624342'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7593305697255624342'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/09/weekly-bionews-1-8-sep-2008.html' title='Weekly BioNews 1 - 8 Sep 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-788896185589953721</id><published>2008-09-01T08:51:00.002+03:00</published><updated>2008-09-01T09:11:12.717+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Articles'/><title type='text'>Candidates weigh in on biomedicine</title><content type='html'>&lt;div align="justify"&gt;&lt;strong&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;img height="195" alt="Barack Obama" src="http://www.sciencenews.org/pictures/campaign/obama.jpg" width="195" /&gt;&lt;img height="195" alt="Barack Obama" src="http://www.sciencenews.org/pictures/campaign/mccain.jpg" width="195" /&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;By Janet Raloff&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;Web edition : Friday, August 29th, 2008 &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As people wait expectantly for answers from John McCain and Barack Obama to the Science Debate ’08 questions, some clues of what might be coming can be gleaned from the senators’ answers to a written questionnaire sent the candidates by Research! America. This group bills itself as the nation's largest not-for-profit public education and advocacy alliance. It should be noted, however, that the Alexandria, Va.-based group has a definite bias. It’s stated mission: “making research to improve health a higher national priority.” &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Earlier this week, I spoke with Stacie M. Propst, the organization’s vice president for science policy and outreach about McCain and Obama. “There are some commonalities between the candidates that come through loud and clear,” she said. “Both would shift to a health-care system that addresses and preempts disease.” Both also value research as the foundation of innovation, back stem-cell research (though McCain with caveats), want to reform the H-1B visa program to allow in more non-immigrant foreign workers with specialty skills (that include but are not limited to engineering, mathematics, physical sciences and medicine), and favor digitizing medical records to streamline costs and limit medical errors. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“We do a lot of opinion research,” Propst says, “and we started to see a trend emerge from the public — that although Americans say they would back a candidate who supports greater funding for research, they don’t actually know that much about the positions on this by their elected officials and candidates.” &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Obama sent in his responses to Research! America’s 17 questions late last year. McCain’s answers arrived much later — this summer. The group also has responses from Chuck O. Baldwin (the Constitution party candidate from Palmyra, N.Y.), Rep. Bob Barr (the Libertarian party candidate from Atlanta), Rep. Cynthia McKinney (the Green party candidate from Atlanta), and Ralph Nader (the Independent candidate from Washington, D.C.). &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;You can view the whole list of responses on the group’s website. Below, I’ve digested what seemed the salient elements of responses from Obama and McCain for people who are more generally interested in the research.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.sciencenews.org/view/generic/id/36048/title/Candidates_weigh_in_on_biomedicine"&gt;Research America’s Questions to Presidential Candidates&lt;/a&gt; (link to the questions)&lt;/div&gt;&lt;div align="center"&gt; &lt;/div&gt;&lt;div align="center"&gt; &lt;/div&gt;&lt;div align="center"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;The stem cell question...&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;em&gt;Do you support or oppose expanded federal funding for research using embryonic stem cells?&lt;/em&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;em&gt;&lt;/em&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;Obama:&lt;/strong&gt; Stem cells hold the promise of treatments and cures for more than 70 major diseases — conditions affecting more than 100 million Americans. “As president, I would: promote embryonic stem cell research" (as he did when he introduced legislation as a member of the Illinois Senate "that specifically permitted embryonic stem cell research in Illinois”). He would also expand the number of stem cell lines available for research. He cosponsored the current Stem Cell Research Enhancement Act. "My plan would reverse the president’s policy that has allowed hundreds of thousands of frozen embryos, left over from in vitro fertilization, to simply be discarded.” &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;McCain:&lt;/strong&gt; ““While I do support federal funding for embryonic stem cell research, I also believe that clear lines should be drawn to reflect a refusal to sacrifice moral values and ethical principles for the sake of scientific progress. Moreover, I believe that recent scientific breakthroughs raise the hope that one day this debate will be rendered academic. I also support funding for other research programs, including amniotic fluid and adult stem cell research which hold much scientific promise and do not involve the use of embryos. I strongly oppose the intentional creation of human embryos for research purposes. I voted to ban the practice of 'fetal farming,' making it a federal crime for researchers to use cells or fetal tissue from an embryo created for research purposes."&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt; &lt;/div&gt;&lt;div align="center"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="color:#000099;"&gt;&lt;strong&gt;Comment:&lt;/strong&gt; clearly Mr. Obama will turn a new leaf in the way that the U.S. federal government handles the issue of stem cell research. Hopefully, the medieval frame of mind of the Bush administration on this matter will be left behind. That would be great news for the global scientific community; undoubtedly the pharmaceutical multinational companies have to change their views and policies about many issues concerning biotechnology under the new probable Obama administration.&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-788896185589953721?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/788896185589953721/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=788896185589953721' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/788896185589953721'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/788896185589953721'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/09/candidates-weigh-in-on-biomedicine.html' title='Candidates weigh in on biomedicine'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-8485324127388712006</id><published>2008-09-01T08:42:00.002+03:00</published><updated>2008-09-01T08:51:31.487+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 25 Aug - 1 Sep 2008</title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Nano-sized 'trojan horse' to aid nutrition &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 25, 2008 12:18 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers from Monash University have designed a nano-sized "trojan horse" particle to ensure healing antioxidants can be better absorbed by the human body.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr Ken Ng and Dr Ian Larson from the University's Faculty of Pharmacy and Pharmaceutical Sciences have designed a nanoparticle, one thousandth the thickness of a human hair, that protects antioxidants from being destroyed in the gut and ensures a better chance of them being absorbed in the digestive tract. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Antioxidants are known to neutralise the harmful effect of free radicals and other reactive chemical species that are constantly generated by our body and are thought to promote better health. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Normally our body's own antioxidant defence is sufficient, but in high-risk individuals, such as those with a poor diet or those at risk of developing atherosclerosis, diabetes or Alzheimer's disease, a nutritional source of antioxidants is required. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr Larson said orally delivered antioxidants were easily destroyed by acids and enzymes in the human body, with only a small percentage of what is consumed actually being absorbed. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The solution is to design a tiny sponge-like chitosan biopolymeric nanoparticle as a protective vehicle for antioxidants. Chitosan is a natural substance found in crab shells. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Antioxidants sit within this tiny trojan horse, protecting it from attack from digestive juices in the stomach," Dr Larson said. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Once in the small intestine the nanoparticle gets sticky and bonds to the intestinal wall. It then leaks its contents directly into the intestinal cells, which allows them to be absorbed directly into the blood stream... "&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/25/nanosized_trojan_horse_to_aid_nutrition.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Study: DNA barcoding in danger of 'ringing up' wrong species&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 26, 2008 01:08 AM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;DNA barcoding is a movement to catalog all life on earth by a simple standardized genetic tag, similar to stores labeling products with unique barcodes. The effort promises foolproof food inspection, improved border security, and better defenses against disease-causing insects, among many other applications.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But the approach as currently practiced churns out some results as inaccurately as a supermarket checker scanning an apple and ringing it up as an orange, according to a new Brigham Young University study. It was funded by the National Science Foundation and published in the prestigious Proceedings of the National Academy of Sciences. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;With the International Barcode of Life project seeking $150 million to build on the 400,000 species that have been "barcoded" to date, this worthy goal warrants more careful execution, the BYU team says. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"To have that kind of data is hugely valuable, and the list of applications is endless and spans all of biology," said study co-author Keith Crandall, professor and chair of the Department of Biology at BYU. "But it all hinges on building an accurate database. Our study is a cautionary tale – if we're going to do it, let's do it right." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Proponents of DNA barcoding seek to establish a short genetic sequence as a way of identifying species in addition to traditional approaches based on external physical features. Their aim is to create a giant library full of these sequences. Scientists foresee a future handheld device like a supermarket scanner – a machine that would sequence a DNA marker from an organism, then compare it with the known encyclopedia of life and spit out the species' name... &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/26/study_dna_barcoding_in_danger_of_ringing_up_wrong_species.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Caltech scientists create DNA tubes with programmable sizes for nanoscale manufacturing&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 30, 2008 11:34 AM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists at the California Institute of Technology (Caltech) have developed a simple process for mass producing molecular tubes of identical--and precisely programmable--circumferences. The technological feat may allow the use of the molecular tubes in a number of nanotechnology applications. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The molecular tubes are composed of wound-up strands of DNA. DNA has been considered an ideal construction material for self-assembling molecular structures and devices because two complementary DNA strands can automatically recognize and bind with each other. DNA has been used to form rigid building blocks, known as tiles, and these tiles can further assemble into extended lattice structures, including tubes. However, it has been difficult to control the diameters of such tubes. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Peng Yin, a senior postdoctoral scholar in bioengineering and computer science at Caltech's Center for Biological Circuit Design, along with his colleagues has designed a series of flexible, single-stranded DNA molecules, called single-stranded DNA tiles. Each single-stranded tile is exactly 42 bases long and contains four modular binding sites. By pairing up the complementary binding sites, these single-stranded tiles bind with each other in a particular orientation like Lego pieces snapped together, forming a tube composed of parallel DNA helices. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The circumference of the resulting tube is determined by the number of different 42-base pieces used in its construction. For example, four pieces create a tube with a circumference of 12 billionths of a meter (or 12 nanometers); five pieces, a 15-nanometer-circumference tube; and six pieces, an 18-nanometer tube... &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/30/caltech_scientists_create_dna_tubes_with_programmable_sizes_for_nanoscale_manufacturing.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Engineers create bone that blends into tendons&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 30, 2008 11:34 AM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Engineers at Georgia Tech have used skin cells to create artificial bones that mimic the ability of natural bone to blend into other tissues such as tendons or ligaments. The artificial bones display a gradual change from bone to softer tissue rather than the sudden shift of previously developed artificial tissue, providing better integration with the body and allowing them to handle weight more successfully. The research appears in the August 26, 2008, edition of the Proceedings of the National Academy of Sciences.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"One of the biggest challenges in regenerative medicine is to have a graded continuous interface, because anatomically that's how the majority of tissues appear and there are studies that strongly suggest that the graded interface provides better integration and load transfer," said Andres Garcia, professor in the George W. Woodruff School of Mechanical Engineering at the Georgia Institute of Technology. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Garcia and former graduate student Jennifer Phillips, along with research technician Kellie Burns and their collaborators Joseph Le Doux and Robert Guldberg, were not only able to create artificial bone that melds into softer tissues, but were also able to implant the technology in vivo for several weeks. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;They created the tissue by coating a three-dimensional polymer scaffold with a gene delivery vehicle that encodes a transcription factor known as Runx2. They generated a high concentration of Runx2 at one end of the scaffold and decreased that amount until they ended up with no transcription factor on the other end, resulting in a precisely controlled spatial gradient of Runx2. After that, they seeded skin fibroblasts uniformly onto the scaffold. The skin cells on the parts of the scaffold containing a high concentration of Runx2 turned into bone, while the skin cells on the scaffold end with no Runx2 turned into soft tissue. The result is an artificial bone that gradually turns into soft tissue, such as tendons or ligaments...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/30/engineers_create_bone_that_blends_into_tendons.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;'Fingerprinting' Helps Make Great Grapes&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 30, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;At about this time next year, nearly all of the 2,800 wild, rare and domesticated grapes in a unique northern California genebank will have had their "genetic profile" or “fingerprint” taken. These fingerprints may help grape breeders pinpoint plants in the collection that have unusual traits--ones that might appeal to shoppers in tomorrow's supermarkets.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Other grapes might be ideal for scientists who are doing basic research.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;That’s according to Agricultural Research Service (ARS) plant geneticist Mallikarjuna Aradhya. He's heading the grape fingerprinting venture.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The grape collection that Aradhya is fingerprinting encompasses vineyards and screened enclosures, called “screenhouses." It is part of what’s officially known as the ARS National Clonal Germplasm Repository for Tree Fruit and Nut Crops and Grapes, in Davis, Calif.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;To glean a distinctive genetic fingerprint of each member of the collection, Aradhya uses pieces of genetic material--or DNA--known as microsatellite markers. Eight markers are all that are needed for a genetic fingerprint of more familiar grapes, like close relatives of those already used for making wine or raisins or for eating out-of-hand...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080830160454.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Treatment For Hearing Loss? Scientists Grow Hair Cells Involved in Hearing&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 30, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Oregon Health &amp;amp; Science University scientists have successfully produced functional auditory hair cells in the cochlea of the mouse inner ear. The breakthrough suggests that a new therapy may be developed in the future to successfully treat hearing loss. The results of this research was recently published by the journal Nature.  &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“One approach to restore auditory function is to replace defective cells with healthy new cells,” said John Brigande, Ph.D., an assistant professor of otolaryngology at the Oregon Hearing Research Center in the OHSU School of Medicine. “Our work shows that it is possible to produce functional auditory hair cells in the mammalian cochlea.”&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The researchers specifically focused on the tiny hair cells located in a portion of the ear’s cochlea called the organ of Corti. It has long been understood that as these hair cells die, hearing loss occurs. Throughout a person’s life, a certain number of these cells malfunction or die naturally leading to gradual hearing loss often witnessed in aging persons. Those who are exposed to loud noises for a prolonged period or suffer from certain diseases lose more sensory hair cells than average and therefore suffer from more pronounced hearing loss...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080830005613.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Life Under The Laser: Unique Technology Illuminates Microscopic Activity In Body's Chemical Messenger System&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 31, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at The University of Nottingham have developed a unique technology that will allow scientists to look at microscopic activity within the body’s chemical messenger system for the very first time, live as it happens.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The cutting edge laser technology has helped to attract £1.3 million from the MRC (Medical Research Council) for a five-year project that will offer a new insight into the tiny world of activity taking place within single cells and could contribute to the design of new drugs to treat human diseases such as asthma and arthritis with fewer side effects.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The team, involving scientists from the University’s Schools of Biomedical Science (Professor Steve Hill and Dr Steve Briddon) and Pharmacy (Dr Barrie Kellam), is concentrating on a type of specialised docking site (receptor) on the surface of a cell that recognises and responds to a natural chemical within the body called adenosine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;These A3-adenosine receptors work within the body by binding with proteins to cause a response within cells and are found in very tiny and highly specialised area of a cell membrane called microdomains. Microdomains contain a collection of different molecules that are involved in telling the cell how to respond to drugs or hormones...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080828120318.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;Diversity Among Parasitic Wasps Is Even Greater Than Suspected&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Sep. 1, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A tiny wasp that lays its eggs under the skin of unwitting caterpillars belongs to one of the most diverse groups of insects on Earth. Now researchers report that its diversity is even higher than previously thought.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;By combining ecological and genetic data with the painstaking detective work of taxonomy, the researchers have dramatically increased – nearly doubling – the estimated number of species reported of six very species-rich genera of parasitoid wasps.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The subfamily to which these wasps belong, Microgastrinae, gets its name from its tiny abdomen. The wasp itself is quite small, about the size of the lead at the tip of a pencil.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;By looking at the physical characteristics (morphology) of more than 2,500 wasps, the taxonomists identified 171 provisional species of microgastrine braconid wasps. But a comparative sequence analysis of a piece of a specific gene, a technique called DNA barcoding, found that there were actually 313 provisional species.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;All of the wasps were reared from caterpillars collected in Area de Conservación Guanacaste (ACG), a biological reserve in northwestern Costa Rica. A decades-long ecological inventory of the area conducted by University of Pennsylvania ecologists Daniel Janzen and Winnie Hallwachs revealed that the wasps are extraordinarily specific to the caterpillar hosts they attack...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080829114915.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;ATP-binding cassette transporter expression&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 27/08/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells. Transcripts for several different ABC-transporters, e.g. MDR-1 (P-gp) and MRPs, were detected in endothelial cells, obtained from brain, aortic artery, pulmonary artery, dermal microvessels and umbilical veins. The ABC-transporter mediated efflux mechanisms decreased intracellular concentrations of the anti-HIV drugs, saquinavir, an HIV protease inhibitor (HPI) and zidovudine, a nucleoside reverse transcriptase inhibitor (NRTI), which are critical components of highly active antiretroviral therapy (HAART) against HIV. Inhibition of ABC-transporters, by using verapamil or MK-571, was shown to increase the intracellular retention of these anti-HIV agents. The MRP transporters were found to play a more dominant role in drug-efflux from endothelial cells. Pre-incubation of cells with the MRP-inhibitor, MK-571 significantly enhanced the intracellular levels of anti-HIV drugs. This study, entitled 'MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells,' will be published in the September 2008 issue of Experimental Biology and Medicine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;These investigations led by Dr. Debasis Mondal, an assistant professor of Pharmacology, and co-authored by Mr. Mark Eilers and Dr. Upal Roy, demonstrated the significance of blocking MRP-transporters on endothelial barriers of blood vessels, in order to increase the pharmacokinetic efficacy of both HPIs and NRTIs. Drug-efflux pumps expressed on the blood-brain-barrier (BBB) were previously known to decrease drug entry into the central nervous system (CNS), however, this is the first evidence that endothelial cells from other organs express functional ABC-transporters, as well. The functional expression of MRPs on vascular endothelial barriers implicates their crucial role in facilitating the persistence of sub-endothelial HIV reservoirs....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/08/27/20969/ATP-binding_cassette_transporter_expression/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Flu protein suppresses immune system&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 26/08/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at Rutgers University and The University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight the much-feared bird flu and other virulent strains of influenza.The researchers have determined the three-dimensional structure of a site on an influenza A virus protein that binds to one of its human protein targets, thereby suppressing a person's natural defences to the infection and paving the way for the virus to replicate efficiently. This so-called NS1 virus protein is shared by all influenza A viruses isolated from humans - including avian influenza, or bird flu, and the 1918 pandemic influenza virus.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A paper detailing this breakthrough discovery appears in the PNAS (Proceedings of the National Academy of Sciences) Early Edition and will be published in an upcoming issue of the PNAS print edition.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;About 10 years ago, Professor Robert M. Krug at The University of Texas at Austin discovered that the NS1 protein binds a human protein known as CPSF30, which is important for protecting human cells from flu infection. Once bound to NS1, the human protein can no longer generate molecules needed to suppress flu virus replication. Now, researchers led by Rutgers Professor Gaetano T. Montelione and Krug identified the novel NS1 binding pocket that grasps the human CPSF30 protein.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Our work uncovers an Achilles heel of influenza A viruses that cause human epidemics and high mortality pandemics," said Montelione, professor of molecular biology and biochemistry. "We have identified the structure of a key target site for drugs that could be developed to effectively combat this disease."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;X-ray crystallography, which was carried out by Kalyan Das, Eddy Arnold, LiChung Ma and Montelione, identified the three-dimensional structure of the NS1 binding pocket. "The X-ray crystal structure gives us unique insights into how the NS1 and human protein bind at the atomic level, and how that suppresses a crucial antiviral response," said Das, research professor at Rutgers.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Rei-Lin Kuo, Jesper Marklund, Karen Twu and Krug at The University of Texas at Austin verified the key role of this binding pocket in flu replication by genetically engineering a change to a single amino acid in the NS1 protein's binding pocket, which in turn eliminated the protein's ability to grasp the human protein that is needed to generate antiviral molecules. These investigators then produced a flu virus with an NS1 pocket mutation and showed that this mutated virus does not block host defences, and as a consequence has a greatly reduced ability to infect human cells...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/08/26/20960/Flu_protein_suppresses_immune_system/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Leptin aids Type-1 diabetics&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 26/08/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center.Since the discovery of insulin in 1922, type 1 diabetes (insulin-dependent diabetes) in humans has been treated by injecting insulin to lower high blood sugar levels and prevent diabetic coma. New findings by UT Southwestern researchers, which appear online and in a future issue of the Proceedings of the National Academy of Sciences, suggest that insulin isn't the only agent that is effective. Leptin, a hormone produced by the body's fat cells, also lowers blood glucose levels and maintains them in a normal range for extended periods, they found.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The fact that these animals don't die and are restored to normal health despite a total lack of insulin is hard for many researchers and clinicians to believe," said Dr. Roger Unger, professor of internal medicine and senior author of the study. "Many scientists, including us, thought it would be a waste of time to give leptin in the absence of insulin. We've been brainwashed into thinking that insulin is the only substance that can correct the consequences of insulin deficiency."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The mechanism of leptin's glucose-lowering action appears to involve the suppression of glucagon, a hormone produced by the pancreas that raises glucose levels. Normally, glucagon is released when the glucose, or sugar, level in the blood is low. In insulin deficiency, however, glucagon levels are inappropriately high and cause the liver to release excessive amounts of glucose into the bloodstream. This action is opposed by insulin, which tells the body's cells to remove sugar from the bloodstream.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In type 1 diabetes, which affects about 1 million people in the U.S., the pancreatic islet cells that produce insulin are destroyed. Type 1 diabetics must take insulin multiple times a day to metabolise blood glucose and regiment their diets. In comparison, patients with non-insulin dependent, or type 2, diabetes make insulin, but their bodies don't respond well to it. Type 2 diabetes affects between 18 million and 20 million people in this country....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/08/26/20957/Leptin_aids_Type-1_diabetics/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-8485324127388712006?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/8485324127388712006/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=8485324127388712006' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8485324127388712006'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/8485324127388712006'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/09/weekly-bionews-25-aug-1-sep-2008.html' title='Weekly BioNews 25 Aug - 1 Sep 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-4822290301047958744</id><published>2008-08-25T09:38:00.002+03:00</published><updated>2008-08-25T09:46:09.786+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 18 - 25 Aug 2008</title><content type='html'>&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Synthetic moleculues could add spice to fight against cancer&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 20, 2008 08:13 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Turning up the heat on the red tomato during processing has the potential to give the popular garden staple added disease-fighting power, Ohio State University research suggests.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists have found that lycopene molecules in tomatoes that are combined with fat and subjected to intense heat during processing are restructured in a way that appears to ease their transport into the bloodstream and tissue. The tomato is the primary food source of lycopene, a naturally occurring pigment linked to the prevention of cancer and other chronic diseases. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In its standard structure in the average red tomato, the lycopene molecule is laid out in a linear configuration. That structure seems to hinder the molecule's absorption through intestinal walls and into the blood, said Steven Schwartz, an investigator in Ohio State's Comprehensive Cancer Center and a professor of food science and technology at Ohio State. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Meanwhile, most of the lycopene that is found circulating in human blood is configured in a bent molecular form. This means that either the human body somehow transforms lycopene molecules through reactions that have yet to be identified, or that the bent molecular structures of lycopene are much more likely to be absorbed into the blood and transported to tissue – a necessary step in preventing disease. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Assuming the latter is true, Schwartz and colleagues have devised a way to process red tomatoes – the variety preferred by American consumers – into a sauce that contains bent molecular forms of lycopene. A clinical trial conducted in collaboration with Steven Clinton, a medical oncologist and physician scientist in Ohio State's Comprehensive Cancer Center, showed that people had more lycopene in their blood after eating the specially processed sauce than they did after eating regular red tomato sauce... &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/20/synthetic_moleculues_could_add_spice_to_fight_against_cancer.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Malaria Researchers Identify New Mosquito Virus&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 22, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at the Johns Hopkins Bloomberg School of Public Health's Malaria Research Institute have identified a previously unknown virus that is infectious to Anopheles gambiae—the mosquito primarily responsible for transmitting malaria.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;According to the researchers, the discovered virus could one day be used to pass on new genetic information to An. gambiae mosquitoes as part of a strategy to control malaria, which kills over one million people worldwide each year.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The virus, AgDNV, is a densonucleosis virus or "densovirus," which are common to mosquitoes and other insects, but do not infect vertebrate animals such as humans. Although the virus does not appear to harm the mosquitoes, the researchers determined it is highly infectious to mosquito larvae and is easily passed on to the adults.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;According to Jason Rasgon, PhD, senior author of the study, the discovery came about serendipitously while the research team was conducting experiments to determine whether Wolbachia bacteria could be used to infect An. gambiae mosquito cells. During the analysis, Xiaoxia Ren, a postdoctoral fellow with Johns Hopkins Malaria Research Institute, noticed an "artifact," that appeared as a prominent band in the gel used to detect the bacteria...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="300" src="http://www.sciencedaily.com/images/2008/08/080821211551-large.jpg" width="400" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;PHOTO&lt;/strong&gt; Anopheles gambiae mosquito infected with GFP-expressing AgDNV. (Credit: Johns Hopkins Bloomberg School of Public Health)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080821211551.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- How Daughter Is Different From Mother ... In Yeast Cells&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 23, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The mother-daughter relationship can be difficult to understand. Why are the two so different? Now a Northwestern University study shows how this happens. In yeast cells, that is.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A research team has discovered a new mechanism for cell fate determination -- how one cell, the daughter, becomes dramatically different from the mother, even though they have the same genetic material. The study shows why mothers and daughters differ in how they express their genes.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;By studying yeast, whose entire genome is known, scientists can learn the basics of cell division and apply that knowledge to the human system. Many of the fundamental mechanisms for cell division in yeast are conserved, or very similar, in mammals; many of the proteins involved in human disease are related to proteins that are involved in yeast cell division.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The new knowledge about cell fate determination could lead to a better understanding of healthy human cells, what goes awry in cancer cells and how human stem cells and germ cells work.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Cancer may reflect a partial and aberrant loss of differentiated character, in which cells that were formerly specified to perform a specific task 'forget' that, and become more like the rapidly dividing stem cells from which they came," said Eric L. Weiss, assistant professor of biochemistry, molecular biology and cell biology in Northwestern's Weinberg College of Arts and Sciences. Weiss led the research team, which included scientists from the Massachusetts Institute of Technology...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="442" src="http://www.sciencedaily.com/images/2008/08/080818220607-large.jpg" width="442" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;PHOTO&lt;/strong&gt; Yeast cells. (Credit: Image courtesy of Wikimedia Commons)&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080818220607.htm"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Exploding Chromosomes Fuel Research About Evolution Of Genetic Storage&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 24, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Human cells somehow squeeze two meters of double-stranded DNA into the space of a typical chromosome, a package 10,000 times smaller than the volume of genetic material it contains.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It is like compacting your entire wardrobe into a shoebox," said Riccardo Levi-Setti, Professor Emeritus in Physics at the University of Chicago.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Now research into single-celled, aquatic algae called dinoflagellates is showing that these and related organisms may have evolved more than one way to achieve this feat of genetic packing. Even so, the evolution of chromosomes in dinoflagellates, humans and other mammals seem to share a common biochemical basis, according to a team Levi-Setti led. The team's findings appear online, in Science Direct's list of papers in press in the European Journal of Cell Biology.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Packing the whole length of DNA into tiny chromosomes is problematic because DNA carries a negative charge that, unless neutralized, prevents any attempt at folding and coiling due to electrostatic repulsion. The larger the quantity of DNA, the more negative charge must be neutralized along its length....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="209" alt="" src="http://www.sciencedaily.com/images/2008/08/080821164306.jpg" width="300" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;PHOTO&lt;/strong&gt; This false-color image of the distribution of calcium in the chromosomes of a deer was obtained using secondary ion mass spectrometry with the University of Chicago's high-resolution scanning ion microprobe.The same technique applied to single-celled organisms called dinoflagellates are providing new insights into the evolution of chromosomes. (Credit: Courtesy of Riccardo Levi-Setti)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080821164306.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Tiny Cellular Antennae Trigger Neural Stem Cells&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 25, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Yale University scientists today reported evidence suggesting that the tiny cilia found on brain cells of mammals, thought to be vestiges of a primeval past, actually play a critical role in relaying molecular signals that spur creation of neurons in an area of the brain involved in mood, learning and memory.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The cilia found on brain cells of mammals until recently had been viewed as a mysterious remnant of a distant evolutionary past, when the tiny hair-like structures were used by single-celled organisms to navigate a primordial world.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“Many neuroscientists are shocked to learn that cells in the brain have cilia. Thus it was even more exciting to show that cilia have a key function in regulating the birth of new neurons in the brain,” said Matthew Sarkisian, post doctoral fellow in the department of neurobiology and co-first author on the study.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the past decade, scientists have discovered primary cilia may have important functions in many animals. For instance, in 2000, Yale University scientists discovered defects in these cilia could lead to rare type of kidney disease. Researchers have been finding new functions for primary cilia ever since...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080822220056.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Questioning sustainable biofuels&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 20/08/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;With oil prices skyrocketing, the search is on for efficient and sustainable biofuels. Research published this month in Agronomy Journal examines one biofuel crop contender: corn stover.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Corn stover is made up of the leaves and stalks of corn plants that are left in the field after harvesting the edible corn grain. Corn stover could supply as much as 25% of the biofuel crop needed by 2030.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists with the USDA-ARS Agroecosystem Unit located at the University of Nebraska examined the long-term sustainability of using corn stover as a biofuel crop.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;When corn stover is not harvested as a biofuel crop, it can be left on the fields to restore vital nutrients to the soil. Full-scale harvesting of corn stover may deplete the soil.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers measured the soil organic carbon levels and residue production over 14 years in fields planted continuously with corn, continuously with soybeans, and with a rotation of corn and soybeans. Organic carbon rates were found to stay steady or even increase in all three field types...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/08/20/20931/Questioning_sustainable_biofuels/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Testing for West Nile virus&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 20/08/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A new test for West Nile virus in horses that could be modified for use on humans and wildlife may help track the spread of the disease, according to an article in the September issue of the Journal of Medical Microbiology.West Nile virus infects a wide range of animals, including humans, horses, dogs, cats, bats, squirrels, rabbits and birds. It is widely distributed in Africa, the Middle East and Europe. It was first reported in North America in 1999, when there were human fatalities in New York City. Since its arrival in the USA it has spread rapidly across the continent. The virus sometimes causes swelling of the brain, or encephalitis, which can be fatal. It is transmitted by several species of mosquito. Because the mosquitoes feed on so many different creatures the virus spreads quickly in areas where it has been introduced.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Thousands of cases of West Nile virus have been reported worldwide, but 80% of infected people don't show any symptoms," said Dr Louis A Magnarelli, Director of The Connecticut Agricultural Experiment Station in the USA. "It is important to have highly sensitive and specific tests to diagnose infections and also to help track the ecology and epidemiology of West Nile encephalitis."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The US researchers have found that a new test designed to detect antibodies produced by horses is highly effective at diagnosing West Nile virus infections. Compared to the standard test for West Nile virus, the new test is much faster and gives accurate results. It was also useful in confirming past infections...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/08/20/20933/Testing_for_West_Nile_virus/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-4822290301047958744?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/4822290301047958744/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=4822290301047958744' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/4822290301047958744'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/4822290301047958744'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/08/weekly-bionews-18-25-aug-2008.html' title='Weekly BioNews 18 - 25 Aug 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-734875703607159263</id><published>2008-08-20T17:58:00.002+03:00</published><updated>2008-08-20T18:02:17.877+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 12 - 18 Aug 2008</title><content type='html'>&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Caltech engineers build mini drug-producing biofactories in yeast &lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 16, 2008 08:58 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at the California Institute of Technology have developed a novel way to churn out large quantities of drugs, including antiplaque toothpaste additives, antibiotics, nicotine, and even morphine, using mini biofactories--in yeast.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A paper describing the research, now available online, will be featured as the cover article of the September issue of Nature Chemical Biology. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Christina D. Smolke, an assistant professor of chemical engineering at Caltech, along with graduate student Kristy Hawkins, genetically modified common baker's yeast (Saccharomyces cerevisiae) so that it contained the genes for several plant enzymes. The enzymes allow the yeast to produce a chemical called reticuline, which is a precursor for many different classes of benzylisoquinoline alkaloid (BIA) molecules. The BIA molecules are a large group of chemically intricate compounds, such as morphine, nicotine, and codeine, which are naturally produced by plants. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;BIA molecules exhibit a wide variety of pharmacological activities, including antispasmodic effects, pain relief, and hair growth acceleration. Other BIAs have shown anticancer, antioxidant, antimalarial, and anti-HIV potential. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"There are estimated to be thousands of members in the BIA family, and having a source for obtaining large quantities of specific BIA molecules is critical to gaining access to the diverse functional activities provided by these molecules," says Smolke, whose lab focuses on using biology as a technology for the synthesis of new chemicals, materials, and products. However, the natural plant sources of BIAs accumulate only a small number of the molecules, usually "end products" like morphine and codeine that, while valuable, can't be turned into other compounds, thus limiting the availability of useful new products... &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/16/caltech_engineers_build_mini_drugproducing_biofactories_in_yeast.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/16/caltech_engineers_build_mini_drugproducing_biofactories_in_yeast.html"&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- MSU to create genomic clearinghouse for biofuel crops&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 16, 2008 08:58 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Michigan State University scientists, armed with a half-million-dollar federal grant, are creating an easily accessible, Web-based genomic database of information on crops that can be used to make ethanol.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Ultimately this will allow us to create better biofuel crops," said C. Robin Buell, associate professor of plant biology and project leader. "Right now, about half of the biofuel crops don't have genomic databases, and the ones that do are in many different places and are annotated differently, which makes it difficult to compare and use the information." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Genomic databases contain information on the molecular biology and genetics of a particular species. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Buell and Kevin Childs, a postdoctoral researcher in her lab, will use the $540,000 joint grant from the departments of Agriculture and Energy to centralize the genomic databases, create uniform annotations (notes or descriptions of the genomes), provide data-mining and search tools, and provide a Web site for scientists from around the world to access the databases. They also will regularly update the information...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/16/msu_to_create_genomic_clearinghouse_for_biofuel_crops.html"&gt;Full Article&lt;br /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/16/msu_to_create_genomic_clearinghouse_for_biofuel_crops.html"&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Mount Sinai researchers discover technology that silences genes&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 18, 2008 12:10 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Mount Sinai researchers have developed a new gene silencing technology that could be used to target genes that can lead to the development of certain diseases. This technology could pave the way for preventing diseases where gene dysfunction plays a role. The groundbreaking research was led by Ming-Ming Zhou, Ph.D., Professor and Chairman of the Department of Structural and Chemical Biology at Mount Sinai School of Medicine. The findings, which will be published in the September issue of Nature Cell Biology, are available on the magazine's web site as of today. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"By being able to silence certain genes, we may be able to suppress genes that can cause diseases such as HIV/AIDS, cancer, inflammation and diseases of the central and peripheral nervous systems. We now know we can focus on these genes and potentially change the ultimate course of many diseases that have a major impact on people's lives," says Dr. Zhou... &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/18/mount_sinai_researchers_discover_technology_that_silences_genes.html"&gt;Full Article&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/18/mount_sinai_researchers_discover_technology_that_silences_genes.html"&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Maelstrom Quashes Jumping Genes&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 18, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists have known for decades that certain genes (called transposons) can jump around the genome in an individual cell. This activity can be dangerous, however, especially when it arises in cells that produce eggs and sperm. Such changes can threaten the offspring and the success of a species. To ensure the integrity of these cells, nature developed a mechanism to quash this genetic scrambling, but how it works has remained a mystery. Now a team of scientists, including researchers at the Carnegie Institution's Department of Embryology, has identified a key protein that suppresses jumping genes in mouse sperm and found that the protein is vital to sperm formation.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"There is a tiny cell component that is unique to germ cells—the precursors to egg and sperm—called nuage, which means 'cloud' in French. Other researchers recently suspected that nuage was involved in keeping genes from jumping around in germ cells of the female fruit fly," explained Carnegie's Alex Bortvin, a senior author of the study. "But until this mouse study, no one knew for sure if it was involved in mammalian germ cells. To test if the mouse nuage played a similar role in mammals, we focused on a mouse protein called Maelstrom whose distant relative protein in the fruit fly was implicated in the other study."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In this research, published in the August 12th issue of Developmental Cell, the scientists first looked at where the protein Maelstrom resides during the formation of sperm. By marking the protein with a fluorescent antibody, they found that it was predominantly located in the cytoplasm, near the nucleus of the germ cell, at the nuage. To understand what Maelstrom does during the formation of sperm, the scientists created mutant mice that did not have the gene to produce the Maelstrom protein...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080811195301.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-734875703607159263?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/734875703607159263/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=734875703607159263' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/734875703607159263'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/734875703607159263'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/08/weekly-bionews-12-18-aug-2008.html' title='Weekly BioNews 12 - 18 Aug 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-7418573275623830585</id><published>2008-08-11T17:56:00.002+03:00</published><updated>2008-08-11T18:03:21.374+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 21 Jul - 12 Aug 2008</title><content type='html'>&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Class of antibiotics can enhance gene-silencing tool&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;July 23, 2008 02:12 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A way to turn off one gene at a time has earned acceptance in biology laboratories over the last decade. Doctors envision the technique, called RNA interference, as a tool to treat a variety of diseases if it can be adapted to humans.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Emory University researchers have discovered that antibiotics known as fluoroquinolones can make RNA interference more effective in the laboratory and reduce potential side effects. The results will be published online this week in the journal Nature Biotechnology. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The surprising aspect is that some fluoroquinolones have this previously unrecognized property," says senior author Peng Jin, PhD, assistant professor of human genetics at Emory University School of Medicine. "The good part is that doctors have years of experience treating bacterial infections with them, so they are generally considered safe." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The most powerful enhancer of RNA interference was enoxacin, which has been used to treat gonorrhea and urinary tract infections. The group of compounds also includes the widely used antibiotic ciprofloxacin. The antibiotics' effect on RNA interference appears to be chemically separate from their bacteria-killing activities. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Significant barriers still prevent RNA interference from working well in people, Jin says.&lt;br /&gt;"The barriers include specificity and toxicity, as well as getting the RNA to the right place in the body," he says. "If we can enhance how potent a given amount of RNA is and reduce dosage, we're tackling both specificity and toxicity." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Some studies have found that side effects come from the amount of RNA injected, which can trigger an anti-viral response, rather than from the genetic sequence of the RNA used...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/07/23/class_of_antibiotics_can_enhance_genesilencing_tool.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.biologynews.net/archives/2008/07/23/class_of_antibiotics_can_enhance_genesilencing_tool.html"&gt;&lt;/a&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Cellular Symmetry: What Cues Tell A Cell To Divide At The Center&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 4, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cells are intrinsically artistic. When the right signals tell a cell to divide, it usually splits down the middle, resulting in two identical daughter cells. (Stem cells are the exception to the rule.) This natural symmetry is visible on the macroscopic scale as well. All living creatures, be they mushrooms or humans, are visibly symmetric, a product of our cells’ preference for equilibrium.&lt;br /&gt;Scientists at the MBL’s Whitman Center for Visiting Research are curious to know what cues tell a cell to divide at the center. Fred Chang, professor of microbiology at Columbia University, his postdoctoral student Nicolas Minc, and David Burgess, professor of biology at Boston College, are placing sea urchin eggs in snug, microscopic chambers shaped like triangles, squares, rectangles, stars, and ice cream cones to see whether the cell will still split 50-50...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080728221402.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www./"&gt;&lt;/a&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Australian Bird Research Could Rewrite 'Ring Theory' Of Speciation&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 4, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;New research has uncovered how different populations of the bird crimson rosella are related to each other – a discovery which has important implications for research into how climate change may affect Australia’s biodiversity.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Published in the journal Proceedings of the Royal Society B, the research investigates the genetic and geographical relationships between different forms of crimson rosellas and the possible ways that these forms may have arisen. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr. Gaynor Dolman of CSIRO’s Australian National Wildlife Collection says there are three main colour ‘forms’ of the crimson rosella – crimson, yellow and orange – which originated from the same ancestral population and are now distributed throughout south eastern Australia.&lt;br /&gt;“Many evolutionary biologists have argued that the different forms of crimson rosellas arose, or speciated, through ‘ring speciation’,” she says...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080731140317.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;p&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080731140317.htm"&gt;&lt;/a&gt; &lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- New Role Found For A 'Foxy Old Gene'&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 5, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at the University of Pennsylvania School of Medicine have discovered that a protein called FOXA2 controls genes that maintain the proper level of bile in the liver. FOXA2 may become the focus for new therapies to treat diseases that involve the regulation of bile salts. The study was published online this week in Nature Medicine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Bile, although made in the liver, is stored in the gall bladder and transported through ducts to the small intestine where it helps to digest fats from food. Bile salts, chemicals in bile that help digest fats and also keep cholesterol dissolved in the bile, are reabsorbed from the intestine and returned to the liver where they are broken up. The liver maintains a balance of bile salts by degrading old bile salts and synthesizing new ones. Problems arise when too many bile salts accumulate in the liver.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Diseases of bile regulation, such as primary sclerosing cholangitis (PSC), are characterized by problems with bile transport from the liver to the gut. The researchers found that in both children with biliary atresia and adults with PSC, syndromes of different etiologies, expression of FOXA2 in the liver is severely reduced. FOXA2 regulates expression of transporter proteins responsible for moving bile out of the liver, as well as several enzymes that function in bile acid detoxification. The study suggests that strategies to maintain FOXA2 expression might be a novel therapeutic goal...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080801152143.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080801152143.htm"&gt;&lt;/a&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Research Exposes New Target For Malaria Drugs&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Aug. 5, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Malaria parasites (plasmodia) are transmitted to people via infected mosquitoes. Once inside their human hosts the parasites first set up shop in liver cells, then move into red blood cells (RBCs) to replicate and wait for the next mosquito to help continue the cycle.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;After plasmodia infect a blood cell, they send out clusters of sticky proteins to the cell surface, enabling them to attach to blood vessels and escape destruction by the host's spleen while they replicate. This tactic can be especially problematic during pregnancy as malaria-infected RBCs congregate in the vessel-rich placenta (the source of food and oxygen for the growing fetus), creating health problems such as anemia, low birth-weight, fever and more.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Targeting these sticky proteins with drugs is difficult, however, as plasmodia contain many different varieties, which they use to evade the human immune system. However, certain parts of the protein have to remain constant for proper function, and in this study, Matthew Higgins generated high-resolution 3-D structures of a malarial sticky protein that binds to placenta, PfEMP1, to detail how plasmodia protect these conserved areas.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080804155125.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/08/080804155125.htm"&gt;&lt;/a&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Key to virulence protein discovered&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 05/08/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have identified the region of a large family of virulence proteins in oomycete plant pathogens that enables the proteins to enter the cells of their hosts. The protein region contains the amino acid sequence motifs RXLR and dEER and has the ability to carry the virulence proteins across the membrane surrounding plant cells without any additional machinery from the pathogen. Once inside the plant cell, the proteins suppress the immune system of the plant allowing the infection to progress. The work, which focused on the virulence protein Avr1b from the soybean plant pathogen Phytophthora sojae, is published in the advance online edition of The Plant Cell.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Oomycetes are fungal-like organisms related to marine algae that cause tens of billions of dollars of losses to agriculture, forestry and natural ecosystems every year. The oomycete Phytophthora infestans caused the Irish potato famine in the nineteenth century. Another Phytophthora species, P. ramorum, is causing Sudden Oak Death disease in California's coastal forests. P. sojae results in $200-300 million in annual losses for commercial soybean farmers in the United States and estimated annual soybean losses of $1-2 billion worldwide. All of these oomycete species contain hundreds of genes that encode for virulence proteins that have the RXLR-dEER region.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The virulence proteins, including Avr1b, enter the soybean host where they are capable of suppressing an important process in plant immunity called programmed cell death. Programmed cell death is an in-built suicide mechanism that kills infected plant tissue, filling it with toxins so the pathogen can no longer feed on it. By preventing this protective mechanism in the host, the virulence proteins ensure that the pathogen can establish an unassailable foothold in the plant tissue from which the pathogen can pursue its destructive path.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Postdoctoral fellow Dr. Daolong Dou, the lead author of the article, commented: "We have suspected for a long time that these virulence proteins had some way of slipping inside plant cells to suppress immunity. Our findings finally nail down that mechanism and enable us to focus on how to block the entry mechanism."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The researchers also demonstrated that the RXLR and dEER motifs could be replaced by similar targeting sequences found in effector proteins produced by the malarial parasite Plasmodium. This hints that the targets of the effectors in the soybean and human hosts may be very ancient...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/08/05/20839/Key_to_virulence_protein_discovered/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/08/05/20839/Key_to_virulence_protein_discovered/"&gt;&lt;/a&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Evolution Canyon reveals bacterial adaptation&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 28/07/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Bacteria living on opposite sides of a canyon have evolved to cope with different temperatures by altering the make-up of their 'skin', or cell membranes. Scientists have found that bacteria change these complex and important structures to adapt to different temperatures by looking at the appearance of the bacteria as well as their genes. The researchers hope their study, published in the August issue of Microbiology, will start a new trend in research.'Evolution Canyons' I and II are in Israel. They are similar, each with a hot south-facing slope and a cooler north-facing slope. The sun-exposed 'African' south-facing slopes get eight times more solar radiation than the shady, green, lush 'European' north-facing slopes. Scientists studied 131 strains of Bacillus simplex and found that bacteria on different slopes have evolved differently, forming different 'ecotypes' of the same species.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We expected that 'ecotype' formation was linked to temperature but we had no initial clue of which specific cell attributes could have led to the adaptation," said Dr Johannes Sikorski from DSMZ in Germany. "To find out, we definitely had to study the appearance of the bacteria, not only their genes."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The cell membrane is one of the most important and complex parts of a cell. Membranes contain different fatty acid molecules; the branching type can change depending on temperature to keep the cell alive. The researchers found significant differences in the fatty acids of several ecotypes that live on different slopes in Evolution Canyon.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Bacteria respond to temperature by altering their fatty acid composition in a constitutive, long-term fashion," said Dr Sikorski. We found that 'African' ecotypes from the hot slopes had more heat-tolerant fatty acids and 'European' ecotypes from the cool slopes had more cold-tolerant fatty acids in their membranes."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In most modern evolutionary studies, scientists rely on genetic data alone. Dr Sikorski and his colleagues focused on the result of the genetic changes instead: what the bacteria look like. "It is not a 'sexy' technique like genomics or proteomics but it gives a more comprehensive insight into the result of adaptation of the cell membrane," said Dr Sikorski...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/07/28/20796/Evolution_Canyon_reveals_bacterial_adaptation/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/07/28/20796/Evolution_Canyon_reveals_bacterial_adaptation/"&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Disarming a possible biological weapon&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 28/07/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently we knew very little about this bacterium. However, according to the August issue of the Journal of Medical Microbiology, research on the bacterium has been reinvigorated and rapid progress has been made in understanding how it causes disease.Infection with F. tularensis can result in a variety of symptoms, depending on the route of infection. For example, infection via an insect bite can lead to a swollen ulcer or fever, chills, malaise, headaches and a sore throat. When infection occurs by eating contaminated food, symptoms can range from mild diarrhoea to an acute fatal disease. If inhaled, F. tularensis infections can have a 30% mortality rate if left untreated.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Only very few bacteria are needed to cause serious disease," said Prof Petra Oyston from Dstl, Porton Down. "Because of this and the fact that tularemia can be contracted by inhalation, Francisella tularensis has been designated a potential biological weapon. Since the events of September 2001 and the subsequent anthrax attacks on the USA, concern about the potential misuse of dangerous pathogens including F. tularensis has increased. As a result, more funding has been made available for research on these organisms and has accelerated progress on developing medical countermeasures."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Tularemia circulates in rodents and animals like rabbits and hares. Outbreaks in humans often happen at the same time as outbreaks in these animals. The disease is probably transmitted by insects like mosquitoes, ticks and deer flies. People can also become infected by contact with contaminated food or water and by breathing in particles containing the bacteria. Farmers, hunters, walkers and forest workers are most at risk of contracting tularemia.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;There is currently no vaccine against tularemia. Because there are few natural cases of tularemia, money was not spent on the development of a vaccine. However, various nations developed F. tularensis as a biological weapon, including the reported production of antibiotic-resistant strains, so research into its pathogenesis has become a biodefence issue...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/07/28/20795/Disarming_a_possible_biological_weapon/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/07/28/20795/Disarming_a_possible_biological_weapon/"&gt;&lt;/a&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Fuel from cellulose&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;August 10, 2008 07:09 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Independence from fossil fuel exporting nations, a reduction in the release of greenhouse gases, conservation of dwindling resources: there are any number of reasons to stop the use of fossil fuels. Hydrogen technology and solar energy will very probably provide the solution to our global energy problem—in the long term. For an initial quick remedy we may look to bioenergy. Biomass can be used to generate alternative carbon-based liquid fuels, allowing the continued use of current automotive combustion engine technology and existing infrastructure. At the same time, the chemical industry would continue to be supplied with the carbon compounds it requires as raw materials for plastics, textiles, etc. Mark Mascal and Edward B. Nikitin at the University of California, Davis (USA) have now developed an interesting new method for the direct conversion of cellulose into furan-based biofuels. As they report in the journal Angewandte Chemie, their simple, inexpensive process delivers furanic compounds in yields never achieved before. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Atmospheric carbon dioxide is viewed as the ultimate carbon source of the future. It is most efficiently "harvested" by plants via photosynthesis. Currently, biofuel producers primarily use starch, which is broken down to form sugars that are then fermented to give ethanol. Cellulose is however the most common form of photosynthetically fixed carbon. The problem is that the degradation of cellulose into its individual sugar components, which could then be fermented, is a slow and expensive process. "Another problem is that the carbon economy of glucose fermentation is poor," explains Mascal, "for every 10 g of ethanol produced, you also release 9.6 g CO2." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Could we avoid the breakdown of cellulose and fermentation? Mascal and Nikitin demonstrate that we can indeed. They have developed a simple process for the conversion of cellulose directly into "furanics", which are furan-based organic liquids. Furans are molecules whose basic unit is an aromatic ring made of one oxygen and four carbon atoms. The main product the researchers obtain under the conditions they have been developing is 5-chloromethylfurfural (CMF). &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.biologynews.net/archives/2008/08/10/fuel_from_cellulose.html"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-7418573275623830585?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/7418573275623830585/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=7418573275623830585' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7418573275623830585'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7418573275623830585'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/08/weekly-bionews-21-jul-12-aug-2008.html' title='Weekly BioNews 21 Jul - 12 Aug 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-7028902420486861218</id><published>2008-07-21T19:07:00.002+03:00</published><updated>2008-07-21T19:12:10.100+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 14 - 21 Jul 2008</title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Fuel from food waste: bacteria provide power&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;July 19, 2008 10:50 AM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers have combined the efforts of two kinds of bacteria to produce hydrogen in a bioreactor, with the product from one providing food for the other. According to an article in the August issue of Microbiology Today, this technology has an added bonus: leftover enzymes can be used to scavenge precious metals from spent automotive catalysts to help make fuel cells that convert hydrogen into energy.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Hydrogen has three times more potential energy by weight than petrol, making it the highest energy-content fuel available. Research into using bacteria to produce hydrogen has been revived thanks to the rising profile of energy issues. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;We throw away a third of our food in the UK, wasting 7 million tonnes a year. The majority of this is currently sent to landfill where it produces gases like methane, which is a greenhouse gas 25 more potent than carbon dioxide. Following some major advances in the technology used to make "biohydrogen", this waste can now be turned into valuable energy. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"There are special and yet prevalent circumstances under which micro-organisms have no better way of gaining energy than to release hydrogen into their environment," said Dr Mark Redwood from the University of Birmingham. "Microbes such as heterotrophs, cyanobacteria, microalgae and purple bacteria all produce biohydrogen in different ways." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;When there is no oxygen, fermentative bacteria use carbohydrates like sugar to produce hydrogen and acids. Others, like purple bacteria, use light to produce energy (photosynthesis) and make hydrogen to help them break down molecules such as acids. These two reactions fit together as the purple bacteria can use the acids produced by the fermentation bacteria. Professor Lynne Macaskie's Unit of Functional Bionanomaterials at the University of Birmingham has created two bioreactors that provide the ideal conditions for these two types of bacteria to produce hydrogen. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"By working together the two types of bacteria can produce much more hydrogen than either could alone," said Dr Mark Redwood. "A significant challenge for the development of this process to a productive scale is to design a kind of photobioreactor that is cheap to construct and able to harvest light from a large area. A second issue is connecting the process with a reliable supply of sugary feedstock." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;With a more advanced pre-treatment, biohydrogen can even be produced from the waste from food-crop cultivation, such as corn stalks and husks. Tens of millions of tonnes of this waste is produced every year in the UK. Diverting it from landfill into biohydrogen production addresses both climate change and energy security....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/07/19/fuel_from_food_waste_bacteria_provide_power.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Genetics of White Horses Unraveled&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (July 20, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The white horse is an icon for dignity which has had a huge impact on human culture across the world. An international team led by researchers at Uppsala University has now identified the mutation causing this spectacular trait and show that white horses carry an identical mutation that can be traced back to a common ancestor that lived thousands of years ago.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The study is interesting for medical research since this mutation also enhance the risk for melanoma.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The great majority of white horses carry the dominant mutation Greying with age. A Grey horse is born coloured (black, brown or chestnut) but the greying process starts already during its first year and they are normally completely white by six to eight years of age but the skin remains pigmented. Thus, the process resembles greying in humans but the process is ultrafast in these horses. The research presented now demonstrates that all Grey horses carry exactly the same mutation which must have been inherited from a common ancestor that lived thousands of years ago.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;"It is a fascinating thought that once upon a time a horse was born that turned grey and subsequently white and the people that observed it were so fascinated by its spectacular appearance that they used the horse for breeding so that the mutation could be transmitted from generation to generation," says Leif Andersson who led the study. Today about one horse in ten carries the mutation for Greying with age.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It is obvious that humans across the world have greatly valued these white horses as documented by the rich collection of stories and paintings featuring white horses. In the paper the white horse as an icon for dignity is illustrated by reproducing a painting from the late 17th century of the Swedish king Karl XI on his white horse Brilliant.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The Grey horse is also very interesting from a medical point of view since the mutation also predisposes for development of melanoma. About 75% of Grey horses older than 15 years of age have a benign form of melanoma that in some cases develops into a malignant melanoma. Thus, the study reported today has also given new insight in a molecular pathway that may lead to tumour development....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080720150203.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- New-generation Of Simpler Sensors For Detecting Disease-causing Microbes And Toxins&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (July 21, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists in Singapore are reporting development of a complete, palm-sized sensor that can detect disease-causing microbes, toxins, and other biological threats instantly without the need for an external power source or a computer.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The long-awaited device, ideal for remote medical clinics, battlefields, and other sites, represents the next-generation of faster, simpler biosensors, according to a new study.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the new study, Pavel Neuzil and Julien Reboud explain that the new device uses an existing method for detecting DNA, proteins or cells based on their interaction with light shown on the nanostructured surface when these materials come into contact with it. Most existing biosensors of this type require the use of an external power source, a complex and costly analyzer and rely on an external personal computer to report the results....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080721093845.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Snow Flea Antifreeze Protein' Could Help Improve Organ Preservation&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (July 21, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists in Illinois and Pennsylvania are reporting development of a way to make the antifreeze protein that enables billions of Canadian snow fleas to survive frigid winter temperatures. Their laboratory-produced first-of-a-kind proteins could have practical uses in extending the storage life of donor organs and tissues for human transplantation, according to new research.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the study, Stephen B. H. Kent and colleagues point out that scientists have tried for years to decipher the molecular structure and produce from chemicals in a laboratory the so-called "snow flea antifreeze protein (sfAFP)." Those steps are critical for obtaining larger amounts of the protein, which exists naturally in only minute quantities in snow fleas. The larger synthetic quantities can be used for further research and potential medical and commercial uses, they say.&lt;br /&gt;The researchers made synthetic sfAFP, and showed that it has the same activity as the natural protein. They also produced variants, including one form of sfAFP with a molecular architecture that is the reverse, or "mirror image," of natural sfAFP and different from any other protein found in living things on Earth.... &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080721093707.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Mouse protein linked to human disease&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Date: 21/07/2008&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;The study of dark-skinned mice has led to a surprising finding about a common protein involved in tumour suppression, report researchers at the Stanford University School of Medicine. The results may lead to new treatments for bone marrow failure in humans.The protein, called p53, has been dubbed the "guardian of the genome" for its ability to recognise DNA damage and halt the division of potentially cancerous cells. However, in a new twist, it appears that p53 also responds to disruptions in the cell's protein factories, leading to changes in skin colour and causing anaemia in mice.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This may be just the tip of an iceberg," said Gregory Barsh, MD, PhD, professor of genetics and of pediatrics. "When we think of p53, we think in extremes: high levels cause cell death, low levels cause cancer. This research shows that even moderate changes can have very important consequences. It also suggests that the activation of p53 may be involved in more pathways than we previously anticipated."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Barsh is the senior author of the study, which will be published on-line in Nature Genetics on July 20. Kelly McGowan, MD, PhD, a dermatologist and postdoctoral scholar in Barsh's laboratory, is the first author.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The researchers studied mutations that darken the feet, tails and ears of normally light-skinned mice. Alterations in pigmentation are not only easy to identify, but also often involve a variety of biologically important pathways that control more than just hair or skin colour.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;McGowan homed in on two skin-darkening mutations, which she found affected specific protein components of the cell's ribosomes. Ribosomes act as cellular protein factories, translating the instructions encoded by RNA molecules into new proteins to do the cell's work.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The discovery was interesting because mutations affecting one of the same ribosomal proteins in humans are associated with Diamond-Blackfan syndrome, a condition that causes a type of anaemia specific to red blood cells. When the scientists examined the dark-skinned mice more closely, they found that these mice exhibited similar abnormalities in red blood cell formation.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Diamond-Blackfan itself is fairly rare," said McGowan, "but the bone marrow failure that sometimes occurs in these individuals happens quite often in many other disorders, including acute myelogenous leukemia and multiple myeloma."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;People with bone marrow failure are unable to produce enough red blood cells, white blood cells and/or platelets. They are susceptible to uncontrolled bleeding, infection and fatigue. Understanding the disorder in mice may help scientists and physicians develop new treatment for other, similar conditions.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/07/21/20772/Mouse_protein_linked_to_human_disease/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-7028902420486861218?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/7028902420486861218/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=7028902420486861218' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7028902420486861218'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7028902420486861218'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/07/weekly-bionews-14-21-jul-2008.html' title='Weekly BioNews 14 - 21 Jul 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-9195067432533760854</id><published>2008-07-19T10:39:00.002+03:00</published><updated>2008-07-19T10:47:02.560+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Videos'/><title type='text'>Visions of the Future:The Biotech Revolution</title><content type='html'>&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;Visions of the Future : The Biotech Revolution&lt;/span&gt;&lt;/strong&gt; From: alwaysblazen&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;p&gt;&lt;img id="BLOGGER_PHOTO_ID_5224628110404519266" style="DISPLAY: block; MARGIN: 0px auto 10px; CURSOR: hand; TEXT-ALIGN: center" alt="" src="http://bp2.blogger.com/_5C_306IztQU/SIGblcwuhWI/AAAAAAAACFE/y0sCIb2ckJ4/s400/visions2_lead.jpg" border="0" /&gt;&lt;/p&gt;&lt;p align="justify"&gt;In this new three-part series, leading theoretical physicist and futurist Dr Michio Kaku explores the cutting edge science of today, tomorrow, and beyond. He argues that humankind is at a turning point in history. In this century, we are going to make the historic transition from the 'Age of Discovery' to the 'Age of Mastery', a period in which we will move from being passive observers of nature to its active choreographers. This will give us not only unparalleled possibilities but also great responsibilities. &lt;/p&gt;&lt;p align="justify"&gt; &lt;/p&gt;&lt;p align="justify"&gt;&lt;strong&gt;2. THE BIOTECH REVOLUTION&lt;/strong&gt;&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Genetics and biotechnology promise a future of unprecedented health and longevity: DNA screening could prevent many diseases, gene therapy could cure them and, thanks to lab-grown organs, the human body could be repaired as easily as a car, with spare parts readily available. Ultimately, the ageing process itself could be slowed down or even halted.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;But what impact will this have on who we are and how we will live? And, with our mastery of the genome, will the human race end up in a world divided by genetic apartheid?&lt;/p&gt;&lt;p&gt;&lt;br /&gt;BBC &lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;Part 1&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/QP9DRk7eLPM&amp;amp;hl=en&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/QP9DRk7eLPM&amp;hl=en&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;Part 2&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/AboBMdYRcIo&amp;amp;hl=en&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/AboBMdYRcIo&amp;hl=en&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;Part 3&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/KX9GJadppdw&amp;amp;hl=en&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/KX9GJadppdw&amp;hl=en&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;Part 4&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/IjlZz0xZ8cc&amp;amp;hl=en&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/IjlZz0xZ8cc&amp;hl=en&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;Part 5&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/yaVfodJWLw4&amp;amp;hl=en&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/yaVfodJWLw4&amp;hl=en&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;Part 6&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/gduXViGNVLo&amp;amp;hl=en&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/gduXViGNVLo&amp;hl=en&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-9195067432533760854?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/9195067432533760854/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=9195067432533760854' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9195067432533760854'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9195067432533760854'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/07/visions-of-futurethe-biotech-revolution.html' title='Visions of the Future:The Biotech Revolution'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://bp2.blogger.com/_5C_306IztQU/SIGblcwuhWI/AAAAAAAACFE/y0sCIb2ckJ4/s72-c/visions2_lead.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-2625500013244805756</id><published>2008-07-15T13:18:00.002+03:00</published><updated>2008-07-15T13:24:21.105+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 7 - 14 Jul 2008</title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- DNA sewing machine&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;July 10, 2008 07:33 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Japanese scientists have made a micro-sized sewing machine to sew long threads of DNA into shape. The work published in the Royal Society of Chemistry journal Lab on a Chip demonstrates a unique way to manipulate delicate DNA chains without breaking them.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists can diagnose genetic disorders such as Down's syndrome by using gene markers, or "probes", which bind to only highly similar chains of DNA. Once bound, the probe's location can be easily detected by fluorescence, and this gives information about the gene problem. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Detecting these probes is often a slow and difficult process, however, as the chains become tightly coiled. The new method presented by Kyohei Terao from Kyoto University, and colleagues from The University of Tokyo, uses micron-sized hooks controlled by lasers to catch and straighten a DNA strand with excellent precision and care. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"When a DNA molecule is manipulated and straightened by microhooks and bobbins, the gene location can be determined easily with high-spatial resolution," says Terao. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The team used optical tweezers – tightly focused laser beams – to control the Z-shaped micro hook and pick up a single DNA "thread". The hook is barbed like an arrow, so the thread can't escape. When caught on the hook, the DNA can be accurately moved around by refocusing the lasers to new positions. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But just like thread in a sewing machine, a long DNA chain can be unwieldy – so the researchers built micro "bobbins" to wind the chain around. The lasers move one bobbin around another, winding the DNA thread onto a manageable spindle... &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/07/10/dna_sewing_machine.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;p&gt; &lt;/p&gt;&lt;p align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Scientists Identify Genetic Basis For The Black Sheep Of The Family&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;ScienceDaily (July 11, 2008)&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Coat color of wild and domestic animals is a critical trait that has significant biological and economic impact. Researchers have now identified the genetic basis for black coat color, and white, in a breed of domestic sheep.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;In the wild, mammalian coat color is essential for camouflage and plays a role in social behavior. Coat color also strongly influences the animals we choose to breed both as livestock and as pets. Understanding the genetic determinants of coat color in livestock species such as sheep, specifically bred for their coat color, is critical for improving efficient selection of the desired trait.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Classical genetics has associated alternative forms, or alleles, of the agouti signaling protein gene (ASIP) with coat color variation in a number of mammals including mice, rats, dogs, cats, pigs, and sheep. However, most research has been focused on the mouse, with little understood about the genetic basis for coat color in economically important livestock species such as sheep.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;The wild-type coat color of sheep is typically dark-bodied with a pale belly, however sheep raisers have strongly selected for a uniformly white coat domestic sheep. A problem for the sheep industry is a recessive black "non-agouti" allele of the ASIP gene carried by white sheep that cannot be distinguished within the flock, resulting in black coat color at a low, but persistent frequency. Determining the exact genetic differences at the ASIP locus could assist in efficient selection for white coat color.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Scientists at the CSIRO Queensland Bioscience Precinct in Australia have now taken this step and identified the molecular mechanisms underlying white and black coat color in domestic sheep. The researchers investigated the genetic architecture of the ASIP gene in several sheep breeds by sequencing the ASIP locus and measuring gene expression. "Surprisingly what we found was in fact that the genetic cause of domestic white and black sheep involves a novel tandem duplication affecting the ovine agouti gene and two other neighboring genes, AHCY and ITCH," explains Dr. Belinda Norris, lead author of the study....&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080710174236.htm"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/p&gt;&lt;p align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- New Mode Of Gene Regulation Discovered In Mammals&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;ScienceDaily (July 13, 2008)&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Researchers at the University of California, Santa Cruz, have discovered a type of gene regulation never before observed in mammals -- a "ribozyme" that controls the activity of an important family of genes in several different species.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;The findings, published July 9 in the journal Nature, describe a new and surprising role for the so-called hammerhead ribozyme, an unusual molecule previously associated with obscure virus-like plant pathogens called viroids. The UCSC researchers found the ribozyme embedded within certain genes in mice, rats, horses, platypuses, and several other mammals. The genes are involved in the immune response and bone metabolism.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;"The unique thing about these ribozymes is that they control the expression of the genes they're embedded in," said Monika Martick, a UCSC postdoctoral researcher and first author of the Nature paper.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;A ribozyme, or "RNA enzyme," is an RNA molecule that can catalyze a chemical reaction. RNA is better known for its ability to encode genetic information, while most biological reactions are carried out by enzymes made of protein. Scientists are discovering, however, that RNA is a remarkably versatile type of molecule.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;"RNA can function in the biology of organisms in more ways than we tend to give it credit for," said coauthor Lucas Horan, a graduate student in molecular, cell, and developmental biology at UCSC.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;When a gene is activated or "expressed," its DNA sequence on the chromosome is transcribed into an RNA molecule called a messenger RNA. The messenger RNA sequence is then translated into the amino acid sequence of a protein molecule, and the protein then carries out the gene's function in the cell.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;In the genes studied by Martick and Horan, the messenger RNA contains sequences that assemble to form an active hammerhead ribozyme. The hammerhead ribozyme is a self-cleaving molecule that essentially cuts itself in two. This self-cleaving action in the messenger RNAs effectively turns off the genes by preventing protein translation. Presumably, another mechanism exists to turn on the genes by stopping the self-cleaving action of the ribozyme...&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080709144215.htm"&gt;Full Article&lt;/a&gt;&lt;/p&gt;&lt;p align="justify"&gt; &lt;/p&gt;&lt;p align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Toothpick: New Molecular Tag IDs Bone And Tooth Minerals&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;ScienceDaily (July 15, 2008)&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Enlisting an army of plant viruses to their cause, materials researchers at the National Institute of Standards and Technology (NIST) have identified a small biomolecule that binds specifically to one of the key crystal structures of the body--the calcium compound that is the basic building block of teeth and bone. With refinements, the researchers say, the new molecule can be a highly discriminating probe for a wide range of diagnostic and therapeutic applications related to bones and teeth.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Although they have somewhat different mechanical properties, the major structural component of both teeth and bones is a crystalline compound of calcium phosphate called hydroxyapatite. Subtle variations in the way the crystal forms account for the differences. Identifying and monitoring the formation of this particular crystal is of paramount importance to biomedical researchers working on a variety of problems including the remineralization of teeth to repair decay damage, the integration of prosthetic joints and tissue-engineered bone materials for joint and bone replacement, and cell-based therapies to regrow bone tissue.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;To date, however, there is no specific, practical method to spot the formation of hydroxyapatite in living systems or tissue samples. Materials scientists can identify the crystal structure with high reliability by the pattern it makes scattering X rays, but it's a complex procedure, requires fairly pure samples and certainly can't be used on living systems. There are some widely used chemical assays--the von Kossa assay, for example--but these also are destructive tests, and more importantly they really test simply for the presence of the elements calcium or phosphorus. They can't distinguish, for example, between deposits of amorphous calcium phosphate--a precursor--and the hydroxyapatite crystal....&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080710113022.htm"&gt;Full Article&lt;/a&gt;&lt;/p&gt;&lt;p align="justify"&gt; &lt;/p&gt;&lt;p align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Ebola protein discovery&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Date: 10/07/2008&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;Described in the July 10, 2008 issue of the journal Nature, the research reveals the shape of the Ebola virus spike protein, which is necessary for viral entry into human cells, bound to an immune system antibody acting to neutralise the virus. The structure provides a major step forward in understanding how the deadly virus works, and may be useful in the development of potential Ebola virus vaccines, or treatments for those infected."Much about Ebola virus is still a mystery," says Erica Ollmann Saphire, the Scripps Research scientist who led the five-year effort. "However, this structure now reveals how this critical piece of the virus is assembled and, importantly, identifies vulnerable sites that we can exploit."&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;There is currently no cure for Ebola hemorrhagic fever. The virus is spread when people come into contact with the bodily fluids of someone who is already infected. Most ultimately die from a combination of dehydration, massive bleeding, and shock. The best treatment consists of administering fluids and taking protective measures to ensure containment, like isolating the patient and washing sheets with bleach.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;The breakthrough described in the Nature article, though, provides hope that one day modern medicine will have more to offer.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;The structure of the antibody together with the viral glycoprotein helps reveal the mechanisms by which the molecules assemble on the viral surface and helps explain how the pathogen evades and exploits the human immune system. The structure also provides a guide for the design of drugs and vaccines to block this protein, potentially preventing disease and death.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;The new research was made possible by an antibody isolated by Dennis Burton, a Scripps Research professor and one of the study's coauthors. The antibody-shown bound to the Ebola virus spike protein in the current research-was derived from bone marrow of one of the few survivors of the 1995 Ebola outbreak in Kikwit, a city in the southwestern part of the Democratic Republic of Congo. The Kikwit outbreak was particularly deadly, with a higher than 90 percent mortality rate for those infected.&lt;/p&gt;&lt;p align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/07/10/20732/Ebola_protein_discovery/"&gt;Full Article&lt;/a&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-2625500013244805756?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/2625500013244805756/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=2625500013244805756' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2625500013244805756'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2625500013244805756'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/07/weekly-bionews-7-14-jul-2008.html' title='Weekly BioNews 7 - 14 Jul 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-1854365901177741363</id><published>2008-07-07T10:09:00.002+03:00</published><updated>2008-07-07T10:17:10.655+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 30 June - 7 Jul 2008</title><content type='html'>&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Synthetic molecules emulate enzyme behavior for the first time&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;July 2, 2008 04:59 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;When chemists want to produce a lot of a substance -- such as a newly designed drug -- they often turn to catalysts, molecules that speed chemical reactions. Many jobs require highly specialized catalysts, and finding one in just the right shape to connect with certain molecules can be difficult. Natural catalysts, such as enzymes in the human body that help us digest food, get around this problem by shape-shifting to suit the task at hand.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Chemists have made little progress in getting synthetic molecules to mimic this shape shifting behavior -- until now. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Ohio State University chemists have created a synthetic catalyst that can fold its molecular structure into a specific shape for a specific job, similar to natural catalysts. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In laboratory tests, researchers were able to cause a synthetic catalyst -- an enzyme-like molecule that enables hydrogenation, a reaction used to transform fats in the food industry -- to fold itself into a specific shape, or into its mirror image. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The study appears in the June 25 issue of the Journal of the American Chemical Society. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Being able to quickly produce a catalyst of a particular shape would be a boon for the pharmaceutical and chemical industries, said Jonathan Parquette, professor of chemistry at Ohio State. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The nature of the fold in a molecule determines its shape and function, he explained. Natural catalysts reconfigure themselves over and over again in response to different chemical cues -- as enzymes do in the body, for example. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;When scientists need a catalyst of a particular shape or function, they synthesize it through a process that involves a lot of trial and error. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It's not uncommon to have to synthesize dozens of different catalysts before you get the shape you're looking for," Parquette said. "Probably the most important contribution this research makes is that it might give scientists a quick and easy way to get the catalyst that they want."&lt;br /&gt;The catalyst in this study is just a prototype for all the other molecules that the chemists hope to make, said co-author and professor of chemistry T.V. RajanBabu....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/07/02/synthetic_molecules_emulate_enzyme_behavior_for_the_first_time.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Study shows quantum dots can penetrate skin through minor abrasions&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;July 2, 2008 05:59 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at North Carolina State University have found that quantum dot nanoparticles can penetrate the skin if there is an abrasion, providing insight into potential workplace concerns for healthcare workers or individuals involved in the manufacturing of quantum dots or doing research on potential biomedical applications of the tiny nanoparticles.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;While the study shows that quantum dots of different sizes, shapes and surface coatings do not penetrate rat skin unless there is an abrasion, it shows that even minor cuts or scratches could potentially allow these nanoparticles to penetrate deep into the viable dermal layer - or living part of the skin - and potentially reach the bloodstream. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr. Nancy Monteiro-Riviere, professor of investigative dermatology and toxicology at NC State's College of Veterinary Medicine, tested the ability of the quantum dots to penetrate rat skin at 8 and 24 hour intervals. The experiment evaluated rat skin in various stages of distress - including healthy skin, skin that had been stripped using adhesive tape and skin that had been abraded by a rough surface. The researchers also assessed whether flexing the skin affected the quantum dots' ability to penetrate into the dermal layer. Monteiro-Riviere co-authored the study with doctoral student Leshuai Zhang. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;While the study indicates that acute - or short-term - dermal exposure to quantum dots does not pose a risk of penetration (unless there is an abrasion), Monteiro-Riviere notes "there is still uncertainty on long-term exposure." Monteiro-Riviere explains that the nanoparticles may be able to penetrate skin if there is prolonged, repeated exposure, but so far no studies have been conducted to date to examine that possibility. Quantum dots are fluorescent nanoparticles that may be used to improve biomedical imaging, drug delivery and diagnostic testing. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/07/02/study_shows_quantum_dots_can_penetrate_skin_through_minor_abrasions.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Nanostructures improve bone response to titanium implants&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;July 3, 2008 01:44 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Titanium implants were successfully introduced by P.-I. Brånemark and co-workers in 1969 for the rehabilitation of edentulous jaws. After 40 years of research and development, titanium is currently the most frequently used biomaterial in oral implantology, and titanium-based materials are often used to replace lost tissue in several parts of the body.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;There are some alternatives to modulating the body's response after implant placement. Modifying the implant surface topography has been a successful path among the scientific community, with the primary goals of achieving faster bone contact to the implant surface and more predictable results after several years. Today, during the 86th General Session of the International Association for Dental Research, convening here, a team of Swedish researchers is reporting the results of experiments that focused on structures, so-called 'nanostructures', one million times smaller than a Canadian one-dollar coin. The results demonstrated enhanced bone response to dental implants modified with such small structures as soon as 4 weeks after implant placement...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/07/03/nanostructures_improve_bone_response_to_titanium_implants.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Manufacturing the natural&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 03/07/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Natural products are highly valued by consumers yet their properties have been difficult to reproduce fully in synthetic materials, placing a drain on our limited natural resources. Until now ...Scientists at the National Physical Laboratory (NPL) are working towards producing the world's first model that will predict how we perceive naturalness. The results could help make synthetic products so good that they are interpreted by our senses as being fully equivalent to the 'real thing', but with the benefits of reduced environmental impact and increased durability.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;NPL began undertaking a real-time experiment at the Royal Society's Summer Science Exhibition. The public were invited to touch and feel 20 wood and wood effect samples and vote on whether they are real or not. The exhibition will now be toured around the UK during the next year to collect a census of data from across the country. This will then be used to help build the first predictive model of how we judge naturalness.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As well as the real-time experiment the travelling exhibition will include a range of interactive exhibits that explore the perceptual process. The first of these will show how we can use body parts to measure an object, as the ancient Egyptians did with the cubit, a standard measure related to the Pharaoh's arm length. There are visual, tactile and auditory experiments designed to demonstrate the limitations of the senses as measurement devices, by exposing how perceptions can be fooled by illusions. Videos will highlight the how the use of Magnetic Resonance Imaging (MRI) brain scans is helping us understand the perceptual process, by allowing researchers to discover which areas of the brain are stimulated when people carry out specific tasks, such as using their vision and touch senses to explore natural and non natural wood samples.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The exhibit is part of a much larger EU-funded project undertaken by a unique set of multidisciplinary of researchers called the Measurement of Naturalness (MONAT). This is one of a series of EU projects trying to 'Measure the Impossible', other projects are investigating subjects as diverse as eyewitness memory, emotional response to computer games, measuring body language and understanding how music induced emotions are processed in the brain.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The MONAT team will work over three years to examine how the perceived naturalness of materials is influenced by their physical properties. It includes:&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;* Neuroscientists who scan the brain activity of individuals as they examine different materials&lt;/div&gt;&lt;div align="justify"&gt;* Psychologists who measure the way people perceive different materials when they use their hands or eyes, or both&lt;/div&gt;&lt;div align="justify"&gt;* NPL's experts in metrology, data analysis and software modelling, who contribute expertise in making accurate physical measurements of the properties of different materials and will build the model of perceived naturalness. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The physical characteristics of a surface, such as its colour, texture and surface roughness, are being linked to what is happening in a person's brain when they see or touch the surface. Once this is understood it should be possible to accurately predict what we will perceive as natural, and manufacturers will be able to design synthetic products to meet this expectation. The results could have a great impact on materials such as wood, animal skin and furs, marble and stone, plants and even prosthetics.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/07/03/20693/Manufacturing_the_natural/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Researchers Are First To Simulate The Binding Of Molecules To A Protein&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (July 3, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;You may not know what it is, but you burn more than your body weight of it every day. Adenosine triphosphate (ATP), a tiny molecule that packs a powerful punch, is the primary energy source for most of your cellular functions.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Now researchers at the University of Illinois have identified a key step in the cellular recycling of ATP that allows your body to produce enough of it to survive. Without this cycling of ATP and its low-energy counterpart, adenosine diphosphate (ADP), into and out of the mitochondrion, where ADP is converted into ATP, life as we know it would end.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers have for the first time simulated the binding of ADP to a carrier protein lodged in the inner membrane of the mitochondrion. It is the first simulation of the binding of a molecule to a protein.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As its name indicates, ATP contains three phosphate groups. The energy produced when one of these groups is detached from the molecule drives many chemical reactions in the cell. This process also yields ADP, which must go through the ADP/ATP carrier (AAC) to get into the mitochondrion to be converted back into ATP.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The AAC acts a lot like a revolving door: For each molecule of ADP going into the mitochondrion, one ATP gets booted out. These two activities are not simultaneous, however. The carrier is either shuttling ADP into the mitochondrion or ejecting ATP into the wider environment of the cell, where it can be put to use...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img src="http://www.sciencedaily.com/images/2008/06/080630173932-large.jpg" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;View of the ATP/ADP carrier from the cytoplasm, with the ADP molecule (blue, aqua, red and white spheres) at the entrance, ready to be funneled into the carrier. (Credit: Image courtesy of Emad Tajkhorshid and Yi Wang, U. of I.)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080630173932.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Puzzle In The Control Of Cell Division Unraveled&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (July 5, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A puzzle in the control of cell division, one of the most fundamental processes in all biology, has been unravelled by Oxford University researchers. Although the steps of cell division are familiar to all pupils studying biology in schools, the details of how cell division is controlled and errors avoided have still to be sorted out.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In a new paper in Nature, the Oxford team show that a protein ring is used to hold two sister copies of each DNA molecule together physically until they are ready to be segregated into each daughter cell after division.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Understanding the mechanics of cell division is important: mis-separation of chromosomes can be one of the defining characteristics of cancerous cells, and such errors are also a leading cause of infertility in women as they get older. Down’s syndrome – the presence of an extra copy of chromosome 21 – is one example of what can happen when chromosome segregation goes wrong.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;‘DNA replication and cell division provides the mechanism for evolution,’ explains Professor Kim Nasmyth, head of the Department of Biochemistry at the University of Oxford. ‘It is the most fundamental process in biology, and chromosome segregation is one of the driving forces.’&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cell division, or mitosis, produces new cells through the growth and division of existing cells. The process begins with the replication of the genetic material held in the chromosomes of the cell. The pairs of sister DNA molecules or chromatids are lined up before being pulled in opposite directions to different sides of the cell. Partitioning of the original cell then gives two new daughter cells each with the full complement of chromosomes....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080703181839.htm"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Potential New Drug Candidates To Combat 'Bird Flu' Identified&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (July 7, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As the specter of a worldwide outbreak of avian or “bird flu” lingers, health officials recognize that new drugs are desperately needed since some strains of the virus already have developed resistance to the current roster of anti-flu remedies.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Now, a team of UC San Diego scientists - with the help of resources at the San Diego Supercomputer Center (SDSC), also at UC San Diego - have isolated more than two dozen promising and novel compounds from which new “designer drugs” might be developed to combat this disease. In some cases, the compounds appeared to be equal or stronger inhibitors than currently available anti-flu remedies.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“If those resistant strains begin to propagate, then that’s when we’re going to be in trouble, because we don’t have any anti-virals active against them,” said Rommie Amaro, a postdoctoral fellow in chemistry at UC San Diego. “So, we should have something as a backup, and that’s exactly why we’re working on this.”&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Avian flu has provoked considerable concern since humans have little or no immune protection against the virus. While flu vaccines are being developed, it could take up to nine months for an effective vaccine to be developed against any new strains, and could still be rendered ineffective if any new strains arise over that time. Should the virus gain the capacity to spread from person to person, the result could be a worldwide outbreak or pandemic...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="549" src="http://www.sciencedaily.com/images/2008/07/080702134900-large.jpg" width="549" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;Using protein structures generated by supercomputers, these renderings of the neuraminidase enzyme may help scientists identify potential new drug candidates to fight Avian flu, as strains of the disease become ever more resistant. Potential candidate drugs are shown docked into the neuraminidase active site in panels A-D. Panel A shows the crystal structure protein; panels B-D show proteins generated with molecular dynamics simulations. The images were generated with the Adaptive Poisson Boltzmann Solver (APBS) and Python Molecular Viewer (PMV). (Credit: Rommie E. Amaro, Lily S. Cheng, UC San Diego. Source: San Diego Supercomputer Center, UC San Diego.)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/07/080702134900.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-1854365901177741363?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/1854365901177741363/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=1854365901177741363' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1854365901177741363'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1854365901177741363'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/07/weekly-bionews-30-june-7-jul-2008.html' title='Weekly BioNews 30 June - 7 Jul 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-3875905849049713089</id><published>2008-06-30T05:47:00.002+03:00</published><updated>2008-06-30T05:57:40.165+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 23 - 30 June 2008</title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- New paradigm for cell-specific gene delivery&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 23, 2008 01:45 AM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers from Northwestern University and Texas A &amp;amp; M University have discovered a new way to limit gene transfer and expression to specific tissues in animals. In studies to determine how plasmids enter the nuclei of non-dividing cells, the group previously identified a region of a smooth muscle cell-specific promoter that was able to mediate nuclear targeting of any plasmid carrying this sequence uniquely in cultured smooth muscle cells but in no other cell type. In their current study to appear in the July 08 issue of Experimental Biology and Medicine, the team, led by Drs. David Dean and Jennifer Young from the Department of Medicine at Northwestern University, in collaboration with Warren Zimmer from Texas A &amp;amp; M University, now demonstrate that such restriction of nuclear entry using this specific DNA sequence can be used in blood vessels of living animals to direct gene transfer and expression specifically to smooth muscle cells. They have also developed a novel gene delivery approach for the vasculature that uses an electric field to transiently permeabilize the plasma membrane of cells to allow entry of DNA. Thus, this work establishes the control of nuclear entry of gene therapy vectors as a novel approach to target genes and gene expression to desired cell types in the body.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Vascular smooth muscle proliferative diseases, including atherosclerosis and restenosis, are among the leading causes of morbidity and mortality in the US. Gene therapy may represent an important alternative for the treatment and prevention of these proliferative diseases of the vasculature. It can be highly cell-specific, mimic or restore normal in vivo function, and can be permanent or transient depending on vector design. Currently, a number of gene delivery systems for use on the arterial wall are being studied, but as yet their low efficiency in gene transfer and lack of cell-specific targeting and expression are major limitations... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/23/new_paradigm_for_cellspecific_gene_delivery.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/23/new_paradigm_for_cellspecific_gene_delivery.html"&gt;&lt;/a&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Gene silencer and quantum dots reduce protein production to a whisper&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 23, 2008 04:10 PM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;More than 15 years ago scientists discovered a way to stop a particular gene in its tracks. The Nobel Prize-winning finding holds tantalizing promise for medical science, but so far it has been difficult to apply the technique, known as RNA interference, in living cells. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Now scientists at the University of Washington in Seattle and Emory University in Atlanta have succeeded in using nanotechnology known as quantum dots to address this problem. Their technique is 10 to 20 times more effective than existing methods for injecting the gene-silencing tools, known as siRNA, into cells. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We believe this is going to make a very important impact to the field of siRNA delivery," said Xiaohu Gao, a UW assistant professor of bioengineering and co-author of a study published online this week in the Journal of the American Chemical Society. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This work helps to overcome the longstanding barrier in the siRNA field: How to achieve high silencing efficiency with low toxicity," said co-author Shuming Nie, a professor in the Wallace H. Coulter Department of Biomedical Engineering, jointly affiliated with the Georgia Institute of Technology and Emory University. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Other co-authors are Maksym Yezhelyev and Ruth O'Regan at Emory and Lifeng Qi at the UW.&lt;br /&gt;Short pieces of RNA, the working copy of DNA, can disable production of a protein by silencing, or deactivating, a stretch of genetic code. Research laboratories regularly use the technique to figure out what a particular gene does. In the body, RNA interference could be used to treat conditions ranging from breast cancer to deteriorating eyesight.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;The recent experiments used quantum dots, fluorescent balls of semiconductor material just six nanometers across (lining up 9,000 dots end to end would equal the width of a human hair). Quantum dots' unique optical properties cause them to emit light of different colors depending on their size. The dots are being developed for cellular imaging, solar cells and light-emitting diodes. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;This paper describes one of the first applications of quantum dots to drug delivery. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Each quantum dot was surrounded by a proton sponge that carried a positive charge. Without any quantum dots attached, the siRNA's negative charge would prevent it from penetrating a cell's wall. With the quantum-dot chaperone, the more weakly charged siRNA complex crosses the cellular wall, escapes from the endosome (a fatty bubble that surrounds incoming material) and accumulates in the cellular fluid, where it can do its work disrupting protein manufacture... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;p align="center"&gt;&lt;img height="302" src="http://www.sciencedaily.com/images/2008/06/080623175355-large.jpg" width="470" /&gt;&lt;/p&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;em&gt;A fluorescent image of the cell taken 15 minutes after introducing the quantum dot-siRNA complex. At this early stage the particles are in the cell membrane. (Credit: Image courtesy of University of Washington)&lt;/em&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/23/gene_silencer_and_quantum_dots_reduce_protein_production_to_a_whisper.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Stopping flagella movement&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;Date: 23/06/2008&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;It has been long been known that bacteria swim by rotating their tail-like structure called the flagellum. (See the swimming bacteria in the figure.) The rotating motion of the flagellum is powered by a molecular engine located at the base of the flagellum. Just as engaging the clutch of a car connects its gear to its engine and delivers power to its wheels, engaging the molecular clutch of a bacterium connects its gear to its engine and delivers power to its flagellum.Now, a paper appearing in the June 20 issue of Science describes, for the first time, how the flagellum's rotations are stopped so that bacteria stop moving. Here's how the stopping mechanism works: while a bacterium is swimming, it releases a protein (shown in red in the stationary bacterium in the figure) that flows between its gear and engine. The presence of this protein detaches the bacterium's gear from its engine and thereby stops the delivery of power to its flagellum. This process is analogous to disengaging the clutch of a car, which detaches its gear from its engine and thereby stops the delivery of power to its wheels.&lt;/div&gt;&lt;br /&gt;&lt;p align="center"&gt; &lt;/p&gt;&lt;p align="center"&gt;&lt;img alt="Stopping flagella movement" src="http://www.scientistlive.com/media/images/flagellum1_h.jpg" /&gt;&lt;/p&gt;&lt;div align="justify"&gt;&lt;br /&gt;Once the delivery of power to bacterium's flagellum stops, the flagellum stops rotating, and the bacterium's swimming ends.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;An improved understanding of how flagella work may give nanotechnologists ideas about how to regulate tiny engines of their own creation. The flagellum is one of nature's smallest and most powerful motors. The flagellum of some bacteria can, for example, rotate more than 200 times per second, driven by 1,400 piconewton-nanometres of torque. That's quite a bit of (miniature) horsepower for a machine whose width stretches only a few dozen nanometres.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/23/20613/Stopping_flagella_movement/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Researchers develop neural implant that learns with the brain&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 24, 2008 04:07 PM &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Devices known as brain-machine interfaces could someday be used routinely to help paralyzed patients and amputees control prosthetic limbs with just their thoughts. Now, University of Florida researchers have taken the concept a step further, devising a way for computerized devices not only to translate brain signals into movement but also to evolve with the brain as it learns.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Instead of simply interpreting brain signals and routing them to a robotic hand or leg, this type of brain-machine interface would adapt to a person's behavior over time and use the knowledge to help complete a task more efficiently, sort of like an assistant, say UF College of Medicine and College of Engineering researchers who developed a model system and tested it in rats. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Until now, brain-machine interfaces have been designed as one-way conversations between the brain and a computer, with the brain doing all the talking and the computer following commands. The system UF engineers created actually allows the computer to have a say in that conversation, too, according to findings published this month online in the Institute of Electrical and Electronics Engineers journal IEEE Transactions on Biomedical Engineering. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"In the grand scheme of brain-machine interfaces, this is a complete paradigm change," said Justin C. Sanchez, Ph.D., a UF assistant professor of pediatric neurology and the study's lead author. "This idea opens up all kinds of possibilities for how we interact with devices. It's not just about giving instructions but about those devices assisting us in a common goal. You know the goal, the computer knows the goal and you work together to solve the task." &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists at UF and other institutions have been studying and refining brain-machine interfaces for years, developing and testing numerous variations of the technology with the goal of creating implantable, computer-chip-sized devices capable of controlling limbs or treating diseases. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The devices are programmed with complex algorithms that interpret thoughts. But the algorithms, or code, used in current brain-machine interfaces don't adapt to change, Sanchez said. &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The status quo of brain-machine interfaces that are out there have static and fixed decoding algorithms, which assume a person thinks one way for all time," he said. "We learn throughout our lives and come into different scenarios, so you need to develop a paradigm that allows interaction and growth." &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;To create this type of brain-machine interface, Sanchez and his colleagues developed a system based on setting goals and giving rewards... &lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/24/researchers_develop_neural_implant_that_learns_with_the_brain.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/24/researchers_develop_neural_implant_that_learns_with_the_brain.html"&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Embryo regeneration&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;Date: 26/06/2008&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;More than 80 years have passed since the German scientist Hans Spemann conducted his famous experiment that laid the foundations for the field of embryonic development. After dividing a salamander embryo in half, Spemann noticed that one half - specifically, the half that gives rise to the salamander's 'belly' (ventral) starts to wither away. However, the other 'back' (dorsal) half that develops into its head, brain and spinal cord, continues to grow, regenerating the missing belly half and develops into a complete, though be it smaller, fully functional embryo. Spemann then conducted another experiment, where this time, he removed a few cells from the back half of one embryo and transplanted them into the belly half of a different embryo. To his surprise, this gave rise to a Siamese twin embryo where an extra head was generated from the transplanted cells. Moreover, although the resulting embryo was smaller than normal, all its tissues and organs developed in the right proportions irrespective of its size, and functioned properly. For this work, Spemann received the Nobel Prize in Physiology or Medicine in 1935.But how does this happen? How exactly is the half embryo able to maintain its tissues and organs in the correct proportions despite being smaller than a normal sized embryo?&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Despite many years of research, this question has remained unanswered - until now. More than 80 years since Spemann's classic experiment, Profs. Naama Barkai, Benny Shilo and research student Danny Ben-Zvi of the Weizmann Institute of Science's Molecular Genetics Department, together with Prof. Abraham Fainsod of the Hebrew University-Hadassah School of Medicine, Jerusalem, have finally discovered the mechanisms involved.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Previous studies have shown that the growth and development of cells and organs within the embryo is somehow linked to a special group of substances called morphogens. These morphogens are produced in one particular area within the embryo and then spread throughout the entire embryo in varying concentrations. Scientists then began to realise that the fate of embryo cells, that is to say, the type of tissue and organ they are eventually going to develop into, is determined by the concentration of morphogen that they come into contact with. But this information does not answer the specific question as to how proportion is maintained between organs?&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The idea for the present research came about when Weizmann Institute scientist Prof. Naama Barkai and her colleagues developed a mathematical model to describe interactions that occur within genetic networks of an embryo.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/26/20642/Embryo_regeneration/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/26/20642/Embryo_regeneration/"&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Evolution Of Fruit Size In Tomato&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (June 28, 2008)&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Domesticated tomatoes can be up to 1000 times larger than their wild relatives. How did they get so big?&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;In general, domesticated food plants have larger fruits, heads of grain, tubers, etc, because this is one of the characteristics that early hunter-gatherers chose when foraging for food. In addition to size, tomatoes have been bred for shape, texture, flavor, shelf-life, and nutrient composition, but it has been difficult to study these traits in tomatoes, because many of them are the result of many genes acting together. These genes are often located in close proximity on chromosomal regions called loci, and regions with groups of genes that influence a particular trait are called quantitative trait loci (QTLs).&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;When a trait is influenced by one gene, it is much simpler to study, but quantitative traits, like skin and eye color in humans or fruit size in tomatoes, cannot be easily defined just by crossing different individuals. Now, with genome sequencing and genomics tools, chromosomal regions with QTLs can be mapped and cloned more easily than in the past. These genomic maps can also be compared across plant genomes to identify similar genes in other species. With this knowledge, breeders can improve tomato varieties as well as other less well known food plants in the family Solanaceae.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr. Steven D. Tanksley and his colleagues, Bin Cong and Luz S. Barrero, are studying QTLs that influence fruit size. Dr. Barrero, of the Corporación Colombiana de Investigación Agropecuaria (CORPOICA), Colombia, will be presenting this work at a symposium on the Biology of Solanaceous Species at the annual meeting of the American Society of Plant Biologists in Mérida, Mexico (June 29, 2008).&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Tomato (Solanum lycopersicum) is a member of the Solanaceae or nightshade family, which also includes potato, eggplant, tobacco, and chili peppers. The center of origin and diversity of tomato and other solanaceous species is in the northern Andes, where endemic wild populations of these species still grow. Tanksley and his colleagues have been employing the data emerging from the International Tomato Genome Sequencing Project as well as the tools of structural genomics to clone and characterize the major gene and QTL responsible for extreme fruit size during tomato domestication--fas.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;The first QTL, fw2.2, was the first ever cloned in plants and may have been the site of one of the earliest mutations in tomato that led to its selection by humans and subsequent domestication. The size of tomato fruit can vary up to 30% as a result of variation at this locus alone. Cloning and sequencing of this locus reveals that the wild type protein codes for a repressor of cell division. When the control sequence is mutated, the repressor protein is not expressed or only very little, leading to higher cell division during fruit development and, consequently, larger fruits.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;However, fw2.2 and associated genes related to cell-cycle control and cell division are not solely responsible for extreme fruit size. Two other loci-- locule-number and fasciated (fas)-- influence fruit size indirectly by affecting the number of carpels, the female parts of the flower that will become seed chambers in the fruit. Most wild tomatoes have only 2-4 locules (ovary chambers) while domesticated varieties can have 8 or more, and it appears that increase in locule number can increase fruit size by 50%. The data indicate that, of the two loci, fas has the larger effect. Tanksley and his colleagues used positional cloning to isolate the fas locus....&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080628065632.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-3875905849049713089?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/3875905849049713089/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=3875905849049713089' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/3875905849049713089'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/3875905849049713089'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/06/weekly-bionews-23-30-june-2008.html' title='Weekly BioNews 23 - 30 June 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-7015404051285356732</id><published>2008-06-23T07:01:00.002+03:00</published><updated>2008-06-23T07:10:13.225+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 16 - 23 June 2008</title><content type='html'>&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Ability to track stem cells in tumors could advance cancer treatments&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 16, 2008 06:34 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms, according to researchers at SNM's 55th Annual Meeting. This ability could lead to major advances in the use of stem cell therapies to treat cancer.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Stem cell cancer therapies are still in the early stages of development, but they offer great promise in delivering personalized medicine that will fight disease at the cellular level," said Hui Wang, a postdoctoral fellow from Prof. Xiaoyuan (Shawn) Chen's group of the Molecular Imaging Program at Stanford (MIPS), Department of Radiology at Stanford University, Stanford, Calif., and lead researcher of the study, Trafficking the Fate of Mesenchymal Stem Cells In Vivo. "Our results indicate that molecular imaging can play a critical role in understanding and improving the process of how stem cells migrate to cancer cells. Eventually, this technique could also be used to determine if gene-modified stem cells are effective in fighting cancer." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;MSCs are adult stem cells that have the ability to transform into many different types of cells, such as bone, fat or cartilage. Many scientists believe that stem cells show great promise in treating different types of diseases—and a few stem cell therapies are already used to fight some types of cancer. Leukemia patients who haven't responded to chemotherapy, for example, may receive bone marrow transplants, through which stem cells of a healthy bone marrow donor are injected into the patient's blood stream. If the transplant is successful, the stem cells will migrate to the patient's bone marrow and begin producing healthy cells that will replace the cancer cells. For other types of cancer, researchers are experimenting with modifying stem cells that could be engineered to deliver chemotherapy more precisely to specific tumor sites. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;For these types of treatments to be successful, the ability to track what happens to stem cells after they are injected into a living organism is essential. Currently, three different tracking techniques are used: radiolabeling, which consists of using a radioactive substance to tag the cells; magnetic labeling, or using magnetic nanoparticles to tag cells for magnetic resonance imaging; and reporter-gene tracking, which involves engineering genes that can adhere to cells and be tracked with molecular imaging technologies. Of these, reporter gene techniques are highly sensitive and able to monitor cell migration, survival and proliferation over time in living organisms.... &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/16/ability_to_track_stem_cells_in_tumors_could_advance_cancer_treatments.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Could New Discovery About A Shape-shifting Protein Lead To A Mighty 'Morpheein' Bacteria Fighter?&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (June 20, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A small molecule that locks an essential enzyme in an inactive form could one day form the basis of a new class of unbeatable, species-specific antibiotics, according to researchers at Fox Chase Cancer Center.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Their findings, highlighted on the cover of the June 23 issue of the journal Chemistry &amp;amp; Biology, take advantage of an emerging body of science regarding "morpheeins" -- proteins made from individual components that are capable of spontaneously reconfiguring themselves into different shapes within living cells.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The researchers discovered a small molecule, which they have named morphlock-1, binds the inactive form of a protein known as porphobilinogen synthase (PBGS), an enzyme used by nearly all forms of cellular life. The functioning form of PBGS is built from eight identical component parts -- in what is called an octamer configuration -- and is essential among nearly all forms of life in the processes that enable cells to use energy. The other configuration is made of six parts -- or a hexamer configuration -- and serves as a "standby" mode for the protein.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"As the name suggests, morphlock-1 essentially locks the hexamer configuration into place, preventing its protein subunits from reconfiguring into the active assembly," says lead investigator Eileen Jaffe, Ph.D, a Senior Member of Fox Chase. "Targeting morpheeins in their inactive assemblies provides an entirely new approach to drug discovery."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;While their study was performed using a pea plant-version of PBGS, the researchers have reason to believe the principle could apply to bacterial versions of PBGS as well. "Using morphlock-1 as a base, we are seeking to fine tune the molecule so that it blocks just the bacterial version of the PBGS enzyme, " Jaffe says....&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;p align="center"&gt;&lt;img height="218" src="http://www.sciencedaily.com/images/2008/06/080620122838-large.jpg" width="400" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;em&gt;Morphlock-1 (yellow) binds the inactive form of a protein known as PBGS, an enzyme used by nearly all living things. The functioning form of PBGS is built from eight identical component parts, in what is called an octamer configuration (pink). The hexamer configuration (blue) is made of six parts. (Credit: FCCC)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080620122838.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;p&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Toward Designing Medications To Enhance Innate Immunity: A Single VSOP Can Do 'Proton' Magic&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (June 20, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;International research group led by Yasushi Okamura, a professor in Japanese National Institute for Physiological Sciences, Okazaki, and Peter Larsson, a professor in Oregon Health &amp;amp; Science University, Oregon, US, found that a single protein of VSOP, Voltage Sensor Only Protein/ Hv1, can carry protons even without making a multimeric complex.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Since VSOP is known to be expressed in phagocytes such as macrophages and neutrophils that remove infected pathogens, this finding may help in the design of new medications for enhancing the activities of innate immunity.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Usually, ion channels on cell membrane form a multimeric complex to make an assembling hole to carry ions though. Surprisingly, the research group found that this VSOP protein forms a dimer but each single subunit can carry protons without any assembling hole. They reached these conclusions through using the techniques of FRET (Fluorescence Resonance Energy Transfer) and biochemistry.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The VSOP keeps the cell inside in an alkaline condition. This finding helps to explain how VSOP regulates pH conditions during the process of removing pathogens such as fungi, bacteria and virus.&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;p align="center"&gt;&lt;img height="238" src="http://www.sciencedaily.com/images/2008/06/080616170804-large.jpg" width="400" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;VSOP/Hv (middle) usually forms a dimer but each subunit can carry protons without making any assembling hole. (Credit: Copyright Yasuhi Okamura)&lt;/em&gt;&lt;/div&gt;&lt;div align="center"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080616170804.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;&lt;em&gt;- Zebra's Stripes, Butterfly's Wings: How Do Biological Patterns Emerge?&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;em&gt;ScienceDaily (June 20, 2008)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;A zebra’s stripes, a seashell’s spirals, a butterfly’s wings: these are all examples of patterns in nature. The formation of patterns is a puzzle for mathematicians and biologists alike. How does the delicate design of a butterfly’s wings come from a single fertilized egg? How does pattern emerge out of no pattern?&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Using computer models and live cells, researchers at Johns Hopkins have discovered a specific pattern that can direct cell movement and may help us understand how metastatic cancer cells move.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“Pattern formation is a classic problem in embryology,” says Denise Montell, Ph.D., a professor of biological chemistry at Hopkins. “At some point, cells in an embryo must separate into those that will become heart cells, liver cells, blood cells and so on. Although this has been studied for years, there is still a lot we don’t understand.”&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;As an example of pattern formation, the researchers studied the process of how about six cells in the fruit fly distinguish themselves from neighboring cells and move from one location in the ovary to another during egg development. “In order for this cell migration to happen, you have to have cells that go and cells that stay,” says Montell. “There must be a clear distinction — a separation between different types of cells, which on the surface look the same.”&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;p align="center"&gt;&lt;img height="549" src="http://www.sciencedaily.com/images/2008/06/080619111748-large.jpg" width="549" /&gt;&lt;/p&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="center"&gt;A zebra's stripes, a seashell's spirals, a butterfly's wings: these are all examples of patterns in nature. The formation of patterns is a puzzle for mathematicians and biologists alike. How does the delicate design of a butterfly's wings come from a single fertilized egg? How does pattern emerge out of no pattern? (Credit: iStockphoto/Ismael Montero Verdu)&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080619111748.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-7015404051285356732?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/7015404051285356732/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=7015404051285356732' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7015404051285356732'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/7015404051285356732'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/06/weekly-bionews-16-23-june-2008.html' title='Weekly BioNews 16 - 23 June 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-9175319853684795537</id><published>2008-06-19T06:39:00.000+03:00</published><updated>2008-06-19T06:41:32.932+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Articles'/><title type='text'>Scientific information largely ignored when forming opinions about stem cell research</title><content type='html'>&lt;div align="justify"&gt;When forming attitudes about embryonic stem cell research, people are influenced by a number of things. But understanding science plays a negligible role for many people. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;That's the surprising finding from a team of University of Wisconsin-Madison communications researchers who have spent the past two years studying public attitudes toward embryonic stem cell research. Reporting in the most recent issue of the International Journal of Public Opinion, the researchers say that scientific knowledge - for many citizens - has an almost negligible effect on how favorably people regard the field. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"More knowledge is good - everybody is on the same page about that. But will that knowledge necessarily help build support for the science?" says Dietram Scheufele, a UW-Madison professor of life sciences communication and one of the paper's three authors. "The data show that no, it doesn't. It does for some groups, but definitely not for others." &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Along with Dominique Brossard, a UW-Madison professor of journalism and mass communication, and graduate student Shirley Ho, Scheufele used national public opinion research to analyze how public attitudes are formed about controversial scientific issues such as nanotechnology and stem cells. What they have found again and again is that knowledge is much less important than other factors, such as religious values or deference to scientific authority. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the case of stem cells, values turn out to be key, says Scheufele. For respondents who reported that religion played a strong role in their lives, scientific knowledge had no effect on their attitudes toward stem cell research. But for those who claimed to be less religious, understanding the science was linked to more positive views of the research. &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Highly religious audiences are different from less religious audiences. They are looking for different things, bringing different things to the table," explains Scheufele. "It is not about providing religious audiences with more scientific information. In fact, many of them are already highly informed about stem cell research, so more information makes little difference in terms of influencing public support. And that's not good or bad. That's just what the data show." &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;On the other hand, a value system held by a much smaller portion of the American public works in just the opposite direction. The attitudes of individuals who are deferential to science - who tend to trust scientists and their work - are influenced by their level of scientific understanding.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Overall, says Brossard, "more understanding doesn't always change attitudes. A lot depends on people's values. And those values need to be considered carefully when we communicate with the public about these issues." Source : &lt;a href="http://www.wisc.edu/"&gt;University of Wisconsin-Madison&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-9175319853684795537?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/9175319853684795537/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=9175319853684795537' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9175319853684795537'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9175319853684795537'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/06/scientific-information-largely-ignored.html' title='Scientific information largely ignored when forming opinions about stem cell research'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-5752408704455963110</id><published>2008-06-16T14:23:00.002+03:00</published><updated>2008-06-16T14:33:01.147+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 9 - 16 June 2008</title><content type='html'>&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Salmonella: Trickier Than We Imagined&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Jun. 15, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Salmonella is serving up a surprise not only for tomato lovers around the country but also for scientists who study the rod-shaped bacterium that causes misery for millions of people.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In research published June 4 in the online journal PloS One, researchers say they've identified a molecular trick that may explain part of the bacteria's fierceness. A team from the University of Rochester Medical Center has identified a protein that allows the bacteria to maintain a low profile in the body, giving the bacteria crucial time to quietly gain a foothold in an organism before the immune system is roused to fight the invader.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Inflammation immediately after a bacterial infection occurs helps the body fight off bugs like Salmonella quickly," said Jun Sun, Ph.D., the leader of the team and assistant professor of Gastroenterology and Hepatology. "But it may be that Salmonella is especially equipped with tools to allow it to evade the immune system early on, growing quietly and then really making the host quite ill. Salmonella is trickier than we imagined."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Sun's team found that a virulence protein known as AvrA dampens the inflammatory response. That helps the bacteria avoid the wrath of the immune system and gives the infection crucial time to grow and develop before it needs to expend energy to fight off immune cells like neutrophils, which would attack the intruder more quickly if the bacteria attacked the body in a more clear-cut fashion.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"AvrA allows Salmonella to make peace with you, buying the bacteria a little time to survive in the body," said Sun. "That's bad news for the body, because then the bacteria spreads. AvrA allows the bacteria to do harm in the body without the body realizing it. Bacteria have been evolving for millions of years. That gives them some tricks that perhaps we don't understand yet."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;AvrA is one of several proteins in Salmonella that affect cells in the wall of the intestines and stomach known as epithelial cells. These cells link up tightly together thanks to molecules known as tight junction proteins, which form an elaborate barrier to keep molecules and substances in or out of the colon. The bacterium employs several proteins enabling it to loosen these junctions, effectively breaking up the barrier and making the body vulnerable to the infection.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;While several of Salmonella's proteins allow it to loosen up and punch through this latticework, Sun's team unexpectedly found that AvrA allows the bacteria to maintain these tight junctions. This ability reduces the body's inflammatory response and allows the bacteria to avoid detection by the immune system for some time, enabling the bacteria to survive in the host. The severe symptoms of infection, including nausea, vomiting, diarrhea, and abdominal cramps, typically hit anywhere from 8 to 72 hours after initial exposure to the bug.....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="319" src="http://www.sciencedaily.com/images/2008/06/080613104801-large.jpg" width="470" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;This scanning electron micrograph (SEM) depicts four highly magnified rod-shaped, motile, Gram-negative Salmonella infantis bacteria, which are attached. (Credit: Janice Carr)&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080613104801.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Woolly Mammoth Gene Study Changes Extinction Theory&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Jun. 12, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A large genetic study of the extinct woolly mammoth has revealed that the species was not one large homogenous group, as scientists previously had assumed, and that it did not have much genetic diversity.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The population was split into two groups, then one of the groups died out 45,000 years ago, long before the first humans began to appear in the region," said Stephan C. Schuster, associate professor of biochemistry and molecular biology at Penn State University and a leader of the research team. "This discovery is particularly interesting because it rules out human hunting as a contributing factor, leaving climate change and disease as the most probable causes of extinction."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The discovery will be published later this week in the early online edition of the Proceedings of the National Academy of Sciences (PNAS).&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research marks the first time scientists have dissected the structure of an entire population of extinct mammal by using the complete mitochondrial genome -- all the DNA that makes up all the genes found in the mitochondria structures within cells. Data from this study will enable testing of the new hypothesis presented by the team, that there were two groups of woolly mammoth -- a concept that previously had not been recognized from studies of the fossil record.&lt;br /&gt;The scientists analyzed the genes in hair obtained from individual woolly mammoths -- an extinct species of elephant adapted to living in the cold environment of the northern hemisphere. The bodies of these mammoths were found throughout a wide swathe of northern Siberia. Their dates of death span roughly 47,000 years, ranging from about 13,000 years ago to about 60,000 years ago.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Schuster and Webb Miller, professor of biology and computer science and engineering at Penn State, led the international research team, which includes Thomas Gilbert at the University of Copenhagen in Denmark and other scientists in Australia, Belgium, France, Italy, Russia, Spain, Sweden, the United Kingdom, and the United States. The team includes experts in the fields of genome evolution, ancient DNA, and mammoth paleontology, as well as curators from various natural-history museums....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080611161038.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080611161038.htm"&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Unraveling Bacteria Communication Pathways&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Jun. 12, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;MIT researchers have figured out how bacteria ensure that they respond correctly to hundreds of incoming signals from their environment.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The researchers also successfully rewired the cellular communications pathways that control those responses, raising the possibility of engineering bacteria that can serve as biosensors to detect chemical pollutants. The work is reported in the June 13 issue of Cell.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Led by MIT biology professor Michael Laub, the team studied genomes of nearly 200 bacteria, which can have hundreds of different pathways that respond to different types of external stimuli. Nutrients, antibiotics, temperature or light can evoke a variety of responses, including transcription of particular genes.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In most cases, the pathways involve two proteins. The first protein, an enzyme known as a histidine kinase, receives the external signal and then activates the second protein, known as a response regulator.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It's critical that each histidine kinase activate only the appropriate response regulator. Different histidine kinases are often very structurally similar, as are the response regulator proteins, so scientists have wondered how cells prevent signals from getting crossed.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"If an organism has tons of this class of signaling pathway, why do we not get a lot of crosstalk?" said Laub. "How does the kinase pick out the right target?"&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Based on earlier studies, the MIT researchers theorized that the specificity of the interaction is determined by a subset of amino acids on the histidine kinase and a corresponding subset of amino acids on the response regulator.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;To confirm their theory, they looked for patterns of amino acid co-evolution in pairs of histidine kinases and their target response regulators.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Co-evolution occurs when a mutation in one of the two proteins is followed by a secondary mutation in the corresponding amino acid on the other protein, allowing the protein pair to maintain their interaction.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;After searching a vast database of nearly 1,300 protein pairs, they identified a small set of co-evolved amino acids. They then confirmed that these amino acids govern signaling specificity by successfully rewiring five of the pathways by mutating the target amino acids....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="224" alt="" src="http://www.sciencedaily.com/images/2008/06/080612125038.jpg" width="300" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;Diagram shows the structure of a histidine kinase (blue ribbons) and its target response regulator (green ribbons). The specificity of the interaction between the two proteins is primarily determined by the orange and red amino acid residues. (Credit: Image / Protein Data Bank, Michael Laub and Jeffrey Skerker)&lt;/em&gt;&lt;/div&gt;&lt;p align="center"&gt; &lt;/p&gt;&lt;p align="center"&gt; &lt;/p&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080612125038.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080612125038.htm"&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Hidden world of protein folding&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Date: 13/06/2008&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;The proteins upon which life depends share an attribute with paper airplanes: Unless folded properly, they just won't fly.But researchers have been puzzled by how the long, linear proteins cranked out by the ribosome factories in a cell are folded into the shapes they must assume to perform their function. They only have known that for many of the most complex and essential proteins, the folding takes place out of sight, hidden in the inner cavity of a type of molecule called a chaperonin.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Now Stanford researchers have begun prying open the lid, literally, on the inner workings of chaperonin molecules by deducing the mechanism by which the lid operates on a barrel-shaped chaperonin called TRiC.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Understanding how the lid opens and closes really helps us understand how everything moves inside the chaperonin," said Judith Frydman, associate professor of biology and one of two senior authors of a paper published online this week in Nature Structural &amp;amp; Molecular Biology.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This is just the beginning, but now we can start to understand how the protein is pushed inside the cavity of the chaperonin and what this folding chamber looks like," Frydman said. Learning how a protein is manipulated inside TRiC while it is being folded is a crucial step in Frydman's larger plan.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Our goal is to eventually exert control," she said. "If we could re-engineer the chaperonin to either fold better misfolded proteins or alternatively to remove them from circulation, then we could prevent those proteins from being harmful to cells."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Misfolded proteins have been implicated in a number of diseases, including some cancers, as well as ailments related to aging, such as Alzheimer's and Parkinson's diseases.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Folding is one of the key steps for the health of the cell," Frydman said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Virtually all proteins have to be folded-some in complex configurations-in order to function properly, and many are known to require a molecule called a chaperone to fold them. Frydman estimates that perhaps 10 percent of the proteins needing chaperones must have one that, like TRiC, is part of the subset called chaperonins. Other work done in Frydman's lab has shown that proteins that have very complex folds seem to require chaperonins.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Many of the proteins that have these complex folds are the most important ones for life," Frydman said. "The proteins that control the cell cycle, tumor suppressers and the proteins that control the shape of the cell are dependent on chaperonins to get to the folded state.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"If the chaperones don't work well, then all these proteins that have been made become toxic," she said.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;TRiC, like all chaperonins, consists of a double-ringed structure that gives it a barrel shape. One ring opens to admit the raw protein into the inner recesses of the folding machine, then closes tightly while, inside the chaperonin "black box," the mysteries of molecular origami unfold-or, more correctly, fold. Upon completion of the folding, the ring at the other end opens up to push out the finished product.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It is really like a nanomachine. It closes off, the protein is trapped inside and something-we don't understand what-happens inside this chamber, and the protein comes out folded," Frydman said. "It is a very complex mechanism."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The rings at each end of the barrel have to synchronize their actions for the sequence of events to happen correctly.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"We don't know how the rings coordinate," Frydman said. "What we have is evidence that this machine works like a two-stroke motor, so that opening one ring closes the other, and when that other ring opens, the first one is closed."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Timing is critical because if a protein does not stay in the chaperonin long enough, it may not have time to fold properly. Conversely, if it lingers too long, it may also fold incorrectly. And sometimes proteins are not made correctly by the ribosome, so they simply do not bind well to their chaperone, making proper folding impossible....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/13/20555/Hidden_world_of_protein_folding/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/13/20555/Hidden_world_of_protein_folding/"&gt;&lt;/a&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Blocking malaria transmission&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Date: 10/06/2008&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent the malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.By genetically altering the malaria parasite through gene knock-out technology, a research team consisting of scientists at the University of Copenhagen and John Hopkins University, Baltimore, has prevented the parasite from going through the normal stages of its life cycle and developing a cyst (egg-like structure or occyst), which spawns new infectious parasites." As it is exclusively the parasites from these oocysts that can infect new individuals, we were able to prevent the disease from being transmitted to theanimals in our tests", explains Assistant Professor, Peter Ellekvist from the University of Copenhagen.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The findings have been published in the scientific journal Proceedings of the National Academy of Sciences, USA, (2008 105: 6398-6402).The intervention "disrupts" the parasites complex life cycle&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The malaria parasite has an extremely complicated lifecycle, which starts with the fertilisation of the parasites male and female gametes and the formation of an oocyst, in the mosquito's stomach wall. The oocyst further develops into sporozoittes, which travel up the mosquito's salivary gland and from there are transmitted to people, when the mosquito secures its next blood meal. After residing for a short period in the liver cells, the parasites then infect the red blood cells, thereby wreaking havoc in the human body. The malaria parasites are able to reproduce both through sexual reproduction when they inhabit a mosquito (and are transmitted to the host) and via asexual reproduction when they reside in the human body (replication in the host). For scientists to successfully counteract malaria, they must tackle both the transmission from person to person by the mosquitoes and the spread of the malaria parasites in the infected individual.The potassium channels are important for all cells&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;All animal and plant cells contain so-called ion channels. These are small pores which allow ions to move in and out through an otherwiseimpermeable cell membrane. The potassium channels are a sub-type of ion channel, found in all cells. Though the function of the potassium channels vary, they play a crucial role in a variety of biological processes, e.g. influencing the ability of the nerves to send electrical signals and the heart muscle to contract rhythmically.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Assistant Professor Peter Ellekvist explains that his interest in malaria led to a research collaboration with Professor Dan Klærke, who studies potassium channels at the University of Copenhagen. In collaboration with Professor Nirbhay Kumar and other colleagues from the Malaria Research Institute at John Hopkins University in Baltimore, the two researchers were able to manipulate the parasite's genes so as to ensure that the potassium channel no longer functioned. To their surprise, however, this intervention did not, in the first instance, appear to have any effect on the parasites....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/10/20533/Blocking_malaria_transmission/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/10/20533/Blocking_malaria_transmission/"&gt;&lt;/a&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Caution on stem cell therapy&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Date: 09/06/2008&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;A single organ may contain more than one type of adult stem cell - a discovery that complicates prospects for using the versatile cells to replace damaged tissue as a treatment for disease, according to a new study from the laboratory of geneticist Mario Capecchi, the University of Utah's Nobel Laureate.In the June 8 online issue of the journal Nature Genetics, Capecchi and geneticist Eugenio Sangiorgi report that when they used a gene named Bmi1 to mark the presence of adult stem cells in the intestines of mice, they were surprised to find the specific cells mostly in the upper third of the mouse intestine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;That indicates at least one or two other types of adult stem cells must exist to maintain and repair the middle and lower thirds of the mouse's guts. The small intestine in a mouse is almost 12 inches long if stretched from end to end.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Adult stem cells are "undifferentiated" cells that can become any type of cell in the organ in which they are found. Medical researchers hope to transplant adult stem cells to treat various diseases. Examples include placing adult stem cells in the pancreas to replace damaged insulin-producing cells, in the heart to replace cardiac muscle cells killed by heart attack, and in the brain to replace dopamine-producing cells damaged in Parkinson's disease patients.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The new discovery "is important because people are talking about stem cell therapy; they want to stick in stem cells to treat disease," says Capecchi, a winner of the 2007 Nobel Prize in Physiology or Medicine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"People always thought about a uniform stem cell population in each organ, but now we are saying there are multiple stem cell populations in a given organ, so if you're going to do therapy, you have to recognise this complexity," adds Capecchi, co-chair and distinguished professor of human genetics at the University of Utah and an investigator with the Howard Hughes Medical Institute.&lt;br /&gt;Sangiorgi, a postdoctoral fellow in human genetics, adds: "There are probably different stem cells in the small intestine doing different things."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;If more than one kind of adult stem cell is required to generate the intestinal lining, "it wouldn't be surprising to see it is true for other organs as well," Capecchi says.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Adult stem cells have been seen as an alternative to embryonic stem cells, which are able to become any kind of cell in the body - not just in a given organ - and are obtained from test-tube fertilisation of eggs left over by couples attempting to have babies. Embryonic stem cells have been controversial because abortion foes consider them to be human beings rather than a small batch of cells.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Capecchi won the Nobel - with Sir Martin Evans and Oliver Smithies - for developing gene targeting, a method of using embryonic stem cells to "knock out" genes in mice, then observing what goes wrong to determine any gene's normal function.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Getting to the Guts of Adult Stem Cells&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Stem cells in the intestine are among the best studied. They are required to produce new cells for the intestinal lining as older ones wear out every two to five days.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"It's a hell of an environment," Capecchi says. "Food is being thrown in there, and enzymes to break down that food. This is a way of maintaining the intestine intact."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The intestinal adult stem cells give rise to various cells in the small intestine: cells to absorb foods; cells to secrete mucus that make the lining smooth and protect it; cells involved in protecting the organism against bacteria and other disease organisms; and cells that produce substances involved in communication among cells.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But researchers have had trouble identifying the stem cells so they can be studied.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Adult stem cells are a giant black box," Sangiorgi says.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Hijacking a Gene to Unveil Stem Cells&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dutch researchers recently found a "marker" named Lgr5 to label intestinal stem cells. Sangiorgi and Capecchi used a similar method but a different "marker" - a gene name Bmi1 - which is "expressed" or activated in adult stem cells in the intestinal lining.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Labelling stem cells containing the Bmi1 gene involved tamoxifen, a drug used to treat and prevent breast cancer. Tamoxifen was used to activate an enzyme in cells that contain the Bmi1 gene so that the cells appeared blue when viewed under a microscope...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/09/20529/Caution_on_stem_cell_therapy/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-5752408704455963110?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/5752408704455963110/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=5752408704455963110' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/5752408704455963110'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/5752408704455963110'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/06/weekly-bionews-9-16-june-2008.html' title='Weekly BioNews 9 - 16 June 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-1249558131777888247</id><published>2008-06-09T05:18:00.002+03:00</published><updated>2008-06-09T05:31:46.109+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 2 - 9 June 2008</title><content type='html'>&lt;div align="center"&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- New fingerprint breakthrough by forensic scientists&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 2, 2008 09:30 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Forensic scientists at the University of Leicester, working with Northamptonshire Police, have announced a major breakthrough in crime detection which could lead to hundreds of cold cases being reopened.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The University's Forensic Research Centre has been working with Northamptonshire Police's scientific support unit to develop new ways of taking fingerprints from a crime scene. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers in the University Department of Chemistry and the Police's scientific support unit have developed the method that enables scientists to 'visualise fingerprints' even after the print itself has been removed. They conducted a study into the way fingerprints can corrode metal surfaces. The technique can enhance – after firing– a fingerprint that has been deposited on a small calibre metal cartridge case before it is fired. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Wiping it down, washing it in hot soapy water makes no difference - and the heat of the shot helps the process we use. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The procedure works by applying an electric charge to a metal - say a gun or bullet - which has been coated in a fine conducting powder, similar to that used in photocopiers. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Even if the fingerprint has been washed off, it leaves a slight corrosion on the metal and this attracts the powder when the charge is applied, so showing up a residual fingerprint...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/02/new_fingerprint_breakthrough_by_forensic_scientists.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Cartilage regeneration&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 05/06/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Bioengineers at Rice University have discovered that intense pressure -- similar to what someone would experience more than a half-mile beneath the ocean's surface -- stimulates cartilage cells to grow new tissue with nearly all of the properties of natural cartilage. The new method, which requires no stem cells, may eventually provide relief for thousands of arthritis sufferers."This tissue-engineering method holds promise not only for cartilage but also for tissues to repair bladders, blood vessels, kidneys, heart valves, bones and more," said lead researcher Kyriacos Athanasiou, Rice's Karl F. Hasselmann Professor of Bioengineering.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The findings appear this week in the journal PLoS ONE. They are the latest from the emerging field of tissue engineering, a new discipline that aims to capitalize on the body's innate healing abilities to develop new ways of growing tissues that can be used to surgically repair wounds without risk of rejection.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cartilage, a tissue in the human body that cannot heal itself, has long been a target of tissue engineers. Cartilage is the skeleton's shock absorber, and its stiffness, strength and other mechanical properties derive not from living cartilage cells but from the densely woven matrix of collagen and proteoglycan that surrounds them. This extracellular matrix, or ECM, is produced during cartilage development in children, but cannot be repaired following injury in adulthood.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Injured cartilage often serves as the focal point for arthritis formation, so tissue engineers have long sought a means of growing new cartilage that can be transplanted into adults to repair damaged joints before arthritis can develop. Unfortunately, cartilage is difficult to engineer, in part because there are no natural healing processes to mimic.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Athanasiou's Musculoskeletal Bioengineering Laboratory has focused on cartilage for more than 10 years, and he said the new process is the first he has studied that produces cartilage that's almost identical to the body's own tissue.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"The combination of hydrostatic pressure and growth factors used in this process result in an engineered cartilage ECM with properties nearly identical to that of native cartilage," he said. "This research appears very promising for treating arthritis, as cartilage can now be produced in our lab that is almost identical in composition to native tissue."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;So far, the process has been tried only with cells from cows and has yet to be tested in live animals. Athanasiou cautions that it will be several years before the process will be ready for clinical testing in humans.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The new findings are based on three years of data collected by graduate student Benjamin Elder, who is simultaneously earning a doctorate in bioengineering at Rice and a medical degree at Baylor College of Medicine under Rice and Baylor's Medical Scientist Training Program...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/05/20516/Cartilage_regeneration/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Hairy blobs in acidic hell&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 05/06/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Close-up, they look like something out of a 1950s B-movie. Colonies of fossilised creatures, dubbed "hairy blobs", have been discovered in one of the harshest environments on Earth. The find may turn out to be crucial for spotting signs of extraterrestrial life in rocks on other planets.Kathleen Benison, a geologist at Central Michigan University, Mount Pleasant, led a team that studied the sediments formed by acidic and very salty lakes in modern day Western Australia, and those deposited around 250 million years ago in North Dakota. It is very difficult to survive in such a tough environments and few signs of life have ever been found in these sorts of lakes.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Inside the halite and gypsum "evaporate" minerals, which form as the lake waters dry up, Benison and colleagues found previously unknown fossilised blobs at both the modern and ancient sites, ranging in size from 0.05 to 1.5 millimetres. They were made up of a mix of inorganic crystals and "hairs" stuck together in a mass (pictured). They named them hairy blobs.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The team argues that each hair was in fact a separate microorganism because the hair fossils are made of disordered graphite which, unlike inorganic graphite, has irregular layers that suggest it was once a live organism..&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Many of the hairs are coated with crystals of gypsum, a calcium sulphate mineral. This link with gypsum suggests that the microorganisms were fuelled by chemical interactions with sulphur in the acidic water - which helped the gypsum to form.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The team also found previously undescribed microorganisms in the lake water, which they say may be the cells that end up as fossilised hairs (Astrobiology, DOI: 10.1089/ast.2006.0034).&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Conditions in acidic saline lakes such as those studied by the team are thought to be similar to those on ancient Mars. The many probes currently exploring the Red Planet have discovered that Martian seas and lakes, such as those once found at Meridiani Planum, were strikingly similar in terms of acidity, salinity and the minerals and sediments present.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Benison says the hairy blobs from the Permian halite seem well preserved. "This argues for long-term preservation of microfossils in halite elsewhere, perhaps even on Mars." Had the organisms lived on Mars, she says, the inorganic minerals surrounding them would have acted as protection from the ultraviolet radiation there...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/06/05/20515/Hairy_blobs_in_acidic_hell/"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Talking to cells&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 5, 2008 08:17 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;For an organism to develop and function, the individual cells must exchange information, or communicate, with each other. Is it possible to learn their language and "talk to" the cells?&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Yes it is: Cameron Alexander and George Pasparakis at the University of Nottingham (UK) have been able to facilitate a conversation between bacterial cells and artificial polymer vesicles. In the journal Angewandte Chemie they report that this first communication occurred by way of sugar groups on the vesicle surface. The vesicles subsequently transfer information to the cells—in the form of dye molecules. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Complex structures made of many sugar components on the surfaces of cells are the "language" used for processes such as cell recognition, for example, in the differentiation of tissues or the identification of endogenous cells and foreign invaders. Scientists would like to be able to use this glycocode to "address" target cells and to intervene directly in cellular processes to treat diseases or to guide regeneration of damaged tissues. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The British scientists took an interesting route to learn more about the "language" of cells: they constructed vesicles, tiny capsules whose outer shell is made of special polymer building blocks. Their special trick: the polymer chains are equipped with side chains bearing glucose units that wind up being exposed on the vesicle surface. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The researchers brought the vesicles together with bacteria that have glucose-binding proteins on their surface. The behavior of the bacteria varies depending on the polymer's composition and the size of the vesicles. Among the bacteria were some individuals that enter into very strong bonds with large vesicles. These associated bacteria are then in a position to receive molecular "information" from the vesicles: dye molecules that were previously placed in the vesicles transferred specifically into the interior of these bacteria...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="143" alt="" src="http://www.sciencedaily.com/images/2008/06/080605105207.jpg" width="300" /&gt;&lt;/p&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;em&gt;The British scientists took an interesting route to learn more about the "language" of cells: they constructed vesicles, tiny capsules whose outer shell is made of special polymer building blocks. Their special trick: the polymer chains are equipped with side chains bearing glucose units that wind up being exposed on the vesicle surface. (Credit: Copyright Wiley-VCH)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Full Article &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/05/talking_to_cells.html"&gt;Source 1&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080605105207.htm"&gt;Source 2&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Measuring the footprint of cells&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 7, 2008 04:22 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Even the slightest differences are important in competitive sport: To improve a ski jumper's performance, the trainer can analyze the jump very accurately using force sensors. Researchers in Jena and Bremen are planning something similar. However, their work is not with athletes but with tiny somatic cells. The experts have developed a low-cost optical sensor to measure the force with which migrating cells push themselves away from an underlying surface. Force analysis devices like these could one day help to identify specific cell types – more reliably than using a microscope or other conventional methods.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The sensor is the outcome of an EU project. It consists of a smooth surface that is studded with 250,000 tiny plastic columns measuring only five microns in diameter, rather like a fakir's bed of nails. These columns are made of elastic polyurethane plastic. When a cell glides across them, it bends them very slightly sideways. This deflection is registered by a digital camera and analyzed by a special software program. The researchers working with project manager Dr. Norbert Danz of the Fraunhofer Institute for Applied Optics and Precision Engineering IOF in Jena have already shown that their 'Cellforce' sensor works. It will be the task of initial biological tests to show how different cell types behave. "Analysis of cell locomotion is important for numerous applications," says Danz. "It could be used to check whether bone cells are successfully populating an implant, or how well a wound is healing."&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img src="http://www.biologynews.net/archives/2008/06/07/8579_rel.jpg" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;The sensor is covered with 250,000 tiny plastic columns only five microns in diameter. When a cell creeps across the tips of the columns, it presses each column very slightly sideways. Credit: © Fraunhofer IFAM&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/07/measuring_the_footprint_of_cells.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Microspheres to carry hydrogen, deliver drugs, filter gases and detect nuclear development&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 7, 2008 04:22 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;What looks like a fertilized egg, flows like water, gets stuffed with catalysts and exotic nanostructures and may have the potential of making the current retail gasoline infrastructure compatible with hydrogen-based vehicles of the future – not to mention also contributing to arenas such as nuclear proliferation and global warming?&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The answer is contained in the June issue of The Bulletin, the monthly magazine of The American Ceramic Society, which carries the first news of a never-before-seen class of materials and technology developed by scientists at the Savannah River National Laboratory.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;The full article can be downloaded at &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.ceramics.org/ASSETS/A9168BABB2A549B59FA6B88F1887D50C/06_08_Wicks.pdf"&gt;http://www.ceramics.org/ASSETS/A9168BABB2A549B59FA6B88F1887D50C/06_08_Wicks.pdf&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;This unique material, dubbed Porous Wall-Hollow Glass Microspheres (PW-HGM), consists of porous glass 'microballoons' that are smaller than the diameter of a human hair. The key characteristic of these 2-100 micron spheres is an interconnected porosity in their thin outer walls that can be produced and varied on a scale of 100 to 3,000 Angstroms. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;SRNL Researchers G.G. Wicks, L.K. Heung, and R.F. Schumacher have been able to use these open channels to fill the microballons with gas absorbents and other materials. Hydrogen or other reactive gases can then enter the microspheres through the pores, creating a relatively safe, contained, solid-state storage system... &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img src="http://www.biologynews.net/archives/2008/06/07/8587_rel.jpg" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;em&gt;SRNL researchers removed the top of a glass microsphere to show how palladium has easily passed through the sphere's pores and assembled itself into a new nanostructure.&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/07/microspheres_to_carry_hydrogen_deliver_drugs_filter_gases_and_detect_nuclear_development.html"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Molecular 'Ratcheting' Of Single Ribosome Molecules Observed In Act Of Building Proteins&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Jun. 6, 2008) &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers have reported that they are the first to observe the dynamic, ratchet-like movements of single ribosomal molecules in the act of building proteins from genetic blueprints.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Their study, published in the journal Molecular Cell, reveals a key mechanism in the interplay of molecules that allows cells to build the proteins needed to sustain life.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cells use a variety of tools to build proteins, beginning with messenger RNA, a ribbon-like molecule that codes for the sequence of amino acids in the protein. Another molecule, transfer RNA (tRNA) is uniquely qualified to read this code, but can do so only within the confines of the ribosome. Transfer RNAs bring individual amino acids into the ribosome where they are assembled into proteins. Various other proteins also participate in the process.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;When protein translation occurs, single tRNAs enter specific sites in the ribosome, read the code and deliver their amino acids – one by one – to a growing protein chain. The ribsome transits along the messenger RNA as the protein is built, releasing the “deacylated” tRNA through an exit site.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A ribosome is made up of two subunits composed of ribonucleic acids (RNAs) and about 50 individual proteins....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080605181153.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- New Way To Think About Earth's First Cells&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Jun. 6, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A team of researchers at Harvard University have modeled in the laboratory a primitive cell, or protocell, that is capable of building, copying and containing DNA.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Since there are no physical records of what the first primitive cells on Earth looked like, or how they grew and divided, the research team's protocell project offers a useful way to learn about how Earth's earliest cells may have interacted with their environment approximately 3.5 billion years ago.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The protocell's fatty acid membrane allows chemical compounds, including the building blocks of DNA, to enter into the cell without the assistance of the protein channels and pumps required by today's highly developed cell membranes. Also unlike modern cells, the protocell does not use enzymes for copying its DNA.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Led by Jack W. Szostak of the Harvard Medical School, the research team published its findings in the June 4, 2008, edition of the journal Nature's advance online publication.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Szostak's group took a creative approach to this research challenge and made a significant contribution to our understanding of small molecule transport through membranes," said Luis Echegoyen, director of the NSF Division of Chemistry.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Some scientists have proposed that ancient hydrothermal vents may have been sites where prebiotic molecules--molecules made before the origin of life, such as fatty acids and amino acids--were formed.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;When fatty acids are in an aqueous environment, they spontaneously arrange so that their hydrophilic, or water-loving, "heads" interact with the surrounding water molecules and their hydrophobic, or water-fearing, "tails" are shielded from the water, resulting in the formation of tiny spheres of fatty acids called micelles.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Depending upon chemical concentrations and the pH of their environment, micelles can convert into layered membrane sheets or enclosed vesicles. Researchers commonly use vesicles to model the cellular membranes of protocells...&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="226" alt="" src="http://www.sciencedaily.com/images/2008/06/080604140959.jpg" width="300" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;Above is a three-dimensional view of a model protocell approximately 100 nanometers in diameter. The protocell's fatty acid membrane allows nutrients and DNA building blocks to enter the cell and participate in non-enzymatic copying of the cell's DNA. The newly formed strands of DNA remain in the protocell. (Credit: Janet Iwasa, Szostak Laboratory, Harvard Medical School and Massachusetts General Hospital)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080604140959.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Possible New Approach To Purifying Drinking Water, Thanks To Genetic Tool&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Jun. 9, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A genetic tool used by medical researchers may also be used in a novel approach to remove harmful microbes and viruses from drinking water.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In a series of proof-of-concept experiments, Duke University engineers demonstrated that short strands of genetic material could successfully target a matching portion of a gene in a common fungus found in water and make it stop working. If this new approach can be perfected, the researchers believe that it could serve as the basis for a device to help solve the problem of safe drinking water in Third World countries without water treatment facilities.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The relatively new technology, known as RNA interference (RNAi), makes use of short snippets of genetic material that match -- like a lock and key -- a corresponding segment of a gene in the target. When these snippets enter a cell and attach to the corresponding segment, they can inhibit or block the action of the target gene. This approach is increasingly being used as a tool in biomedical research, but has not previously been applied to environmental issues.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Pathogens, whether bacterial or viral, represent one of the major threats to drinking water in developed and undeveloped countries," said Sara Morey, a Ph.D. candidate in the lab of Claudia Gunsch, assistant professor of civil engineering at Duke's Pratt School of Engineering. "Our data showed that we could silence the action of a specific gene in a fungus in water, leading us to believe that RNAi shows promise as a gene-silencing tool for controlling the proliferation of waterborne bacteria and viruses."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Morey presented the results of her experiments June 3, 2008, during the annual meeting of the American Society of Microbiology in Boston...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/06/080603104414.htm"&gt;Full Article &lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-1249558131777888247?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/1249558131777888247/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=1249558131777888247' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1249558131777888247'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/1249558131777888247'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/06/weekly-bionews-2-9-june-2008.html' title='Weekly BioNews 2 - 9 June 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6087310466410543764</id><published>2008-06-02T10:05:00.002+03:00</published><updated>2008-06-02T10:19:13.701+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 26 - 03 May - Jun 2008</title><content type='html'>&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Life, but not as we know it?&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;May 28, 2008 04:32 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at The University of Nottingham have taken some important first steps to creating a synthetic copycat of a living cell, a leading science journal reports.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr Cameron Alexander and PhD student George Pasparakis in the University's School of Pharmacy have used polymers — long-chain molecules — to construct capsule-like structures that have properties mimicking the surfaces of a real cell. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In work published as a 'VIP paper' in the journal Angewandte Chemie International Edition, they show how in the laboratory they have been able to encourage the capsules to 'talk' to natural bacteria cells and transfer molecular information. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The breakthrough could have a number of potential medical uses. Among them could be the development of new targeted drug delivery systems, where the capsules would be used to carry drug molecules to attack specific diseased cells in the body, while leaving healthy cells intact, thereby reducing the number of side affects that can be associated with treatments for life-threatening illnesses such as cancer. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The technology could also be used as an anti-microbial agent, allowing doctors to destroy harmful bacteria, without attacking other health-promoting bacteria in the body, which could offer a new weapon in the fight against superbugs.... &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/05/28/life_but_not_as_we_know_it.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Mind over matter: Monkey feeds itself using its brain&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;May 28, 2008 04:32 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A monkey has successfully fed itself with fluid, well-controlled movements of a human-like robotic arm by using only signals from its brain, researchers from the University of Pittsburgh School of Medicine report in the journal Nature. This significant advance could benefit development of prosthetics for people with spinal cord injuries and those with “locked-in” conditions such as Lou Gehrig’s disease, or amyotrophic lateral sclerosis. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“Our immediate goal is to make a prosthetic device for people with total paralysis,” said Andrew Schwartz, Ph.D., senior author and professor of neurobiology at the University of Pittsburgh School of Medicine. “Ultimately, our goal is to better understand brain complexity.” &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Previously, work has focused on using brain-machine interfaces to control cursor movements displayed on a computer screen. Monkeys in the Schwartz lab have been trained to command cursor movements with the power of their thoughts. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“Now we are beginning to understand how the brain works using brain-machine interface technology,” said Dr. Schwartz. “The more we understand about the brain, the better we’ll be able to treat a wide range of brain disorders, everything from Parkinson’s disease and paralysis to, eventually, Alzheimer’s disease and perhaps even mental illness.” &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Using this technology, monkeys in the Schwartz lab are able to move a robotic arm to feed themselves marshmallows and chunks of fruit while their own arms are restrained. Computer software interprets signals picked up by probes the width of a human hair. The probes are inserted into neuronal pathways in the monkey’s motor cortex, a brain region where voluntary movement originates as electrical impulses. The neurons’ collective activity is then evaluated using software programmed with a mathematic algorithm and then sent to the arm, which carries out the actions the monkey intended to perform with its own limb. Movements are fluid and natural, and evidence shows that the monkeys come to regard the robotic device as part of their own bodies. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/05/28/mind_over_matter_monkey_feeds_itself_using_its_brain.html"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Rapid wound healing&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;May 29, 2008 04:46 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In Germany alone, about three million – mostly elderly – patients suffer from poorly healing large-area wounds caused by complaints such as diabetes, burns or bedsores. The wounds can be treated with conventional collagen dressings or polylactic acid dressings, but the success rate is not as good as it should be.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A new type of dressing made of silica gel fibers, developed by scientists at the Fraunhofer Institute for Silicate Research ISC in Wurzburg, shall solve the problem. This novel dressing has many advantages: it is shape-stable, pH-neutral and 100 percent bioresorbable. Once applied it remains in the body, where it gradually degrades without leaving any residues. What’s more, the fibre fleece provides the healthy cells around the edges of the wound with the structure they additionally need for a proper supply of growth-supporting nutrients. To prevent any infection, treatment of the wound must be absolutely sterile. “As only the outer bandage needs to be changed, the risk of contaminating the wound is low,” explains Dr. Jorn Probst of the ISC. And thanks to the supporting matrix for the cells, the chances of a scar-free natural closure of the wound are very good. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The fibers are produced by means of wet-chemical material synthesis, a sol-gel process in which a transparent, honey-like gel is produced from tetraethoxysilane (TEOS), ethanol and water in a multi-stage, acidically catalyzed synthesis process. The gel is processed in a spinning tower: “We press it through fine nozzles at constant temperatures and humidity levels,” explains Walther Glaubitt, the inventor of the silica gel fibers. “This produces fine endless threads which are collected on a traversing table and spun in a specific pattern to produce a roughly A4-sized multi-layer textile web.” The dressings are then cut, packed and sterilized. Dr. Jorn Probst and Dipl.-Ing. Walther Glaubitt will receive the Joseph von Fraunhofer Prize 2008 for developing the biocompatible dressing..... &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.biologynews.net/archives/2008/05/29/rapid_wound_healing.html"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- New stem cell therapy may aid the repair of damaged brains&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;June 1, 2008 03:44 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;According to some experts, newly born neuronal stem cells in the adult brain may provide a therapy for brain injury. But if these stem cells are to be utilized in this way, the process by which they are created, neurogenesis, must be regulated. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A new study, led by Laurence Katz, Co-Director of the Carolina Resuscitation Research Group at the University of the North Carolina School of Medicine, suggests a way in which this might be achieved. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;According to the research, neurogenesis can be regulated through induced hypothermia. In rat subjects, a mild decrease in body temperature was found to substantially decrease the proliferation of newly-born neurons, a discovery that marks a major step forward for the development of neuronal stem cell-based brain therapies. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Since the 1930s, brain damage from stroke, head injury, near drowning and cardiac arrest was considered to be permanent because of a lack of repair mechanisms like other parts of the body. However, discovery of neuronal stem cells in the adult brain challenges that belief. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“Many questions remain before we adequately understand how to control these cells to repair a damaged brain,” says Katz. “However, the findings represent an important step in demonstrating that these cells can be controlled by simple external forces like hypothermia.....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/06/01/new_stem_cell_therapy_may_aid_the_repair_of_damaged_brains.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt; - Sticky Business: Researchers Devise New Way Of Mapping The Viscosity Of Cells&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (May 30, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A fluorescent dye can be used to map how viscous, or 'gloopy', different parts of a cell are, according to new research published in the Journal of the American Chemical Society.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Changes in viscosity have been linked to disease and malfunction in human cells. For example, changes in the viscosity of the membranes of red blood cells have been observed in diabetes patients. Knowing more about these changes could lead to a greater understanding of how some diseases affect the human body.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Now a team of scientists from Imperial in collaboration with Kings College London has demonstrated that a fluorescent dye can be used to show how viscous different parts of a cell are, compared to one another.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The dye is made of a molecule which has a component that can freely rotate or naturally spin, like a molecular rotor. The researchers demonstrated that the speed of rotation of this molecule can be used to monitor local viscosity.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;One of the lead authors on the paper, Dr Gokhan Yahioglu from Imperial's Department of Chemistry and the Imperial spin-out company PhotoBiotics Ltd explains: "We have taken a molecule often used as a fluorescent marker in cells and used it as a true molecular rotor where the intensity and duration of the molecule's fluorescence is strongly linked to the viscosity of the cell into which it is introduced. This means we have developed a sensitive and versatile method for measuring the local micro-viscosity in biological systems....&lt;/div&gt;&lt;p align="center"&gt;&lt;img height="494" alt="" src="http://www.sciencedaily.com/images/2008/05/080523201301.jpg" width="300" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;em&gt;The flourescent dye is used to map viscosity in human ovarian cancer cells. (Credit: Image courtesy of Imperial College London)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080523201301.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Olfactory Receptor Neurons Select Which Odor Receptors To Express&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (May 31, 2008) &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Scientists have looked at the problem of understanding the regulatory mechanisms that create different cells from a single template by using the olfactory system of the fruit fly. The ability to discriminate odors depends on receptor cells expressing different patterns of receptor genes, despite each cell having the same genes. Receptor patterns are controlled by DNA sequences upstream of the receptor genes.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;It may appear difficult to reconcile the fact that almost every cell in the body of an animal has an identical dose of genes with the variety of different appearances and properties cells can display--bone, skin, hair, muscle, and many more. This may seem even more complex given that all of these tissue types derive originally from a single fertilized egg cell. Understanding the many regulatory mechanisms that create different cells from a single template is the work of developmental biology.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A new paper looks at this problem in the olfactory system of the fruit fly, where the ability to discriminate odors depends on receptor cells expressing different patterns of receptor genes, despite each cell having the same set of genes to choose from. The paper, by Anandasankar Ray and colleagues at Yale University, shows that receptor patterns are controlled by DNA sequences upstream of the receptor genes.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the fruit fly Drosophila, there are two organs involved in smell: the antennae and the maxillary palps--the latter being part of the mouth. In these palps, there are always six types of neurons, cells that transmit information from the sensing part to the brain. Each type of neuron has a different, predictable pattern of olfactory receptors. How a neuron knows which receptors to express was, until now, a mystery.....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080527201826.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Invasion Strategy Of World's Largest Virus Revealed&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (May 31, 2008) &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A Weizmann Institute study provides important new insights into the process of viral infection. The study, reported in the online journal PLoS Biology, reveals certain mechanisms by which mimivirus – a virus so called because it was originally thought to mimic bacteria in various aspects of their behavior – invades amoeba cells.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Living cells become infected by viruses in two steps. First, the virus penetrates the cell. Next, in the second and crucial step, the cell starts producing new viruses, which spread and infect additional cells. At the beginning of this production process, the cell makes the outer wall of the virus, which is a container of sorts composed of proteins and known as the capsid. The cell then makes copies of viral DNA and inserts it into the capsid. The result is a new, functioning virus that is ready to leave the host cell and infect more cells.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Understanding how viruses infect cells and how new viruses are produced in the course of the infection allows scientists to interrupt the infection cycle, blocking viral diseases. One of the difficulties, however, is that the invasion strategies of different viruses greatly vary from one another.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The mimivirus, known, among other things, for its exceptional size – it is five to ten times larger than any other known virus – poses an interesting challenge in this respect. This virus was discovered only in the late twentieth century, as its extraordinary size made it impossible to identify it by regular means. In addition, it contains much more genetic material than other viruses, a feature that forces the mimivirus to develop particularly efficient methods for introducing its viral DNA into the host cell and for inserting the genetic “parcel” into the protein container during the production of new viruses in the host cell....&lt;/div&gt;&lt;p align="center"&gt;&lt;img height="229" src="http://www.sciencedaily.com/images/2008/05/080531090353-large.jpg" width="470" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;(A) TEM image of cryo-fixed sectioned and stained extracellular Mimivirus particles revealing a star-shaped structure at a unique vertex. (B) Cryo-TEM image of a whole vitrified fiber-less Mimivirus. (C) SEM image of the star-shaped structure in a mature extracellular Mimivirus particle. (D) Cryo-SEM of an immature, fiber-less particle. (E) Tomographic slice of a mature intracellular Mimivirus particle captured at a late (12 h post infection) infection stage. As shown in Video S1, at this late stage the host cell is packed with mature viral particles. (F and G) Volume reconstruction of the particle shown in (E), revealing the presence of an outer (red) and inner (orange) capsid shells. The star-shaped structure is present in both shells but adopts partially open (dark, star-like region), and completely sealed configurations in the outer and inner shells, respectively. (H) Superposition of the two shells in (F) and (G). (Credit: Distinct DNA Exit and Packaging Portals in the Virus Acanthamoeba polyphaga mimivirus Zauberman N, Mutsafi Y, Halevy DB, Shimoni E, Klein E, et al. PLoS Biology Vol. 6, No. 5, e114 doi:10.1371/journal.pbio.0060114)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080531090353.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Fruit Fly Protein Acts As Decoy To Capture Tumor Growth Factors&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (Jun. 2, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at the University of Pennsylvania School of Medicine have shown how Argos, a fruit fly protein, acts as a 'decoy' receptor, binding growth factors that promote the progression of cancer. Knowing how Argos neutralizes tumor growth may lead to new drug designs for inhibiting cancer. The study appeared online in Nature in advance of print publication.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Many types of tumors grow because of over-expression of a protein known as the epidermal growth factor receptor (EGFR) or a peptide hormone called epidermal growth factor (EGF) that binds and activates EGFR. Argos mimics EGFR by binding to EGF. But, unlike EGFR, Argos does not signal cells to grow.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In theory, surmise the researchers, a drug designed to resemble Argos could bind cancer growth factors and prevent them from signaling cancer cell growth. The investigators previously found that Argos works this way in the fruit fly, binding and neutralizing the fly version of EGF called Spitz. Inhibition of Spitz in this way is crucial for proper development of the fly eye.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"There are several 'designer' cancer drugs that fight tumors driven by EGFR-like receptors, such as Herceptin, Erbitux and Tarceva," says lead author Mark A. Lemmon, PhD, Professor of Biochemistry and Biophysics. "Whereas these drugs all attack the receptor itself, an Argos-like drug would instead neutralize the cancer growth factor by mimicking a silent receptor. This is a change in paradigm for tumor-growth inhibition in this class of cancers."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Approaches using molecules that neutralize growth factors have proven themselves in other cases. The Avastin antibody works well to block the molecule that activates the vascular endothelial growth factor receptor and several drugs can block tumor necrosis factor-α in arthritis, including Remicade, Humira and Enbrel. An Argos-like drug would work the same way in EGFR signaling, suggests Lemmon....&lt;/div&gt;&lt;p align="center"&gt;&lt;img src="http://www.sciencedaily.com/images/2008/05/080528155632-large.jpg" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;How Argos, a fruit fly protein, acts as a "decoy" receptor, binding and neutralizing growth factor molecules (green) that promote the progression of cancer. (Credit: Mark Lemmon, &lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080528155632.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Encephalitis vaccines produced&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 30/05/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;University of Texas Medical Branch at Galveston researchers have developed new vaccines to protect against West Nile and Japanese encephalitis viruses. The investigators created the vaccines using an innovative technique that they believe could also enable the development of new vaccines against other diseases, such as yellow fever and dengue fever, which are caused by similar viruses.The scientists showed that the vaccines successfully protected laboratory mice and hamsters against the viruses, which can cause fatal brain inflammation in humans. They reported their findings in back-to-back papers published in the current issue of the journal Vaccine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"These vaccines were created using a system that we think is applicable to producing vaccines that can protect against a wide range of diseases caused by the flaviviruses, an important family of viruses that afflict populations throughout the world," said UTMB pathology professor Peter Mason, senior author of the Vaccine papers. "Flaviviruses cause tremendous human suffering, but we still only have vaccines for a few of them."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Currently approved flavivirus vaccines are either "live-attenuated virus" vaccines, which contain weakened but still genetically intact versions of the target virus, or "inactivated-virus" vaccines, which contain viruses that have been chemically neutralised. In each case, the viral material stimulates the immune system to block the progress of any future infection by the virus in question.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The new vaccines - based on a concept devised by Mason and UTMB microbiology and immunology associate professor Ilya Frolov - are known as "single-cycle" or "pseudoinfectious" vaccines, and contain flaviviruses that have been genetically modified so that each virus can only infect a single cell. Unable to spread from cell to cell and create disease, these crippled viruses nonetheless continue to copy themselves within the cells they infect, thus producing the viral proteins needed to induce immune protection.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"With these vaccines, we mimic a viral infection and get amplification of the antigens that are important for stimulating an immune response without amplification of the virus," Mason said....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/05/30/20496/Encephalitis_vaccines_produced/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Tumor suppressor genes&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 30/05/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Mayo Clinic researchers have developed an animal model that can test the function of two prominent tumor suppressor genes, p16 and p19, in the aging process. Scientists knew that both these genes were expressed at increased levels as humans and mice age, but their role in the ageing process was not clear. Findings by the Mayo team show that p16 provides gas to accelerate cellular ageing, while p19 stops that process.The findings, to be published May 30 in the online issue of Nature Cell Biology, could help explain the development of some characteristics associated with ageing, such as loss of muscle mass and strength or cataracts, and how they might be retarded.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Scientists interested in ageing have developed mice that lack p16 or p19, but these mice were not suitable for studies on ageing because they all die of cancer before they even begin to age," says the study's first author, Darren Baker, a laboratory technician at Mayo Clinic and a doctoral candidate. "By crossing these mice with a mouse strain that ages five times faster than normal due to a mutation in the BubR1 gene, we were able to bypass this problem."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;While other genes are involved in ageing, the researchers firmly established that when too much p16 is produced, tissues start to age. Instead of driving ageing, the p19 gene was found to counteract the effects of p16. This was completely unexpected, says Jan van Deursen, Ph.D., a molecular biologist at Mayo Clinic, because tissue culture experiments had predicted that p19 expression promotes ageing....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/05/30/20494/Tumor_suppressor_genes/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Nature's blowtorch&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 30/05/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Uncontrolled reaction of organic compounds with oxygen is easy: we call it fire. But nature often needs to do oxidations very specifically, adding oxygen to a particular carbon atom in a complicated molecule without disturbing anything else. Usually, this job falls to an enzyme called cytochrome P450. Because cytochrome P450 can catalyse molecular oxidations with pinpoint accuracy, it has been called "nature's blowtorch," and its job is analogous to that of a welder doing a tricky repair in a highly flammable wooden house. It needs to do the repair without burning itself or the house.Brandeis University researchers have been trying to understand the details of how P450 does this job so efficiently; that is, "burning" the right places in the target molecule (substrate) while not "burning down the house."&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In new research online in the Cell Press journal Structure, chemistry graduate student Bo OuYang, along with fellow grad student Marina Dang and advisors Thomas and Susan Pochapsky, describe a new insight into how P450 works. The researchers discovered that the protein chain in P450 can change its structure by a 180 degree rotation around a single peptide bond. In one orientation, both oxygen and the molecule to be oxidised (substrate) can get in and out of the P450 active site, but the oxygen is not "activated," that is, it is not in a state to react with the substrate (or anything else, for that matter).&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the other orientation, however, the substrate is held tightly in the correct orientation for the oxidation, and the oxygen can be activated to do "the burn." The activated form of the molecule is generated by binding a helper protein, called Pdx, to the P450. This binding drives the reorientation around the peptide bond, and moves the P450 from the form in which substrate binds to the active form. After the reaction is finished, the Pdx falls off, the P450 moves back to the unactivated state, and the oxidised products are free to leave...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/05/30/20497/Nature"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-6087310466410543764?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/6087310466410543764/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=6087310466410543764' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6087310466410543764'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/6087310466410543764'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/06/weekly-bionews-26-03-may-jun-2008.html' title='Weekly BioNews 26 - 03 May - Jun 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-2151107019734761944</id><published>2008-05-26T08:16:00.002+03:00</published><updated>2008-05-26T08:26:23.211+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Weekly BioNews'/><title type='text'>Weekly BioNews 19 - 26 May 2008</title><content type='html'>&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Scientists 'paint' viruses to track their fate in the body&lt;/span&gt;&lt;/strong&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;May 20, 2008 05:40 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Biologists from Austria and Singapore developed a technique that adds a new twist on the relationship between biology and art. In an article recently published online in The FASEB Journal (&lt;a href="http://www.fasebj.org/"&gt;http://www.fasebj.org&lt;/a&gt;) and scheduled for the August 2008 print issue, these researchers describe how they were able to coat—or paint—viruses with proteins. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;This breakthrough should give a much-needed boost to the efficiency of some forms of gene therapy, help track and treat viral disease and evolution, improve the efficiency of vaccines, and ultimately allow health care professionals track the movement of viral infections within the body. Specifically, the new method should make it easier to track and treat infectious diseases such as HIV/AIDS, influenza, hepatitis C, and dengue fever. And because viruses can also be used to introduce biotechnology drugs and replacement genes, and act as vaccines, this research should lead to new treatments for cancer, cardiovascular, metabolic and inherited disorders.....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/05/20/scientists_paint_viruses_to_track_their_fate_in_the_body.html"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Fluorescent nano-barcodes could revolutionize diagnostics&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;May 22, 2008 07:31 PM &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A new technology with research and clinical application including the early detection of disease has been invented and developed by University of Queensland researchers. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr Krassen Dimitrov, from UQ's Australian Institute for Bioengineering &amp;amp; Nanotechnology, has developed fluorescent “barcodes” called nanostrings, offers greater sensitivity and accuracy than current detection methods. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The research has been published the prestigious international journal Nature Biotechnology. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Dr Dimitrov said nanostrings bind to RNA molecules for digital gene expression analysis. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“Because this system can count the exact number of biomolecules present we can get an extremely accurate and sensitive picture of gene expression at a particular point in time,” Dr Dimitrov said. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“This quantitative data is superior to other gene expression systems such as microarrays, which rely on the analogue measurement of fluorescence and therefore are less accurate and have a limited range. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;“The nanostring is an important technological development in both clinical and research settings. We will be able to more accurately detect molecules associated with particular diseases and in the research arena, we will be able to identify new molecules associated with diseases and trace these back to the genes responsible." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.biologynews.net/archives/2008/05/22/fluorescent_nanobarcodes_could_revolutionize_diagnostics.html"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Plant Flavonoid In Celery And Green Peppers Found To Reduce Inflammatory Response In The Brain&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (May 23, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers at the University of Illinois report that a plant compound found in abundance in celery and green peppers can disrupt a key component of the inflammatory response in the brain. The findings have implications for research on aging and diseases such as Alzheimer's and multiple sclerosis.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Inflammation can be a blessing or a blight. It is a critical part of the body's immune response that in normal circumstances reduces injury and promotes healing. When it goes awry, however, the inflammatory response can lead to serious physical and mental problems.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Inflammation plays a key role in many neurodegenerative diseases and also is implicated in the cognitive and behavioral impairments seen in aging.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The new study looked at luteolin (LOO-tee-OH-lin), a plant flavonoid known to impede the inflammatory response in several types of cells outside the central nervous system. The purpose of the study was to determine if luteolin could also reduce inflammation the brain, said animal sciences professor and principal investigator Rodney Johnson....&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080520094115.htm"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Many Paths, Few Destinations: How Stem Cells Decide What They'll Become&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (May 24, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;How does a stem cell decide what specialized identity to adopt -- or simply to remain a stem cell? A new study suggests that the conventional view, which assumes that cells are "instructed" to progress along prescribed signaling pathways, is too simplistic. Instead, it supports the idea that cells differentiate through the collective behavior of multiple genes in a network that ultimately leads to just a few endpoints -- just as a marble on a hilltop can travel a nearly infinite number of downward paths, only to arrive in the same valley.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;p align="center"&gt;&lt;img src="http://www.sciencedaily.com/images/2008/05/080521131552-large.jpg" /&gt;&lt;/p&gt;&lt;div align="center"&gt;&lt;em&gt;When exposed to a growth factor, a blood stem cell, represented by a blue marble, falls into a new "attractor state," depicted as a valley in a landscape, to become a red blood cell. Different influences, such as differentiation factors, can lead stem cells to the same attractor state, but each cell can take very different paths though the landscape to get there (just as a marble might take a different path each time it rolls down a hill). (Credit: Children's Hospital Boston)&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The findings, published in the May 22 issue of Nature, give a glimpse into how that collective behavior works, and show that cell populations maintain a built-in variability that nature can harness for change under the right conditions. The findings also help explain why the process of differentiating stem cells into specific lineages in the laboratory has been highly inefficient.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Led by Sui Huang, MD, PhD, a Visiting Associate Professor in the Children's Hospital Boston Vascular Biology Program (now also on the faculty of the University of Calgary), and Hannah Chang, an MD/PhD student in Children's Vascular Biology Program, the researchers examined how blood stem cells "decide" to become white blood cell progenitors or red blood cell progenitors......&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080521131552.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt; Scientists Back The Use Of Maize As An Efficient 'Factory' For Protein-based Pharmaceutical Products&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;ScienceDaily (May 25, 2008)&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Scientists from the Universidad de Lleida (University of Lleida) have published a study supporting the argument that maize seeds are an effective and sure platform within molecular agriculture to alleviate diseases. Over the next few years AIDS could be one of the first diseases to benefit from these results, although regulations for this technology are being developed at the same time as research is being undertaken.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Maize, the third most important cereal in the world, has a great number of advantages for molecular agriculture. Among these are its physiology, its capacity to express recombinant proteins in the seeds, its widespread cultivation and its genetic diversity, as well as being anti-allergenic and non-toxic.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Last March, transgenic maize became the first plant to be developed commercially for medical use. The PNAS review published the following findings: a maize seed with genes from the 2G12 antibody (already known for its capacity to neutralise infection from the virus) could produce antibodies against the transmission of HIV. Researchers from the Departamento de Producción Vegetal y Ciencia Forestal [Department of Plant Production and Forest Science] at the Universidad de Lleida, were those who actually designed this drug during an international project known as Pharma-Planta (made up of 39 European and South African teams), and headed by the British man Paul Christou...&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080525085111.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;strong&gt;- Real-time Observation Of DNA-repair Mechanism&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;ScienceDaily (May 25, 2008)&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;For the first time, researchers at Delft University of Technology have witnessed the spontaneous repair of damage to DNA molecules in real time. They observed this at the level of a single DNA molecule. Insight into this type of repair mechanism is essential as errors in this process can lead to the development of cancerous cells.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers from the Kavli Institute of Nanoscience Delft are to publish an article on this in the journal Molecular Cell.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Cells have mechanisms for repairing the continuous accidental damage occurring in DNA. These damages can vary from a change to a single part of the DNA to a total break in the DNA structure. These breaks can, for instance, be caused by ultraviolet light or X-rays, but also occur during cell division, when DNA molecules split and form two new DNA molecules. If this type of break is not properly repaired it can be highly dangerous to the functioning of the cell and lead to the creation of a cancerous cell.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;One major DNA-repair mechanism involved in repairing these breaks is known as homologous recombination. This mechanism has been observed for the first time by Delft University of Technology researchers in real time and at the level of a single DNA molecule....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.sciencedaily.com/releases/2008/05/080522120610.htm"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Seasonal patterns of flu&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 21/05/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Outbreaks of the most common type of influenza virus, A (H3N2), are seeded by viruses that originate in East and Southeast Asia and migrate around the world, new research has found. This discovery may help to further improve flu vaccines and make the evolution of the virus more predictable.Scientists at the University of Cambridge, in collaboration with scientists from the World Health Organisation (WHO) Global Influenza Surveillance Network, found that each year since 2002 influenza A (H3N2) viruses have migrated out of what the authors call the 'East and Southeast Asian circulation network' (which includes tropical, subtropical, and temperate countries) and spread throughout the world. Their findings are reported in the current edition of Science.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Annual influenza epidemics are thought to infect 5 - 15 per cent of the world population each year, cause 3 to 5 million cases of severe illness, and between 250000 and 500 000 deaths, according to the WHO. The flu vaccine protects the 300 million people vaccinated each year.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Because the flu virus evolves so quickly, there are a number of challenges involved in making the vaccine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In order to create an effective vaccine, each year in February and September a WHO committee meets to select the strains of flu to use in the influenza virus vaccine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;These scientists (many of whom are co-authors on this study) decide which strains pose the greatest threat for the next flu season.....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/05/21/20438/Seasonal_patterns_of_flu/"&gt;Full Article&lt;/a&gt;&lt;br /&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;- Turning back the clock&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Date: 19/05/2008&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Myelin-making Schwann cells have an ability every ageing Hollywood star would envy: they can become young again. According to a study appearing in the May 19 issue of the Journal of Cell Biology, David B. Parkinson (University College London, London, UK) and colleagues have pinned down a protein that returns the cells to their youth, a finding that might help researchers understand why myelin production falters in some diseases.Wrapped around neurons in the peripheral nervous system, Schwann cells can "dedifferentiate" into a state in which they can't manufacture myelin. Reverting to an immature type of cell speeds healing of injured nerves. Researchers knew that the protein Krox-20 pushes immature Schwann cells to specialise and form myelin, but they didn't know what prompts the reversal. One suspect was a protein called c-Jun, which youthful Schwann cells make but Krox-20 blocks.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Parkinson et al. cultured neurons with Schwann cells whose c-Jun gene they could activate. Turning on the gene curbed myelination, suggesting that c-Jun prevents young Schwann cells from growing up. c-Jun also prodded mature Schwann cells to become youthful again, the researchers discovered. Schwann cells that are separated from neurons normally dedifferentiate, but the team found that the cells remained specialised if c-Jun was missing. They suspect that c-Jun works in part by activating Sox-2, as this protein also inhibits myelination.....&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a href="http://www.scientistlive.com/lab/?/Biotechnology/2008/05/19/20409/Turning_back_the_clock/"&gt;Full Article&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-2151107019734761944?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/2151107019734761944/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=2151107019734761944' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2151107019734761944'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/2151107019734761944'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/05/weekly-bionews-19-26-may-2008.html' title='Weekly BioNews 19 - 26 May 2008'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-9023919898952645173</id><published>2008-05-21T12:08:00.001+03:00</published><updated>2008-05-21T12:10:58.918+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Articles'/><title type='text'>Monkeys genetically modified to have Huntington's</title><content type='html'>Sun May 18, 2008 4:10pm EDT&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;By Will Dunham&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;WASHINGTON (Reuters) - Scientists have created monkeys genetically modified to have Huntington's disease in an effort to gain a deeper understanding of the fatal ailment and uncover clues to possible new treatments.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;In the journal Nature on Sunday, the researchers said one of two surviving rhesus macaque monkeys engineered to have the defective gene that causes Huntington's in humans already is showing tell-tale symptoms at age 10 months.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Huntington's -- incurable and hereditary -- is caused by a single abnormal gene in which certain nerve cells in the brain waste away. People are born with the gene but symptoms typically do not appear until middle age.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Researchers often study laboratory animals such as mice to get insights into the underlying biology of diseases. But monkeys and other primates are more similar to people than rodents in physiological, neurological and genetic features.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The scientists at Emory University's Yerkes National Primate Research Center in Atlanta said the monkeys are the first primates genetically modified to have a human disease.&lt;br /&gt;They hope studying the monkeys will allow for greater knowledge of Huntington's and ideas for new drugs.&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;"Rodent species can capture some of the characteristics of the disease, but they have not been satisfactory in being able to really capture the essence of the disease," Stuart Zola, head of the Yerkes center, said in a telephone interview.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"Now we have a genetically modified nonhuman primate that really has captured the clinical signs that we see in patients with Huntington's disease."&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;Those with the progressive, degenerative disease experience uncontrolled movements, emotional disturbances and mental deterioration.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Drugs can help manage symptoms but do not stop the physical and mental decline. People typically die within 10 to 15 years after symptoms arise.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The researchers said they chose Huntington's as the disease for creating the genetically modified monkeys with an eye toward simplicity -- because it is linked to mutations in a single gene rather than multiple genes.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Zola said the achievement could pave the way for creating genetically modified primates with other neurodegenerative ailments such as Parkinson's disease and Alzheimer's disease.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;"This research allows scientists to advance beyond mouse models, which do not replicate all of the changes in the brain and behavior that humans with Huntington's disease experience," said John Harding, a primate resources official at the National Institutes of Health, which funded the study.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Using so-called viral vector technology, the researchers transferred the Huntington's gene into a monkey egg cell. After using in vitro fertilization, the egg grew into a four-cell embryo and was then placed in the womb of a female monkey acting as a surrogate mother.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Of the five baby monkeys born using this process, two died within about a day, another one died in about a month and two are still living at age 10 months, according to Anthony Chan of the Yerkes center and Emory University School of Medicine.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;One of the two surviving monkeys has developed symptoms including involuntary movements of the hands and face, Chan said. The other has no symptoms of the disease yet but may develop them later, he added.&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;(Editing by John O'Callaghan)&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;a href="http://www.reuters.com/article/scienceNews/idUSN1640586620080518"&gt;Article&lt;/a&gt; &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1791467271689801021-9023919898952645173?l=freebiotechnology.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://freebiotechnology.blogspot.com/feeds/9023919898952645173/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=1791467271689801021&amp;postID=9023919898952645173' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9023919898952645173'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1791467271689801021/posts/default/9023919898952645173'/><link rel='alternate' type='text/html' href='http://freebiotechnology.blogspot.com/2008/05/monkeys-genetically-modified-to-have.html' title='Monkeys genetically modified to have Huntington&apos;s'/><author><name>Mr Arkadin</name><uri>http://www.blogger.com/profile/15491707228767238762</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='30' height='32' src='http://bp2.blogger.com/_5C_306IztQU/R2joIeS3RJI/AAAAAAAABb0/f9rqYnViH2I/S220/MrArkadinBLOG.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1791467271689801021.post-6492629171255571123</id><published>2008-05-20T09:58:00.002+03:00</published><updated>2008-05-20T10:05:35.868+03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Articles'/><title type='text'>MPs back hybrid embyro research</title><content type='html'>&lt;div align="justify"&gt;BBC Page last updated at 21:57 GMT, Monday, 19 May 2008 22:57 UK&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;The government has survived two big challenges to its controversial plans to change the law on embryo research for the first time in 20 years. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A cross-party attempt to ban hybrid human animal embryos was defeated on a free vote, by 336 to 176. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Catholic cabinet ministers Ruth Kelly, Des Browne and Paul Murphy voted for a ban. PM Gordon Brown and Tory leader David Cameron both opposed it. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;A bid to ban "saviour siblings" was voted down by 342 votes to 163. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The votes followed two impassioned debates in the committee stage of the Human Fertilisation and Embryology Bill, aimed at updating laws from 1990 in line with scientific advances. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#3333ff;"&gt;'Ethically wrong'&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;On Tuesday, MPs have a further free vote on the emotive issue of cutting the abortion time limit. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Mr Cameron, along with Mr Brown, has backed the use of hybrid embryos as a means to develop treatments for cancer and conditions such as Parkinson's and Alzheimer's disease. They also both support the creation of "saviour siblings". &lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;div align="justify"&gt;However, the majority of the Tory shadow cabinet, including shadow foreign secretary William Hague and shadow home secretary David Davis, backed the unsuccessful attempt to ban hybrids. &lt;/div&gt;&lt;p align="center"&gt;&lt;img height="170" alt="A human embryo" hspace="0" src="http://newsimg.bbc.co.uk/media/images/44667000/jpg/_44667741_humanembryo_spl226b.jpg" width="226" border="0" /&gt;&lt;/p&gt;&lt;p align="center"&gt;&lt;em&gt;Critics say tinkering with human embryos is 'immoral'&lt;/em&gt;&lt;/p&gt;&lt;div align="justify"&gt;&lt;br /&gt;Ex-minister Edward Leigh, who led the fight against the creation of hybrid "admixed" embryos, said they were "ethically wrong and almost certainly medically useless". &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;He said there was "no evidence yet to substantiate" claims the work could lead to treatment for degenerative diseases like Parkinson's and Alzheimer's. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;The bill would allow regulated research using hybrid or "admix" embryos, where the nuclei of human cells are inserted into animal eggs. The resulting embryos would be kept for up to 14 days to harvest stem cells. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;Health Minister Dawn Primarolo says any research done using human embryos "must satisfy the Human Fertilisation and Embryology Authority that it was necessary or desirable". &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;No human "admix" embryo would be implanted into a woman or animal, she says. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;span style="color:#3333ff;"&gt;'Too human'?&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;But Mr Leigh said: "We do not believe that regulation is enough. We believe this is a step too far and therefore should be banned. &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a name="text"&gt;&lt;/a&gt;"In embryos, we do have the genetic make up of a complete human being and we could not and should not be spliced together with the animal kingdom." &lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;a class="bodl" href="http://news.bbc.co.uk/1/hi/uk_politics/7407589.stm#graphic"&gt;How hybrid embryos might be created&lt;/a&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /
